data_2kyx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kyx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.4 HD12 ' CE1' ' A' ' 54' ' ' PHE . 19.1 mt -112.98 160.9 17.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.922 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.764 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.3 t80 -114.87 136.93 52.56 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.763 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.1 t -108.39 123.59 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.681 0.277 . . . . 0.0 110.332 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.07 116.57 2.49 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.37 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 77' ' ' ILE . . . 119.18 41.27 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.759 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 84.8 mt -95.03 -176.91 3.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.616 0.722 . . . . 0.0 112.749 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.56 -171.9 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.651 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.27 4.23 27.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.112 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.99 -21.28 16.32 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG12 ' HB3' ' A' ' 13' ' ' LEU . 7.1 p -90.3 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 111.739 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.556 ' N ' HG21 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -153.15 -174.74 5.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.972 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.36 -30.15 71.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 109.996 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -64.67 -48.63 74.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.416 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.63 -41.78 71.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.945 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD21 ' CE1' ' A' ' 26' ' ' PHE . 2.2 mt -60.52 -35.57 76.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.667 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -60.3 -56.14 25.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.689 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.65 -40.35 84.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.293 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -70.63 -37.76 73.82 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.529 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 4.4 m-85 -95.52 -8.02 36.37 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 23' ' ' HIS . 1.9 tp -63.29 -39.22 48.06 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.687 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 28.1 Cg_endo -61.8 -39.86 49.27 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.54 1.493 . . . . 0.0 111.331 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -74.41 -22.86 58.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.796 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 170.0 129.73 1.14 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.412 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.2 m-20 -60.19 104.06 0.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 111.27 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.481 HD12 ' C ' ' A' ' 26' ' ' PHE . 3.9 mp -59.4 152.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.169 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.458 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -119.47 -31.76 4.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.852 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.93 146.32 23.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.431 -0.507 . . . . 0.0 112.004 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.484 HD12 HG23 ' A' ' 35' ' ' ILE . 26.8 mt -141.96 118.54 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.885 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.44 130.47 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 112.156 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.617 178.77 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.759 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.684 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 9.1 m-85 -139.16 151.46 46.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 111.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 176.68 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.39 129.32 55.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 54' ' ' PHE . 27.8 t -111.39 129.36 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.707 0.289 . . . . 0.0 110.772 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' O ' HG21 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -114.12 137.9 51.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' CZ ' HG11 ' A' ' 52' ' ' VAL . 24.2 m-85 -114.6 158.5 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.254 0.55 . . . . 0.0 111.637 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.79 -33.09 58.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.348 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 97.4 mt -113.03 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.857 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.44 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.735 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.43 -30.55 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.5 m-20 -61.05 -37.83 84.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.81 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.76 88.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.04 -34.07 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.57 -45.7 71.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.954 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.75 87.44 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 95.5 mt -62.75 -50.94 77.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.829 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.6 -10.26 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.021 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.659 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.36 -45.04 4.78 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.01 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 13.6 mmt -83.62 -20.52 33.51 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 24.8 t-20 -61.53 113.63 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 65.41 39.26 5.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.7 -166.23 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.83 125.46 41.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 110.814 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.08 123.21 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 55.96 34.29 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 110.238 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 19.61 79.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.233 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -125.6 145.42 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 111.01 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -86.25 119.84 26.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.679 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 12' ' ' GLY . 12.6 pt -112.34 152.65 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 111.81 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -126.64 135.22 50.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.656 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 61.4 t -123.55 150.62 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.164 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.44 ' N ' HG12 ' A' ' 79' ' ' VAL . 58.9 t30 -157.89 156.88 32.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.66 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.878 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 9.6 mt -118.28 158.36 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.692 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.8 t80 -110.74 136.41 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 39.7 t -108.36 123.09 63.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.02 115.72 2.76 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.274 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 76' ' ' THR . . . 119.61 50.58 0.29 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.705 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 74.4 mt -107.49 -174.55 2.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.985 -0.608 . . . . 0.0 112.16 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.77 -167.13 1.93 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.41 -3.09 57.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.13 -31.71 20.28 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG11 ' HB3' ' A' ' 13' ' ' LEU . 9.1 p -73.03 144.04 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.619 0.723 . . . . 0.0 112.173 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.56 -178.91 7.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.936 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 42.0 t0 -62.9 -30.49 71.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.346 0.593 . . . . 0.0 110.386 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 7.8 pttp -67.15 -48.16 68.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.188 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -72.21 -44.92 63.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.081 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.474 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.6 mt -60.84 -38.14 84.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.502 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 19.0 t-80 -58.43 -55.33 36.43 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.998 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.34 76.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.645 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.4 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.61 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 3.9 m-85 -94.3 -11.27 30.44 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.2 tp -59.87 -40.9 82.23 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.154 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 27.1 Cg_endo -60.97 -39.02 64.23 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.423 1.415 . . . . 0.0 110.808 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -73.29 -24.68 60.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.665 178.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.38 126.13 0.82 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.3 m-20 -54.39 105.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.237 0.541 . . . . 0.0 111.542 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.566 HD13 ' C ' ' A' ' 26' ' ' PHE . 3.3 mp -63.53 151.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.799 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.481 ' N ' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -114.37 -34.61 5.23 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.386 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -156.89 150.87 24.84 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.715 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 28.1 mt -143.46 118.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.631 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.68 125.87 50.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.506 . . . . 0.0 111.918 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.173 178.315 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.768 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.768 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 17.0 m-85 -147.6 150.83 35.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.057 0.428 . . . . 0.0 111.139 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.04 170.04 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.257 0.551 . . . . 0.0 112.213 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -117.44 126.9 53.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.205 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.14 129.92 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.0 110.992 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.568 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -114.31 134.35 55.02 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CD2' ' HA3' ' A' ' 30' ' ' GLY . 7.2 m-85 -107.71 161.18 15.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.13 0.49 . . . . 0.0 111.01 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.22 -29.48 57.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -123.73 131.33 53.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.82 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.284 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.87 -38.46 91.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.451 . . . . 0.0 110.819 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.4 m-20 -61.3 -37.49 83.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.24 87.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 64' ' ' ILE . . . -53.62 -33.63 55.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -65.98 -45.04 83.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.39 -35.54 80.76 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 61' ' ' ALA . 92.5 mt -63.46 -52.76 54.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.554 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.79 -10.63 59.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.841 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.9 t-20 -100.78 -41.39 6.89 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.403 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -88.76 -28.37 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -57.5 110.78 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 110.418 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.04 43.61 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.042 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.68 -161.57 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -132.22 124.47 29.02 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.7 tp -139.11 124.79 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 53.02 34.28 16.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.029 0.442 . . . . 0.0 110.59 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.0 12.05 84.3 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.729 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.78 143.4 51.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.17 0.509 . . . . 0.0 111.693 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 88.7 m -82.9 131.95 35.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.173 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.401 HG13 ' HG3' ' A' ' 67' ' ' MET . 0.2 OUTLIER -120.37 157.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.585 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 55.2 ttt180 -132.21 135.95 46.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.7 t -117.41 152.0 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 111.882 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -157.08 164.66 37.66 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.553 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 4.7 mt -122.84 160.6 25.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.6 t80 -110.31 136.35 49.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.316 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.94 122.83 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.99 113.84 2.04 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.057 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.84 46.41 0.34 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 67.6 mt -101.41 -176.76 3.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.307 0.575 . . . . 0.0 112.054 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -135.62 -171.71 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.925 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.36 0.0 34.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.68 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.5 -29.96 14.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.596 HG23 HD22 ' A' ' 13' ' ' LEU . 11.8 p -81.79 144.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.676 0.75 . . . . 0.0 111.579 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.7 p30 -153.02 179.12 8.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.122 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 7.0 p-10 -58.89 -30.37 67.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.057 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.57 -47.55 72.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' N ' ' HG3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -71.5 -42.0 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.27 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 2.5 mt -60.34 -33.53 72.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.659 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -59.25 -55.7 31.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.637 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' O ' HG21 ' A' ' 27' ' ' ILE . . . -68.02 -44.53 76.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.427 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.01 93.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.557 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 4.4 m-85 -93.05 -10.36 36.4 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 tp -61.46 -40.24 69.61 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.818 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.85 -43.39 49.72 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.5 1.467 . . . . 0.0 111.333 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.557 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.7 m-85 -71.7 -21.25 61.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.01 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.6 131.72 1.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.523 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.459 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 m-20 -59.85 109.54 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.574 0.702 . . . . 0.0 111.554 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 33' ' ' THR . 4.0 mp -64.31 153.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.349 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.492 ' N ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -117.38 -34.5 4.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.701 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -153.64 149.4 27.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 120.984 0.421 . . . . 0.0 111.672 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.6 mt -143.7 120.1 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -121.1 126.59 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 111.364 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.321 179.496 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.761 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.788 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.685 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.9 m-85 -144.54 151.26 38.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.004 0.402 . . . . 0.0 111.209 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.2 178.45 9.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.244 0.545 . . . . 0.0 112.004 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.5 m-85 -122.39 135.14 54.64 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.914 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.31 129.12 67.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -113.1 134.29 54.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -109.08 160.64 15.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.393 0.616 . . . . 0.0 111.496 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 -30.85 51.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 88.4 mt -119.49 131.09 55.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.725 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -42.23 91.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.423 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.49 -32.38 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.0 m-20 -64.65 -38.33 90.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.592 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -59.32 -45.48 91.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.691 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.18 -33.7 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.441 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -67.26 -45.33 77.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.907 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.71 78.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 96.7 mt -65.43 -52.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.445 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.42 -13.49 59.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.126 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 6.3 m-20 -99.34 -46.27 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.604 ' HB3' HG21 ' A' ' 79' ' ' VAL . 2.7 tpt -79.89 -23.29 41.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.753 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 11.0 t30 -56.84 114.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 110.795 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.82 30.05 2.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -174.47 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -137.79 130.04 29.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.719 0.295 . . . . 0.0 111.725 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.415 HD22 HD13 ' A' ' 77' ' ' ILE . 4.4 pp -138.93 130.74 27.66 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 58.65 40.59 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.104 0.478 . . . . 0.0 110.032 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.7 23.5 67.2 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.012 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HG3' ' HB3' ' A' ' 14' ' ' ALA . 9.4 mmt180 -128.59 132.7 48.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 112.059 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.2 m -83.72 124.56 30.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.747 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.415 HD13 HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -120.34 156.33 23.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.327 0.584 . . . . 0.0 111.697 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -129.85 137.64 50.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.661 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.8 t -121.05 151.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 t30 -157.98 164.41 36.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.257 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.529 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.573 HD13 HG13 ' A' ' 64' ' ' ILE . 28.9 mt -118.18 155.29 30.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -110.05 133.45 53.19 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.87 123.53 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -123.11 121.53 4.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.957 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 116.16 38.88 0.91 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 68.8 mt -93.56 179.11 5.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.83 0.824 . . . . 0.0 113.046 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.48 -175.21 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.328 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.43 -1.02 39.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.637 0.256 . . . . 0.0 111.26 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -37.22 14.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' A' ' 13' ' ' LEU . 9.9 p -65.87 143.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.579 0.704 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -151.89 178.31 9.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.856 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -61.69 -29.6 70.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.357 0.598 . . . . 0.0 109.551 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.76 -49.11 69.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.593 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.72 -44.52 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.29 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 2.4 mt -61.24 -34.24 74.81 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 109.579 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.636 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 25.8 t-80 -62.64 -54.91 32.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.584 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 27' ' ' ILE . . . -67.71 -41.52 83.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.897 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.68 75.91 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.533 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 4.9 m-85 -96.82 -9.4 28.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.678 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -61.29 -40.3 71.14 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.549 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.2 Cg_endo -57.38 -43.74 49.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.599 1.533 . . . . 0.0 111.162 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 3.3 m-85 -71.65 -24.08 61.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.029 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 169.95 129.82 1.14 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.48 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 16.3 m-20 -59.58 105.07 0.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.585 0.707 . . . . 0.0 111.23 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 33' ' ' THR . 4.4 mp -59.03 151.64 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.206 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.484 ' N ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -116.32 -32.55 5.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.679 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 9.7 t0 -155.07 146.67 23.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.459 ' CG1' HG21 ' A' ' 32' ' ' ILE . 42.9 mt -139.87 118.72 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.414 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -120.48 129.45 53.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.314 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.501 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.725 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 19.0 m-85 -143.57 151.34 40.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 0.0 110.958 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.83 176.2 12.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.384 0.611 . . . . 0.0 112.195 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 2.5 m-85 -124.34 125.53 44.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.211 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.2 t -107.13 124.98 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.551 0.215 . . . . 0.0 110.602 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -107.74 136.65 47.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 8' ' ' LEU . 3.9 m-85 -114.17 158.59 21.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.027 0.441 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -77.17 -30.93 55.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.314 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 95.8 mt -115.01 124.68 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.664 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.71 -36.39 76.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.229 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.84 -31.93 68.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 110.486 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 7.6 m-20 -61.72 -38.03 86.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.55 -40.74 83.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.723 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.32 -34.24 56.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.252 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.66 -45.14 72.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.505 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -63.35 -35.02 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.573 HG13 HD13 ' A' ' 8' ' ' LEU . 96.6 mt -66.98 -52.88 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.747 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.51 -12.67 60.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.894 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 7.0 t-20 -100.04 -29.35 12.58 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -104.49 -19.45 14.02 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 15.5 p-10 -52.76 113.42 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.02 45.34 4.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.749 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.09 -168.17 1.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.76 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 127.15 42.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.952 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HG ' ' CD2' ' A' ' 73' ' ' PHE . 12.7 tp -139.47 123.78 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.402 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 49.2 m-85 58.98 36.3 24.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 109.705 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.01 8.31 64.22 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.438 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 136.3 53.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.408 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -76.94 119.45 20.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.06 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 12' ' ' GLY . 22.4 pt -111.89 154.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 111.579 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.71 134.56 48.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.284 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 92.1 t -118.16 151.88 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.798 0.333 . . . . 0.0 111.666 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.469 ' N ' HG11 ' A' ' 79' ' ' VAL . 7.7 t-20 -156.72 156.72 33.84 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.193 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.924 0.392 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.36 157.91 23.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.783 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.7 t80 -116.25 137.31 52.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.47 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 79' ' ' VAL . 17.3 t -107.83 123.68 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.428 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -120.37 112.85 2.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.824 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.82 57.67 0.25 Allowed Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.758 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 48.0 mt -115.3 155.25 27.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.86 168.69 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.692 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -23.34 30.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.134 0.492 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.429 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 1.8 mt-10 -66.71 -38.51 86.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.462 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 13' ' ' LEU . 12.1 p -74.52 142.75 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 111.593 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.435 ' O ' ' CD1' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -155.29 -171.98 4.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.426 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 54.7 t0 -64.67 -30.64 71.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.562 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.448 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 9.4 ptmt -66.51 -48.64 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.624 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' CG1' HG21 ' A' ' 17' ' ' VAL . 1.3 p -71.61 -43.61 70.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.311 0.576 . . . . 0.0 110.651 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' A' ' 18' ' ' ASP . 2.8 mt -60.21 -36.28 77.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.872 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.675 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -60.35 -55.63 31.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.06 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.92 80.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.827 . . . . 0.0 113.01 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.4 -31.92 67.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.547 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 2.6 m-85 -98.01 -12.5 21.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' HIS . 1.2 tp -61.76 -39.83 63.86 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.513 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.63 -44.57 40.36 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.233 1.289 . . . . 0.0 110.785 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -68.17 -22.1 64.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.921 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 162.12 133.47 1.48 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.0 m-20 -58.25 106.2 0.35 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.744 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 27' ' ' ILE . 3.2 mp -57.72 149.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.887 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -114.7 -32.45 5.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.627 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.1 m-20 -154.92 145.27 22.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.988 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 31.0 mt -143.06 118.33 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.713 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -109.77 127.66 54.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.158 0.504 . . . . 0.0 112.098 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.411 178.624 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.758 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 23.6 m-85 -151.55 151.36 31.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.822 0.344 . . . . 0.0 111.507 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.83 174.82 13.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.935 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.3 m-85 -117.47 131.7 56.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.201 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.46 128.04 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -116.11 136.94 52.56 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -111.38 155.05 23.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.188 0.518 . . . . 0.0 111.103 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.12 -30.02 64.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.949 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.23 121.09 42.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.272 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.76 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.282 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -31.88 70.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.0 m-20 -68.07 -37.06 80.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.419 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.1 -44.22 87.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.962 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 64' ' ' ILE . . . -52.57 -33.74 47.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.034 0.445 . . . . 0.0 110.37 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.42 -45.14 73.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.68 78.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 93.2 mt -64.34 -52.38 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.086 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -78.22 -15.17 59.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.776 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 9.1 m120 -95.11 -48.9 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.493 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.3 tpt -73.75 -28.18 61.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.4 OUTLIER -60.7 121.93 13.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.171 0.51 . . . . 0.0 110.593 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 66.22 54.38 0.96 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.82 -166.57 1.46 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -131.03 124.95 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.445 HD21 HD12 ' A' ' 77' ' ' ILE . 13.8 tp -139.67 121.7 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 16' ' ' GLU . 34.2 m-85 58.47 40.56 23.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.217 0.532 . . . . 0.0 110.57 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.58 13.58 68.58 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.195 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.31 154.89 47.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -88.22 131.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.468 HD12 HG21 ' A' ' 77' ' ' ILE . 29.6 pt -120.65 153.42 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 mmt180 -133.26 133.79 43.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.4 t -121.07 152.37 24.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.891 0.376 . . . . 0.0 111.283 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -158.01 160.06 37.06 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 tp . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.678 179.618 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 6.2 mt -118.8 153.74 33.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.963 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -109.2 135.64 49.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.981 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 25.0 t -108.91 123.45 64.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 110.396 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.3 123.21 5.06 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.726 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.96 48.74 0.71 Allowed Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.803 ' HB3' HG13 ' A' ' 17' ' ' VAL . 44.7 mt -105.79 -174.73 2.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.62 -0.79 . . . . 0.0 112.939 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -144.25 166.43 25.07 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.718 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -24.7 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.606 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.35 -40.16 96.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.803 HG13 ' HB3' ' A' ' 13' ' ' LEU . 8.1 p -70.82 143.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.834 0.826 . . . . 0.0 112.518 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' HD12 ' A' ' 22' ' ' LEU . 69.7 m-20 -156.02 175.97 13.27 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.789 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 10.0 p-10 -62.36 -28.94 70.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.87 -48.03 72.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.912 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 3.8 p -72.57 -44.52 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 110.501 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' CD2' ' CE1' ' A' ' 26' ' ' PHE . 3.1 mt -60.25 -34.75 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.648 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -63.02 -55.51 24.97 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.784 178.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.88 79.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.436 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 21' ' ' VAL . . . -76.47 -36.01 58.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.55 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 3.9 m-85 -94.43 -9.06 36.79 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.815 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.666 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 tp -62.59 -39.99 60.45 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.479 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 23.6 Cg_endo -59.68 -42.65 44.81 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.387 1.391 . . . . 0.0 110.764 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -73.13 -23.68 60.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.876 178.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 171.36 132.69 1.52 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.624 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.472 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.0 m-20 -63.47 104.97 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.405 0.622 . . . . 0.0 111.303 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 mp -61.03 148.23 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.855 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.526 ' N ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -112.44 -34.13 5.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.514 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -153.71 149.61 27.68 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.405 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 21.0 mt -143.37 121.07 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.081 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 127.03 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.853 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.608 178.686 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.801 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 13.2 m-85 -142.04 150.38 41.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.59 171.3 16.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.237 0.541 . . . . 0.0 112.007 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 5.5 m-85 -121.82 126.6 49.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.88 124.24 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.516 0.198 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -111.38 136.51 50.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -113.64 157.17 22.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.343 0.592 . . . . 0.0 111.453 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -31.57 59.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.3 mt -115.54 126.81 54.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.388 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.34 87.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.712 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -30.73 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.453 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -64.5 -37.8 88.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.49 -45.04 89.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.37 -33.68 54.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.081 0.467 . . . . 0.0 110.656 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.05 -45.14 74.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.64 -34.13 76.43 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 85.0 mt -67.13 -52.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.857 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.29 -13.99 60.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 8.5 m-20 -99.67 -36.38 9.51 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.449 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -91.63 -22.46 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 8.5 t30 -58.33 112.41 1.55 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 72.03 52.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.694 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.77 -172.47 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -121.57 127.0 50.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.297 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.45 HD22 HD11 ' A' ' 77' ' ' ILE . 3.4 tp -139.39 122.52 16.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.618 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 66.1 m-85 55.31 37.91 29.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.86 16.16 69.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.264 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -124.29 146.07 49.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.105 0.479 . . . . 0.0 111.221 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -82.79 120.42 25.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.061 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.45 HD11 HD22 ' A' ' 72' ' ' LEU . 19.0 pt -110.97 152.26 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.042 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -132.13 139.65 48.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.874 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.0 t -119.52 151.53 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.291 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.458 ' N ' HG13 ' A' ' 79' ' ' VAL . 1.5 m120 -157.74 156.71 32.09 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.333 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.41 ' HG ' HD11 ' A' ' 64' ' ' ILE . 1.7 mt . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.652 0.263 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . 12.7 mt -117.06 159.18 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.982 0.42 . . . . 0.0 111.396 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.7 t80 -113.16 136.29 52.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.99 123.62 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 111.035 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.614 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -123.07 119.73 3.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.692 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.3 46.0 0.65 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.814 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 58.9 mt -102.02 159.43 15.37 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.749 -0.725 . . . . 0.0 111.918 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.48 177.09 4.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.38 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -75.4 1.56 13.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.496 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.12 -26.62 15.94 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' A' ' 13' ' ' LEU . 7.5 p -76.57 138.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.425 0.631 . . . . 0.0 111.228 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.452 ' O ' HD11 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -151.02 -175.05 4.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.322 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 39.9 t0 -62.16 -32.25 72.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.292 0.568 . . . . 0.0 109.617 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.75 -48.16 78.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -71.72 -43.86 69.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.178 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 6.4 mt -60.55 -36.83 79.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.668 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.3 OUTLIER -60.63 -56.24 23.74 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.18 178.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.0 -43.41 78.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.712 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' VAL . . . -71.77 -33.41 68.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.532 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 3.3 m-85 -95.95 -12.61 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.191 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.677 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -60.93 -40.27 72.85 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -57.29 -43.99 47.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.503 1.469 . . . . 0.0 111.018 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.532 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.7 m-85 -69.9 -26.03 63.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.82 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.47 136.59 2.12 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.434 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.0 m-20 -63.4 103.37 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.494 0.664 . . . . 0.0 111.157 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 27' ' ' ILE . 4.1 mp -56.01 149.53 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.289 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.43 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -115.44 -32.91 5.44 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.872 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.0 t0 -153.71 145.61 23.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.163 0.506 . . . . 0.0 111.892 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.418 ' CG1' HG23 ' A' ' 32' ' ' ILE . 41.5 mt -143.3 118.53 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.011 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -117.93 132.5 56.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.203 0.525 . . . . 0.0 111.611 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.033 179.212 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.814 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.5 m-85 -141.53 150.54 42.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.858 0.329 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.86 177.41 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.796 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -123.55 127.7 48.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.62 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.7 t -111.6 128.03 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -112.7 137.6 50.76 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 59' ' ' ASP . 83.3 m-85 -112.3 154.21 26.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.156 0.503 . . . . 0.0 110.734 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -75.01 -25.91 59.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.989 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 87.5 mt -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.538 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.39 97.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.33 -30.15 70.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 8.6 m-20 -60.72 -43.51 97.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.273 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.569 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -60.86 -46.56 90.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.761 0.315 . . . . 0.0 110.336 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.61 -33.92 61.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.521 . . . . 0.0 110.45 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -66.73 -45.31 79.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.856 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.28 -33.34 75.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.7 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 97.1 mt -66.12 -51.79 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.171 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -12.59 60.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.02 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.7 m-80 -105.15 -46.06 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.428 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 2.5 tpt -76.84 -30.02 56.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.7 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 5.0 t-20 -57.38 115.42 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mt-10 67.0 57.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 -166.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.531 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -135.98 125.56 25.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' A' ' 77' ' ' ILE . 4.7 tp -139.41 123.54 17.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 56.18 41.5 29.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.125 0.488 . . . . 0.0 110.142 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.77 65.95 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.449 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 mmt-85 -124.51 137.65 54.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.937 0.399 . . . . 0.0 111.758 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.4 m -84.38 119.96 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.985 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 72' ' ' LEU . 19.4 pt -113.26 152.86 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 0.0 111.589 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 15.9 ptp180 -131.49 136.87 48.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.027 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 97.3 t -117.33 152.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.081 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.4 m120 -148.21 164.21 34.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.455 ' HB3' HD13 ' A' ' 64' ' ' ILE . 1.2 pt? . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 121.145 0.498 . . . . 0.0 111.239 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.449 HD13 ' CE1' ' A' ' 54' ' ' PHE . 10.9 mt -118.14 160.46 21.52 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.014 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.7 t80 -114.17 136.51 52.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.645 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.6 t -108.69 123.89 64.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.98 117.17 2.93 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.897 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 76' ' ' THR . . . 118.75 42.18 0.58 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.682 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 89.6 mt -97.99 -177.51 3.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.365 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.18 -172.35 2.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.547 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -82.42 2.92 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.565 0.222 . . . . 0.0 111.564 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.15 -30.24 13.62 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' A' ' 13' ' ' LEU . 13.2 p -69.0 142.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.718 0.77 . . . . 0.0 111.986 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 7.7 m-20 -155.18 175.12 14.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 6.4 p-10 -57.62 -29.78 64.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.609 ' HG2' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.28 -47.39 73.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.082 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.609 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -71.98 -44.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.52 HD22 ' CE1' ' A' ' 26' ' ' PHE . 1.3 mt -60.39 -36.25 77.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.584 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.646 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -59.17 -55.73 31.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.886 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.48 84.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.364 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.85 65.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.535 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 5.6 m-85 -97.01 -9.86 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.647 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.16 -39.81 67.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.45 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 26.9 Cg_endo -60.73 -41.93 42.81 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.309 1.339 . . . . 0.0 110.834 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.535 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.0 m-85 -68.28 -26.02 65.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.476 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.22 132.03 1.32 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 3.2 m-20 -56.36 110.21 0.73 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.521 0.676 . . . . 0.0 111.834 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 27' ' ' ILE . 3.3 mp -64.64 150.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.869 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -115.42 -34.81 4.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.661 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 2.3 m-20 -153.56 147.12 25.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 111.628 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.426 ' CG1' HG23 ' A' ' 32' ' ' ILE . 45.3 mt -141.19 118.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.866 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.76 129.83 53.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.888 0.375 . . . . 0.0 111.584 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.178 179.222 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.74 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 120.06 -0.3 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 15.8 m-85 -145.92 150.65 36.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.004 0.402 . . . . 0.0 111.16 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.91 174.32 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 18.1 m-85 -119.03 129.12 54.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.442 HG11 ' CE1' ' A' ' 54' ' ' PHE . 2.8 t -108.63 129.09 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.535 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -112.54 136.61 51.87 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CE1' HD13 ' A' ' 8' ' ' LEU . 15.2 m-85 -111.73 157.46 20.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 0.0 111.497 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -74.89 -32.84 61.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.076 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 95.5 mt -113.5 117.39 31.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.395 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.27 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.684 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -66.5 -31.74 72.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.3 m-20 -61.21 -37.51 83.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.79 -41.63 82.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.11 -33.8 63.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.934 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.32 -45.25 73.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.202 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.43 ' HB1' ' CZ ' ' A' ' 54' ' ' PHE . . . -62.83 -37.54 87.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 55.2 mt -63.7 -52.26 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.189 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.36 -9.62 58.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.613 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 2.0 m120 -104.15 -39.25 6.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 26' ' ' PHE . 3.9 mmm -89.86 -19.59 24.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 6.2 p30 -57.92 116.1 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 25.9 mt-10 65.24 42.07 4.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.5 OUTLIER -105.39 -165.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.5 124.64 32.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.5 tp -139.38 129.86 25.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 55.09 28.4 10.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.3 4.49 89.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -119.93 160.45 22.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.429 0.633 . . . . 0.0 111.533 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.442 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 8.8 m -91.12 124.75 35.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.061 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -114.79 156.28 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.213 0.53 . . . . 0.0 111.325 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -133.52 138.79 46.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.831 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 96.7 t -116.96 150.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 111.117 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -157.81 164.48 36.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.962 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.467 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.4 m . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.868 0.366 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 13.2 mt -118.46 160.41 21.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.7 t80 -113.18 135.26 54.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.793 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 21.6 t -108.79 123.55 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.35 118.27 3.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.748 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.51 37.07 0.87 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.787 ' HB3' HG13 ' A' ' 17' ' ' VAL . 79.2 mt -91.42 -174.65 3.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.598 0.713 . . . . 0.0 112.233 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.46 -171.53 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.124 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -84.63 5.27 28.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.583 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -32.29 13.0 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.787 HG13 ' HB3' ' A' ' 13' ' ' LEU . 14.9 p -70.14 143.73 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.657 0.741 . . . . 0.0 112.213 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -153.3 179.5 8.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.823 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.42 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.192 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.03 -47.96 75.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 22' ' ' LEU . 1.4 p -71.86 -46.37 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.48 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 2.3 mt -60.78 -37.22 81.15 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.02 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.616 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 16.7 t-160 -57.14 -55.27 36.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.496 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.17 82.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.611 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' VAL . . . -70.88 -36.57 72.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.547 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 5.4 m-85 -95.78 -7.91 35.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.671 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -63.98 -39.62 46.71 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -58.68 -42.05 57.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.54 1.493 . . . . 0.0 111.012 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -72.03 -23.9 61.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.911 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.41 130.02 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 m-20 -57.18 107.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.365 0.602 . . . . 0.0 111.722 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.494 HD13 ' C ' ' A' ' 26' ' ' PHE . 2.8 mp -60.55 152.88 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.113 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -118.08 -32.74 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.793 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.57 145.65 23.71 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.112 0.482 . . . . 0.0 111.717 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 30.3 mt -141.52 118.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.312 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -118.73 129.27 55.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.064 0.459 . . . . 0.0 112.049 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.779 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.903 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.689 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.0 m-85 -142.32 150.62 41.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.166 0.483 . . . . 0.0 110.802 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.93 173.57 16.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.107 0.48 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 6.2 m-85 -120.0 129.91 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.29 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.75 128.33 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.657 0.265 . . . . 0.0 110.77 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.6 OUTLIER -115.44 136.77 52.75 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.455 ' CE1' HD12 ' A' ' 8' ' ' LEU . 9.4 m-85 -113.24 159.12 19.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.153 0.502 . . . . 0.0 111.317 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.87 -31.57 56.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.532 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 93.7 mt -113.61 120.2 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.64 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.2 -35.82 70.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.363 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.06 -30.85 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -66.25 -37.55 85.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.539 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.25 -41.54 84.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.096 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.81 54.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.09 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.69 -45.31 71.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.75 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 -36.3 83.07 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.71 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 63.6 mt -64.26 -53.1 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.702 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.68 -19.0 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.024 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 15.8 m-20 -94.0 -31.92 14.05 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.987 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.428 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 1.3 tpt -100.53 -15.8 17.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.71 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -50.5 111.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.733 0.302 . . . . 0.0 111.033 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 62.24 40.03 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 t -90.78 -168.29 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.456 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -127.13 125.6 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.403 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tp -139.32 125.36 19.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.299 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 58.18 35.78 25.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 109.916 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.38 75.66 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.244 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -126.61 143.95 51.06 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.155 0.502 . . . . 0.0 111.503 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.8 m -87.02 120.56 28.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.162 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.4 pt -112.45 159.13 12.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.163 0.506 . . . . 0.0 111.695 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 mtt-85 -127.53 135.94 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 97.9 t -116.94 152.16 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -156.45 161.49 40.06 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.382 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 17.1 mt -107.13 155.18 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.389 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 5.6 t80 -111.74 136.26 51.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.27 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 42.7 t -108.84 123.89 65.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.829 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.36 115.73 2.6 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.048 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.91 46.77 0.33 Allowed Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.826 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 54.9 mt -102.31 -176.06 3.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.615 0.722 . . . . 0.0 112.668 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.73 -172.73 3.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.491 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -83.42 6.14 21.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.567 0.222 . . . . 0.0 111.551 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.49 -21.82 16.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.794 0.33 . . . . 0.0 111.531 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 13' ' ' LEU . 12.3 p -82.0 153.36 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 111.441 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.5 m-20 -163.88 -178.6 5.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.152 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -63.73 -29.27 70.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.288 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -66.89 -48.48 68.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.3 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' CG1' HG22 ' A' ' 17' ' ' VAL . 2.2 p -71.74 -44.21 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.283 0.564 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 18' ' ' ASP . 1.7 mt -60.63 -33.7 73.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.347 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.618 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -59.88 -55.3 35.88 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 178.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.3 85.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.41 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -69.38 -32.85 72.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.545 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 5.0 m-85 -99.86 -9.75 22.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.66 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.78 -39.58 61.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 24.5 Cg_endo -60.07 -41.84 48.93 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.393 1.395 . . . . 0.0 111.037 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.8 m-85 -72.0 -26.24 62.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.921 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.64 128.72 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.75 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.3 m-20 -59.02 104.24 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.471 0.653 . . . . 0.0 110.984 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 3.8 mp -58.93 154.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.894 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -124.24 -25.64 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.58 141.66 20.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.409 ' CG1' HG23 ' A' ' 32' ' ' ILE . 24.4 mt -143.31 118.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.318 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -127.29 128.31 45.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.981 0.419 . . . . 0.0 111.979 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.951 179.172 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.826 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.64 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.6 m-85 -140.43 151.38 44.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.524 0.202 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.89 170.95 19.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -115.71 141.94 47.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.698 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 39.2 t -120.81 124.42 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -103.89 141.55 35.95 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.499 ' CD1' ' OD1' ' A' ' 59' ' ' ASP . 97.0 m-85 -124.5 153.12 42.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.146 0.498 . . . . 0.0 111.298 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.06 -31.4 62.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.104 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.494 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 65.6 mt -119.65 127.97 53.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.053 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.48 70.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.08 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.37 -35.15 63.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' CD1' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 59' ' ' ASP . . . -58.59 -41.38 85.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.534 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.26 -33.79 54.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.154 0.502 . . . . 0.0 110.67 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.03 -44.52 80.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.628 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.65 78.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 90.4 mt -67.1 -53.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.67 -16.22 59.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.016 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 29' ' ' PHE . 10.0 t-20 -99.86 -39.49 8.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 2.2 tpt -85.2 -22.47 28.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.757 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 10.9 t30 -53.38 113.63 1.22 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 66.96 49.64 1.13 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.68 -165.7 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -135.05 128.72 32.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.18 122.95 17.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.443 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 57.68 39.03 27.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.947 0.404 . . . . 0.0 110.024 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.0 13.75 69.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -120.66 137.8 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 m -75.63 120.51 21.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -110.98 152.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.29 0.566 . . . . 0.0 111.467 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 63.7 ttt180 -134.27 137.72 44.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.054 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 90.0 t -119.37 151.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 111.563 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 63.8 m-20 -157.9 164.5 36.83 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.601 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.734 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 24.9 m 58.26 90.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.763 0.316 . . . . 0.0 110.911 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.5 m -92.34 -56.18 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 p 50.72 70.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -139.63 -171.54 3.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.758 0.313 . . . . 0.0 110.777 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -133.46 -5.05 2.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.569 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.504 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.4 HD12 ' CE1' ' A' ' 54' ' ' PHE . 19.1 mt -112.98 160.9 17.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.922 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.764 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.3 t80 -114.87 136.93 52.56 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.763 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.1 t -108.39 123.59 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.681 0.277 . . . . 0.0 110.332 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.07 116.57 2.49 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.37 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 77' ' ' ILE . . . 119.18 41.27 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.759 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 84.8 mt -95.03 -176.91 3.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.616 0.722 . . . . 0.0 112.749 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.56 -171.9 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.651 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.27 4.23 27.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.112 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.99 -21.28 16.32 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG12 ' HB3' ' A' ' 13' ' ' LEU . 7.1 p -90.3 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 111.739 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.556 ' N ' HG21 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -153.15 -174.74 5.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.972 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.36 -30.15 71.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 109.996 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -64.67 -48.63 74.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.416 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.63 -41.78 71.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.945 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD21 ' CE1' ' A' ' 26' ' ' PHE . 2.2 mt -60.52 -35.57 76.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.667 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -60.3 -56.14 25.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.689 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.65 -40.35 84.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.293 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -70.63 -37.76 73.82 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.529 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 4.4 m-85 -95.52 -8.02 36.37 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 23' ' ' HIS . 1.9 tp -63.29 -39.22 48.06 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.687 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 28.1 Cg_endo -61.8 -39.86 49.27 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.54 1.493 . . . . 0.0 111.331 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -74.41 -22.86 58.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.796 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 170.0 129.73 1.14 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.412 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.2 m-20 -60.19 104.06 0.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 111.27 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.481 HD12 ' C ' ' A' ' 26' ' ' PHE . 3.9 mp -59.4 152.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.169 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.458 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -119.47 -31.76 4.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.852 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.93 146.32 23.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.431 -0.507 . . . . 0.0 112.004 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.484 HD12 HG23 ' A' ' 35' ' ' ILE . 26.8 mt -141.96 118.54 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.885 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.44 130.47 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 112.156 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -121.49 108.17 35.87 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.617 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' O ' ' CD2' ' A' ' 46' ' ' HIS . 72.5 Cg_endo -76.72 154.62 34.7 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.489 2.126 . . . . 0.0 113.166 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.98 168.63 19.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 10.0 m-20 -83.47 -178.89 7.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -107.71 -30.8 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.717 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.24 -32.9 19.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -114.59 -23.29 9.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.452 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.7 pt-20 45.9 36.21 2.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.58 120.86 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -68.45 -168.38 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.52 -47.85 3.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.406 0.622 . . . . 0.0 109.36 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.759 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 159.31 45.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.672 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 9.1 m-85 -139.16 151.46 46.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 111.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 176.68 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.39 129.32 55.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 54' ' ' PHE . 27.8 t -111.39 129.36 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.707 0.289 . . . . 0.0 110.772 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' O ' HG21 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -114.12 137.9 51.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' CZ ' HG11 ' A' ' 52' ' ' VAL . 24.2 m-85 -114.6 158.5 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.254 0.55 . . . . 0.0 111.637 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.79 -33.09 58.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.348 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 97.4 mt -113.03 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.857 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . . . -56.12 -43.44 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.735 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.43 -30.55 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.5 m-20 -61.05 -37.83 84.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.81 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.76 88.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.04 -34.07 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.57 -45.7 71.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.954 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.75 87.44 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 95.5 mt -62.75 -50.94 77.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.829 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.6 -10.26 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.021 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.659 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.36 -45.04 4.78 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.01 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 13.6 mmt -83.62 -20.52 33.51 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 24.8 t-20 -61.53 113.63 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 65.41 39.26 5.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.7 -166.23 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.83 125.46 41.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 110.814 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.08 123.21 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 55.96 34.29 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 110.238 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 19.61 79.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.233 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -125.6 145.42 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 111.01 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -86.25 119.84 26.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.679 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 12' ' ' GLY . 12.6 pt -112.34 152.65 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 111.81 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -126.64 135.22 50.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.656 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 61.4 t -123.55 150.62 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.164 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' N ' HG12 ' A' ' 79' ' ' VAL . 58.9 t30 -157.89 156.88 32.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.66 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 123.36 25.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.878 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.66 175.72 0.77 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.62 146.94 44.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.21 -26.18 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.507 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 m -125.52 159.39 32.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.005 0.431 . . . . 0.0 111.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 19.6 mmtt -136.46 154.55 50.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER 165.58 -24.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.98 134.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 111.139 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 9.6 mt -118.28 158.36 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.692 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.8 t80 -110.74 136.41 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 39.7 t -108.36 123.09 63.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.02 115.72 2.76 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.274 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 76' ' ' THR . . . 119.61 50.58 0.29 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.705 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 74.4 mt -107.49 -174.55 2.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.985 -0.608 . . . . 0.0 112.16 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.77 -167.13 1.93 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.41 -3.09 57.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.13 -31.71 20.28 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG11 ' HB3' ' A' ' 13' ' ' LEU . 9.1 p -73.03 144.04 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.619 0.723 . . . . 0.0 112.173 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.56 -178.91 7.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.936 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 42.0 t0 -62.9 -30.49 71.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.346 0.593 . . . . 0.0 110.386 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 7.8 pttp -67.15 -48.16 68.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.188 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -72.21 -44.92 63.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.081 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.474 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.6 mt -60.84 -38.14 84.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.502 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 19.0 t-80 -58.43 -55.33 36.43 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.998 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.34 76.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.645 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.4 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.61 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 3.9 m-85 -94.3 -11.27 30.44 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.2 tp -59.87 -40.9 82.23 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.154 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 27.1 Cg_endo -60.97 -39.02 64.23 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.423 1.415 . . . . 0.0 110.808 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -73.29 -24.68 60.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.665 178.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.38 126.13 0.82 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.3 m-20 -54.39 105.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.237 0.541 . . . . 0.0 111.542 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.566 HD13 ' C ' ' A' ' 26' ' ' PHE . 3.3 mp -63.53 151.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.799 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.481 ' N ' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -114.37 -34.61 5.23 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.386 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -156.89 150.87 24.84 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.715 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 28.1 mt -143.46 118.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.631 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.68 125.87 50.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.506 . . . . 0.0 111.918 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.439 HG23 ' CD2' ' A' ' 46' ' ' HIS . 4.3 mt -110.58 108.02 58.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.173 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HG2' ' HE2' ' A' ' 46' ' ' HIS . 59.6 Cg_endo -69.35 77.12 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.449 2.099 . . . . 0.0 113.164 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.09 -179.96 5.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.463 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -86.83 167.66 14.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -101.07 -22.64 14.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.017 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.0 -35.08 15.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.1 p -120.82 -28.25 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.654 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.91 46.54 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.223 0.535 . . . . 0.0 110.197 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -128.96 119.1 23.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.429 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.48 ' HE2' ' HG2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -79.65 -169.05 1.78 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.504 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -119.64 -45.24 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.973 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.768 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . 161.99 47.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.779 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.768 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 17.0 m-85 -147.6 150.83 35.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.057 0.428 . . . . 0.0 111.139 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.04 170.04 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.257 0.551 . . . . 0.0 112.213 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -117.44 126.9 53.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.205 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.14 129.92 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.0 110.992 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.568 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -114.31 134.35 55.02 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CD2' ' HA3' ' A' ' 30' ' ' GLY . 7.2 m-85 -107.71 161.18 15.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.13 0.49 . . . . 0.0 111.01 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.22 -29.48 57.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -123.73 131.33 53.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.82 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.284 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.87 -38.46 91.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.451 . . . . 0.0 110.819 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.4 m-20 -61.3 -37.49 83.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.24 87.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 64' ' ' ILE . . . -53.62 -33.63 55.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -65.98 -45.04 83.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.39 -35.54 80.76 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 61' ' ' ALA . 92.5 mt -63.46 -52.76 54.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.554 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.79 -10.63 59.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.841 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.9 t-20 -100.78 -41.39 6.89 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.403 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -88.76 -28.37 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -57.5 110.78 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 110.418 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.04 43.61 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.042 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.68 -161.57 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -132.22 124.47 29.02 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.7 tp -139.11 124.79 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 53.02 34.28 16.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.029 0.442 . . . . 0.0 110.59 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.0 12.05 84.3 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.729 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.78 143.4 51.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.17 0.509 . . . . 0.0 111.693 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 88.7 m -82.9 131.95 35.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.173 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.401 HG13 ' HG3' ' A' ' 67' ' ' MET . 0.2 OUTLIER -120.37 157.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.585 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 55.2 ttt180 -132.21 135.95 46.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.7 t -117.41 152.0 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 111.882 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -157.08 164.66 37.66 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 35.65 0.56 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.553 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.13 167.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.53 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.696 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.4 t -139.36 113.94 9.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -129.44 -11.21 4.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.757 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 81' ' ' LEU . 8.8 t 45.18 34.29 1.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.562 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.73 -93.47 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.43 -35.95 0.0 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.041 0.448 . . . . 0.0 110.401 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 m -83.32 132.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 4.7 mt -122.84 160.6 25.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.6 t80 -110.31 136.35 49.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.316 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.94 122.83 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.99 113.84 2.04 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.057 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.84 46.41 0.34 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 67.6 mt -101.41 -176.76 3.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.307 0.575 . . . . 0.0 112.054 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -135.62 -171.71 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.925 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.36 0.0 34.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.68 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.5 -29.96 14.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.596 HG23 HD22 ' A' ' 13' ' ' LEU . 11.8 p -81.79 144.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.676 0.75 . . . . 0.0 111.579 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.7 p30 -153.02 179.12 8.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.122 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 7.0 p-10 -58.89 -30.37 67.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.057 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.57 -47.55 72.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' N ' ' HG3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -71.5 -42.0 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.27 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 2.5 mt -60.34 -33.53 72.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.659 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -59.25 -55.7 31.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.637 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' O ' HG21 ' A' ' 27' ' ' ILE . . . -68.02 -44.53 76.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.427 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.01 93.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.557 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 4.4 m-85 -93.05 -10.36 36.4 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 tp -61.46 -40.24 69.61 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.818 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.85 -43.39 49.72 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.5 1.467 . . . . 0.0 111.333 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.557 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.7 m-85 -71.7 -21.25 61.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.01 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.6 131.72 1.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.523 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 m-20 -59.85 109.54 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.574 0.702 . . . . 0.0 111.554 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 33' ' ' THR . 4.0 mp -64.31 153.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.349 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.492 ' N ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -117.38 -34.5 4.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.701 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -153.64 149.4 27.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 120.984 0.421 . . . . 0.0 111.672 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.6 mt -143.7 120.1 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -121.1 126.59 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 111.364 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.65 108.19 56.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.321 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.21 125.79 14.19 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.123 . . . . 0.0 113.169 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mt -132.44 174.85 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.533 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.61 165.23 14.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.523 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -97.12 -24.29 15.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.01 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -100.72 -29.79 12.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.062 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.8 p -112.4 -31.4 6.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.24 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 57.59 37.67 27.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 111.237 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -114.23 114.33 25.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -70.97 -179.8 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 110.852 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -63.7 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.834 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.761 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 172.85 38.17 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.375 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.685 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.9 m-85 -144.54 151.26 38.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.004 0.402 . . . . 0.0 111.209 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.2 178.45 9.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.244 0.545 . . . . 0.0 112.004 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.5 m-85 -122.39 135.14 54.64 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.914 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.31 129.12 67.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -113.1 134.29 54.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -109.08 160.64 15.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.393 0.616 . . . . 0.0 111.496 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 -30.85 51.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 88.4 mt -119.49 131.09 55.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.725 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -42.23 91.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.423 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.49 -32.38 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.0 m-20 -64.65 -38.33 90.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.592 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -59.32 -45.48 91.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.691 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.18 -33.7 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.441 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -67.26 -45.33 77.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.907 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.71 78.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 96.7 mt -65.43 -52.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.445 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.42 -13.49 59.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.126 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 6.3 m-20 -99.34 -46.27 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.604 ' HB3' HG21 ' A' ' 79' ' ' VAL . 2.7 tpt -79.89 -23.29 41.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.753 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 11.0 t30 -56.84 114.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 110.795 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.82 30.05 2.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -174.47 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -137.79 130.04 29.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.719 0.295 . . . . 0.0 111.725 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.415 HD22 HD13 ' A' ' 77' ' ' ILE . 4.4 pp -138.93 130.74 27.66 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 58.65 40.59 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.104 0.478 . . . . 0.0 110.032 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.7 23.5 67.2 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.012 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HG3' ' HB3' ' A' ' 14' ' ' ALA . 9.4 mmt180 -128.59 132.7 48.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 112.059 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.2 m -83.72 124.56 30.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.747 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.415 HD13 HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -120.34 156.33 23.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.327 0.584 . . . . 0.0 111.697 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -129.85 137.64 50.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.661 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.8 t -121.05 151.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 t30 -157.98 164.41 36.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.257 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 0.4 OUTLIER -77.87 -24.55 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.529 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.12 160.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.1 mttp . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.812 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.102 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 5.2 m 62.91 159.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -128.12 -77.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.813 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m 59.09 92.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.18 101.19 13.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.378 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 8.2 mtp180 -134.63 1.59 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.68 131.17 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.332 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.573 HD13 HG13 ' A' ' 64' ' ' ILE . 28.9 mt -118.18 155.29 30.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -110.05 133.45 53.19 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.87 123.53 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -123.11 121.53 4.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.957 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 116.16 38.88 0.91 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 68.8 mt -93.56 179.11 5.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.83 0.824 . . . . 0.0 113.046 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.48 -175.21 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.328 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.43 -1.02 39.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.637 0.256 . . . . 0.0 111.26 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -37.22 14.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' A' ' 13' ' ' LEU . 9.9 p -65.87 143.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.579 0.704 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -151.89 178.31 9.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.856 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -61.69 -29.6 70.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.357 0.598 . . . . 0.0 109.551 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.76 -49.11 69.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.593 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.72 -44.52 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.29 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 2.4 mt -61.24 -34.24 74.81 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 109.579 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.636 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 25.8 t-80 -62.64 -54.91 32.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.584 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 27' ' ' ILE . . . -67.71 -41.52 83.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.897 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.68 75.91 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.533 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 4.9 m-85 -96.82 -9.4 28.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.678 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -61.29 -40.3 71.14 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.549 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.2 Cg_endo -57.38 -43.74 49.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.599 1.533 . . . . 0.0 111.162 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 3.3 m-85 -71.65 -24.08 61.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.029 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 169.95 129.82 1.14 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.48 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 16.3 m-20 -59.58 105.07 0.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.585 0.707 . . . . 0.0 111.23 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 33' ' ' THR . 4.4 mp -59.03 151.64 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.206 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.484 ' N ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -116.32 -32.55 5.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.679 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 9.7 t0 -155.07 146.67 23.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.459 ' CG1' HG21 ' A' ' 32' ' ' ILE . 42.9 mt -139.87 118.72 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.414 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -120.48 129.45 53.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.314 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.05 108.19 48.72 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -44.82 125.69 6.73 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.869 2.379 . . . . 0.0 113.505 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mt -135.2 164.42 27.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.721 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 5.8 m-20 -87.32 170.37 11.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.772 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -98.6 -33.29 11.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.13 -23.32 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.591 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -116.93 -20.13 9.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.629 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 37.19 38.69 0.12 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 43' ' ' THR . 8.6 mttp -117.32 109.39 16.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -64.88 -179.89 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.782 0.325 . . . . 0.0 110.542 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -115.03 -65.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.074 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.725 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 177.26 40.1 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.284 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 19.0 m-85 -143.57 151.34 40.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 0.0 110.958 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.83 176.2 12.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.384 0.611 . . . . 0.0 112.195 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 2.5 m-85 -124.34 125.53 44.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.211 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.2 t -107.13 124.98 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.551 0.215 . . . . 0.0 110.602 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 0.5 OUTLIER -107.74 136.65 47.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 8' ' ' LEU . 3.9 m-85 -114.17 158.59 21.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.027 0.441 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -77.17 -30.93 55.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.314 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 95.8 mt -115.01 124.68 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.664 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.71 -36.39 76.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.229 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.84 -31.93 68.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 110.486 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 7.6 m-20 -61.72 -38.03 86.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.55 -40.74 83.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.723 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.32 -34.24 56.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.252 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.66 -45.14 72.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.505 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -63.35 -35.02 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.573 HG13 HD13 ' A' ' 8' ' ' LEU . 96.6 mt -66.98 -52.88 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.747 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.51 -12.67 60.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.894 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 7.0 t-20 -100.04 -29.35 12.58 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -104.49 -19.45 14.02 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 15.5 p-10 -52.76 113.42 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.02 45.34 4.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.749 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.09 -168.17 1.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.76 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 127.15 42.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.952 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HG ' ' CD2' ' A' ' 73' ' ' PHE . 12.7 tp -139.47 123.78 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.402 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 49.2 m-85 58.98 36.3 24.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 109.705 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.01 8.31 64.22 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.438 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 136.3 53.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.408 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -76.94 119.45 20.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.06 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 12' ' ' GLY . 22.4 pt -111.89 154.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 111.579 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.71 134.56 48.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.284 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 92.1 t -118.16 151.88 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.798 0.333 . . . . 0.0 111.666 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.469 ' N ' HG11 ' A' ' 79' ' ' VAL . 7.7 t-20 -156.72 156.72 33.84 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.83 151.6 31.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.73 -165.07 1.14 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.995 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.776 -0.13 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.18 170.77 19.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.589 0.233 . . . . 0.0 110.509 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m 59.09 158.38 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.016 0.436 . . . . 0.0 110.912 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.4 p -71.45 -178.14 2.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.271 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.0 125.17 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.104 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -138.35 3.7 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.706 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.63 120.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.778 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.36 157.91 23.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.783 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.7 t80 -116.25 137.31 52.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.47 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 79' ' ' VAL . 17.3 t -107.83 123.68 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.428 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -120.37 112.85 2.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.824 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.82 57.67 0.25 Allowed Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.758 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 48.0 mt -115.3 155.25 27.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.86 168.69 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.692 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -23.34 30.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.134 0.492 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 1.8 mt-10 -66.71 -38.51 86.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.462 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 13' ' ' LEU . 12.1 p -74.52 142.75 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 111.593 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.435 ' O ' ' CD1' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -155.29 -171.98 4.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.426 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 54.7 t0 -64.67 -30.64 71.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.562 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 9.4 ptmt -66.51 -48.64 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.624 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' CG1' HG21 ' A' ' 17' ' ' VAL . 1.3 p -71.61 -43.61 70.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.311 0.576 . . . . 0.0 110.651 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' A' ' 18' ' ' ASP . 2.8 mt -60.21 -36.28 77.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.872 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.675 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -60.35 -55.63 31.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.06 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.92 80.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.827 . . . . 0.0 113.01 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.4 -31.92 67.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.547 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 2.6 m-85 -98.01 -12.5 21.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' HIS . 1.2 tp -61.76 -39.83 63.86 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.513 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.675 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.63 -44.57 40.36 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.233 1.289 . . . . 0.0 110.785 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -68.17 -22.1 64.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.921 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 162.12 133.47 1.48 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.0 m-20 -58.25 106.2 0.35 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.744 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 27' ' ' ILE . 3.2 mp -57.72 149.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.887 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -114.7 -32.45 5.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.627 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.1 m-20 -154.92 145.27 22.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.988 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 31.0 mt -143.06 118.33 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.713 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -109.77 127.66 54.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.158 0.504 . . . . 0.0 112.098 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.0 mt -119.09 108.3 40.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.411 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 141.13 14.03 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 113.489 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.79 -169.18 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.868 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.73 143.87 26.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.757 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.36 43.12 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.212 0.53 . . . . 0.0 110.494 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.43 -40.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.272 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -99.11 -28.78 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.788 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 62.13 29.31 17.52 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.766 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -127.14 114.66 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -57.26 -178.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -40.92 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.62 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.758 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 144.77 49.52 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.864 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 23.6 m-85 -151.55 151.36 31.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.822 0.344 . . . . 0.0 111.507 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.83 174.82 13.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.935 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.3 m-85 -117.47 131.7 56.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.201 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.46 128.04 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -116.11 136.94 52.56 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -111.38 155.05 23.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.188 0.518 . . . . 0.0 111.103 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.12 -30.02 64.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.949 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.23 121.09 42.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.272 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.76 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.282 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -31.88 70.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.0 m-20 -68.07 -37.06 80.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.419 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.1 -44.22 87.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.962 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 64' ' ' ILE . . . -52.57 -33.74 47.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.034 0.445 . . . . 0.0 110.37 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.42 -45.14 73.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.68 78.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 93.2 mt -64.34 -52.38 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.086 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -78.22 -15.17 59.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.776 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 9.1 m120 -95.11 -48.9 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.493 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.3 tpt -73.75 -28.18 61.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.4 OUTLIER -60.7 121.93 13.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.171 0.51 . . . . 0.0 110.593 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 66.22 54.38 0.96 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.82 -166.57 1.46 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -131.03 124.95 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.445 HD21 HD12 ' A' ' 77' ' ' ILE . 13.8 tp -139.67 121.7 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 16' ' ' GLU . 34.2 m-85 58.47 40.56 23.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.217 0.532 . . . . 0.0 110.57 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.58 13.58 68.58 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.195 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.31 154.89 47.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 110.934 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -88.22 131.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.468 HD12 HG21 ' A' ' 77' ' ' ILE . 29.6 pt -120.65 153.42 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 mmt180 -133.26 133.79 43.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.4 t -121.07 152.37 24.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.891 0.376 . . . . 0.0 111.283 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -158.01 160.06 37.06 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 tp -72.18 141.37 49.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.678 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.87 94.76 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.069 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 117.5 23.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -80.34 139.8 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -94.27 46.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.093 0.473 . . . . 0.0 110.635 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 1.9 mptt 61.43 159.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.63 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -147.66 18.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.056 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.77 129.91 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 6.2 mt -118.8 153.74 33.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.963 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -109.2 135.64 49.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.981 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 25.0 t -108.91 123.45 64.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 110.396 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.3 123.21 5.06 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.726 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.96 48.74 0.71 Allowed Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.803 ' HB3' HG13 ' A' ' 17' ' ' VAL . 44.7 mt -105.79 -174.73 2.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.62 -0.79 . . . . 0.0 112.939 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -144.25 166.43 25.07 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.718 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -24.7 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.606 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.35 -40.16 96.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.803 HG13 ' HB3' ' A' ' 13' ' ' LEU . 8.1 p -70.82 143.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.834 0.826 . . . . 0.0 112.518 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' HD12 ' A' ' 22' ' ' LEU . 69.7 m-20 -156.02 175.97 13.27 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.789 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 10.0 p-10 -62.36 -28.94 70.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.87 -48.03 72.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.912 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 3.8 p -72.57 -44.52 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 110.501 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' CD2' ' CE1' ' A' ' 26' ' ' PHE . 3.1 mt -60.25 -34.75 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.648 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -63.02 -55.51 24.97 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.784 178.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.88 79.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.436 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 21' ' ' VAL . . . -76.47 -36.01 58.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.55 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 3.9 m-85 -94.43 -9.06 36.79 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.815 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.666 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 tp -62.59 -39.99 60.45 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.479 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 23.6 Cg_endo -59.68 -42.65 44.81 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.387 1.391 . . . . 0.0 110.764 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -73.13 -23.68 60.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.876 178.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 171.36 132.69 1.52 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.624 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.0 m-20 -63.47 104.97 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.405 0.622 . . . . 0.0 111.303 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 33' ' ' THR . 4.6 mp -61.03 148.23 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.855 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.526 ' N ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -112.44 -34.13 5.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.514 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -153.71 149.61 27.68 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.405 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 21.0 mt -143.37 121.07 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.081 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 127.03 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.853 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.02 108.17 51.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.608 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.8 142.23 15.76 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.507 2.138 . . . . 0.0 113.377 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.554 HD22 ' C ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -146.37 -167.33 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.301 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 1.9 m-20 -68.22 151.89 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -83.72 -17.42 41.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -110.44 -34.7 6.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.38 -3.11 15.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.605 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 5.7 pt-20 34.72 49.88 0.4 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -116.52 107.67 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.844 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.47 -177.92 1.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.412 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -115.77 -56.33 2.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.134 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.801 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 171.5 45.61 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.381 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 13.2 m-85 -142.04 150.38 41.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.59 171.3 16.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.237 0.541 . . . . 0.0 112.007 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 5.5 m-85 -121.82 126.6 49.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.88 124.24 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.516 0.198 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -111.38 136.51 50.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -113.64 157.17 22.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.343 0.592 . . . . 0.0 111.453 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -31.57 59.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.3 mt -115.54 126.81 54.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.388 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.34 87.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.712 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -30.73 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.453 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -64.5 -37.8 88.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.49 -45.04 89.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.37 -33.68 54.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.081 0.467 . . . . 0.0 110.656 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.05 -45.14 74.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.64 -34.13 76.43 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 85.0 mt -67.13 -52.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.857 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.29 -13.99 60.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 8.5 m-20 -99.67 -36.38 9.51 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.449 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -91.63 -22.46 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 8.5 t30 -58.33 112.41 1.55 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 72.03 52.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.694 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.77 -172.47 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -121.57 127.0 50.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.297 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.45 HD22 HD11 ' A' ' 77' ' ' ILE . 3.4 tp -139.39 122.52 16.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.618 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 66.1 m-85 55.31 37.91 29.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.86 16.16 69.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.264 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -124.29 146.07 49.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.105 0.479 . . . . 0.0 111.221 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -82.79 120.42 25.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.061 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.45 HD11 HD22 ' A' ' 72' ' ' LEU . 19.0 pt -110.97 152.26 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.042 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -132.13 139.65 48.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.874 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.0 t -119.52 151.53 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.291 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.458 ' N ' HG13 ' A' ' 79' ' ' VAL . 1.5 m120 -157.74 156.71 32.09 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.333 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.41 ' HG ' HD11 ' A' ' 64' ' ' ILE . 1.7 mt -85.03 118.99 24.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.009 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 5' ' ' LYS . . . -85.24 166.42 16.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 111.023 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.4 p -121.05 29.01 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 t -172.36 90.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 57.23 80.14 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 121.28 7.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.604 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -159.49 61.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.257 0.551 . . . . 0.0 111.336 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 m -85.77 134.64 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.742 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . 12.7 mt -117.06 159.18 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.982 0.42 . . . . 0.0 111.396 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.7 t80 -113.16 136.29 52.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.99 123.62 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 111.035 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.614 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -123.07 119.73 3.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.692 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.3 46.0 0.65 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.814 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 58.9 mt -102.02 159.43 15.37 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.749 -0.725 . . . . 0.0 111.918 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.48 177.09 4.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.38 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -75.4 1.56 13.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.496 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.12 -26.62 15.94 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' A' ' 13' ' ' LEU . 7.5 p -76.57 138.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.425 0.631 . . . . 0.0 111.228 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.452 ' O ' HD11 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -151.02 -175.05 4.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.322 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 39.9 t0 -62.16 -32.25 72.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.292 0.568 . . . . 0.0 109.617 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.75 -48.16 78.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -71.72 -43.86 69.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.178 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 6.4 mt -60.55 -36.83 79.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.668 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.3 OUTLIER -60.63 -56.24 23.74 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.18 178.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.0 -43.41 78.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.712 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' VAL . . . -71.77 -33.41 68.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.532 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 3.3 m-85 -95.95 -12.61 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.191 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.677 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -60.93 -40.27 72.85 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -57.29 -43.99 47.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.503 1.469 . . . . 0.0 111.018 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.532 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.7 m-85 -69.9 -26.03 63.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.82 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.47 136.59 2.12 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.434 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.0 m-20 -63.4 103.37 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.494 0.664 . . . . 0.0 111.157 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 27' ' ' ILE . 4.1 mp -56.01 149.53 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.289 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.43 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -115.44 -32.91 5.44 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.872 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.0 t0 -153.71 145.61 23.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.163 0.506 . . . . 0.0 111.892 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.418 ' CG1' HG23 ' A' ' 32' ' ' ILE . 41.5 mt -143.3 118.53 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.011 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -117.93 132.5 56.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.203 0.525 . . . . 0.0 111.611 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt -120.15 110.25 36.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.033 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.68 143.85 38.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.238 1.959 . . . . 0.0 112.503 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.88 -164.14 1.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.018 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 41' ' ' TYR . 1.5 m-20 -96.09 -17.6 20.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.39 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HB3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 81.39 -47.87 0.24 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.69 0.396 . . . . 0.0 110.326 -179.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 1.9 pt-20 -78.65 -41.23 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.535 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -111.75 -16.49 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.528 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.92 42.71 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.612 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 8.0 pttm -132.03 123.52 27.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.046 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -66.33 -175.71 0.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -118.09 -67.44 0.99 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.105 0.479 . . . . 0.0 110.15 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.814 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -175.9 37.83 0.1 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.252 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.5 m-85 -141.53 150.54 42.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.858 0.329 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.86 177.41 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.796 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -123.55 127.7 48.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.62 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.7 t -111.6 128.03 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -112.7 137.6 50.76 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 59' ' ' ASP . 83.3 m-85 -112.3 154.21 26.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.156 0.503 . . . . 0.0 110.734 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -75.01 -25.91 59.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.989 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 87.5 mt -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.538 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.583 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -60.6 -43.39 97.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.33 -30.15 70.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 8.6 m-20 -60.72 -43.51 97.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.273 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 6' ' ' ARG . . . -60.86 -46.56 90.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.761 0.315 . . . . 0.0 110.336 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.61 -33.92 61.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.521 . . . . 0.0 110.45 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -66.73 -45.31 79.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.856 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.28 -33.34 75.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.7 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 97.1 mt -66.12 -51.79 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.171 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -12.59 60.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.02 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.7 m-80 -105.15 -46.06 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.428 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 2.5 tpt -76.84 -30.02 56.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.7 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 5.0 t-20 -57.38 115.42 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mt-10 67.0 57.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 -166.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.531 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -135.98 125.56 25.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' A' ' 77' ' ' ILE . 4.7 tp -139.41 123.54 17.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 56.18 41.5 29.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.125 0.488 . . . . 0.0 110.142 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.77 65.95 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.449 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 mmt-85 -124.51 137.65 54.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.937 0.399 . . . . 0.0 111.758 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.4 m -84.38 119.96 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.985 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 72' ' ' LEU . 19.4 pt -113.26 152.86 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 0.0 111.589 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 15.9 ptp180 -131.49 136.87 48.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.027 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 97.3 t -117.33 152.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.081 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.4 m120 -148.21 164.21 34.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.455 ' HB3' HD13 ' A' ' 64' ' ' ILE . 1.2 pt? -101.44 110.12 22.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.145 0.498 . . . . 0.0 111.239 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.29 82.67 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.949 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 tttt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.851 -179.779 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.55 -53.17 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.704 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 p -117.21 121.29 40.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.624 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -126.13 -74.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.2 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -164.85 163.79 21.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.673 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 5' ' ' LYS . 11.0 mtm180 174.14 -34.06 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.959 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 m -86.67 134.39 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 111.556 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.449 HD13 ' CE1' ' A' ' 54' ' ' PHE . 10.9 mt -118.14 160.46 21.52 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.014 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.7 t80 -114.17 136.51 52.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.645 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.6 t -108.69 123.89 64.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.98 117.17 2.93 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.897 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 76' ' ' THR . . . 118.75 42.18 0.58 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.682 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 89.6 mt -97.99 -177.51 3.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.365 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.18 -172.35 2.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.547 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -82.42 2.92 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.565 0.222 . . . . 0.0 111.564 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.15 -30.24 13.62 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' A' ' 13' ' ' LEU . 13.2 p -69.0 142.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.718 0.77 . . . . 0.0 111.986 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 7.7 m-20 -155.18 175.12 14.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 6.4 p-10 -57.62 -29.78 64.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.609 ' HG2' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.28 -47.39 73.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.082 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.609 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -71.98 -44.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.52 HD22 ' CE1' ' A' ' 26' ' ' PHE . 1.3 mt -60.39 -36.25 77.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.584 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.646 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -59.17 -55.73 31.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.886 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.48 84.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.364 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.85 65.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.535 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 5.6 m-85 -97.01 -9.86 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.647 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.16 -39.81 67.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.45 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 26.9 Cg_endo -60.73 -41.93 42.81 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.309 1.339 . . . . 0.0 110.834 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.535 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.0 m-85 -68.28 -26.02 65.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.476 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.22 132.03 1.32 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 3.2 m-20 -56.36 110.21 0.73 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.521 0.676 . . . . 0.0 111.834 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 27' ' ' ILE . 3.3 mp -64.64 150.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.869 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -115.42 -34.81 4.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.661 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 2.3 m-20 -153.56 147.12 25.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 111.628 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.426 ' CG1' HG23 ' A' ' 32' ' ' ILE . 45.3 mt -141.19 118.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.866 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.76 129.83 53.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.888 0.375 . . . . 0.0 111.584 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.42 120.43 29.87 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.178 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.42 139.57 14.64 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.386 2.058 . . . . 0.0 113.036 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.88 -162.2 0.94 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.175 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.27 -16.94 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 82.81 -48.7 0.16 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.595 0.358 . . . . 0.0 110.823 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -78.64 -42.18 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.014 0.435 . . . . 0.0 110.487 179.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.591 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 14.4 t -111.34 2.9 17.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.437 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER 39.41 32.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 43' ' ' THR . 4.2 mttp -116.41 122.51 45.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.646 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -57.9 175.51 0.19 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.81 -67.44 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.818 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.74 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . 176.02 35.09 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 15.8 m-85 -145.92 150.65 36.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.004 0.402 . . . . 0.0 111.16 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.91 174.32 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 18.1 m-85 -119.03 129.12 54.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.442 HG11 ' CE1' ' A' ' 54' ' ' PHE . 2.8 t -108.63 129.09 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.535 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -112.54 136.61 51.87 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CE1' HD13 ' A' ' 8' ' ' LEU . 15.2 m-85 -111.73 157.46 20.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 0.0 111.497 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -74.89 -32.84 61.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.076 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 95.5 mt -113.5 117.39 31.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.395 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.27 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.684 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -66.5 -31.74 72.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.3 m-20 -61.21 -37.51 83.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.79 -41.63 82.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.11 -33.8 63.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.934 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.32 -45.25 73.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.202 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.43 ' HB1' ' CZ ' ' A' ' 54' ' ' PHE . . . -62.83 -37.54 87.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 55.2 mt -63.7 -52.26 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.189 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.36 -9.62 58.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.613 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 2.0 m120 -104.15 -39.25 6.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 26' ' ' PHE . 3.9 mmm -89.86 -19.59 24.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 6.2 p30 -57.92 116.1 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 25.9 mt-10 65.24 42.07 4.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.5 OUTLIER -105.39 -165.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.5 124.64 32.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.5 tp -139.38 129.86 25.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 55.09 28.4 10.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.3 4.49 89.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -119.93 160.45 22.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.429 0.633 . . . . 0.0 111.533 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.442 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 8.8 m -91.12 124.75 35.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.061 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -114.79 156.28 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.213 0.53 . . . . 0.0 111.325 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -133.52 138.79 46.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.831 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 96.7 t -116.96 150.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 111.117 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -157.81 164.48 36.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.962 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.434 ' HB3' ' H ' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -62.06 -105.68 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.467 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 81' ' ' LEU . . . 172.32 -53.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.848 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.9 m -131.27 -176.87 4.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.29 115.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.662 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.4 m -101.82 -40.68 6.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.239 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.03 145.18 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.124 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -139.98 -45.65 0.43 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.121 0.486 . . . . 0.0 109.971 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.4 m -86.31 132.03 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.658 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 13.2 mt -118.46 160.41 21.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.7 t80 -113.18 135.26 54.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.793 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 21.6 t -108.79 123.55 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.35 118.27 3.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.748 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.51 37.07 0.87 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.787 ' HB3' HG13 ' A' ' 17' ' ' VAL . 79.2 mt -91.42 -174.65 3.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.598 0.713 . . . . 0.0 112.233 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.46 -171.53 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.124 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -84.63 5.27 28.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.583 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -32.29 13.0 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.787 HG13 ' HB3' ' A' ' 13' ' ' LEU . 14.9 p -70.14 143.73 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.657 0.741 . . . . 0.0 112.213 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -153.3 179.5 8.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.823 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.42 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.192 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.03 -47.96 75.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 22' ' ' LEU . 1.4 p -71.86 -46.37 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.48 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 2.3 mt -60.78 -37.22 81.15 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.02 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.616 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 16.7 t-160 -57.14 -55.27 36.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.496 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.17 82.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.611 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' VAL . . . -70.88 -36.57 72.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.547 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 5.4 m-85 -95.78 -7.91 35.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.671 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -63.98 -39.62 46.71 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -58.68 -42.05 57.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.54 1.493 . . . . 0.0 111.012 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -72.03 -23.9 61.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.911 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.41 130.02 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 m-20 -57.18 107.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.365 0.602 . . . . 0.0 111.722 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.494 HD13 ' C ' ' A' ' 26' ' ' PHE . 2.8 mp -60.55 152.88 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.113 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -118.08 -32.74 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.793 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.57 145.65 23.71 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.112 0.482 . . . . 0.0 111.717 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 30.3 mt -141.52 118.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.312 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -118.73 129.27 55.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.064 0.459 . . . . 0.0 112.049 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.55 109.01 46.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.21 145.25 54.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.407 2.072 . . . . 0.0 113.198 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.78 -176.51 3.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.883 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -16.04 59.41 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.725 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER 74.44 1.47 3.85 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.58 -41.81 0.17 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.92 0.39 . . . . 0.0 110.505 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 p -100.87 -21.55 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 2.6 pt-20 40.28 62.38 1.33 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.706 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.93 -0.13 8.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.735 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 63.01 152.81 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.95 0.405 . . . . 0.0 111.15 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -114.67 -74.4 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.157 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.779 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 174.76 41.74 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.903 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.689 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.0 m-85 -142.32 150.62 41.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.166 0.483 . . . . 0.0 110.802 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.93 173.57 16.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.107 0.48 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 6.2 m-85 -120.0 129.91 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.29 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.75 128.33 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.657 0.265 . . . . 0.0 110.77 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.6 OUTLIER -115.44 136.77 52.75 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.455 ' CE1' HD12 ' A' ' 8' ' ' LEU . 9.4 m-85 -113.24 159.12 19.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.153 0.502 . . . . 0.0 111.317 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.87 -31.57 56.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.532 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 93.7 mt -113.61 120.2 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.64 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.2 -35.82 70.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.363 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.06 -30.85 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -66.25 -37.55 85.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.539 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.25 -41.54 84.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.096 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.81 54.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.09 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.69 -45.31 71.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.75 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 -36.3 83.07 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.71 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 63.6 mt -64.26 -53.1 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.702 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.68 -19.0 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.024 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 15.8 m-20 -94.0 -31.92 14.05 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.987 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.428 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 1.3 tpt -100.53 -15.8 17.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.71 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -50.5 111.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.733 0.302 . . . . 0.0 111.033 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 62.24 40.03 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 t -90.78 -168.29 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.456 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -127.13 125.6 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.403 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tp -139.32 125.36 19.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.299 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 58.18 35.78 25.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 109.916 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.38 75.66 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.244 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -126.61 143.95 51.06 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.155 0.502 . . . . 0.0 111.503 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.8 m -87.02 120.56 28.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.162 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.4 pt -112.45 159.13 12.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.163 0.506 . . . . 0.0 111.695 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 mtt-85 -127.53 135.94 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 97.9 t -116.94 152.16 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -156.45 161.49 40.06 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.382 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.78 103.55 14.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.95 169.97 13.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.999 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.87 -41.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.048 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.93 138.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.739 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 t -104.52 113.2 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.13 176.22 8.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -130.28 -0.05 4.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -111.61 118.57 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 111.015 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 17.1 mt -107.13 155.18 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.389 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 5.6 t80 -111.74 136.26 51.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.27 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 42.7 t -108.84 123.89 65.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.829 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.36 115.73 2.6 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.048 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.91 46.77 0.33 Allowed Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.826 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 54.9 mt -102.31 -176.06 3.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.615 0.722 . . . . 0.0 112.668 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.73 -172.73 3.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.491 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -83.42 6.14 21.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.567 0.222 . . . . 0.0 111.551 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.49 -21.82 16.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.794 0.33 . . . . 0.0 111.531 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 13' ' ' LEU . 12.3 p -82.0 153.36 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 111.441 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.5 m-20 -163.88 -178.6 5.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.152 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -63.73 -29.27 70.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.288 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -66.89 -48.48 68.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.3 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' CG1' HG22 ' A' ' 17' ' ' VAL . 2.2 p -71.74 -44.21 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.283 0.564 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 18' ' ' ASP . 1.7 mt -60.63 -33.7 73.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.347 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.618 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -59.88 -55.3 35.88 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 178.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.3 85.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.41 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -69.38 -32.85 72.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.545 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . 5.0 m-85 -99.86 -9.75 22.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.66 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.78 -39.58 61.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 24.5 Cg_endo -60.07 -41.84 48.93 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.393 1.395 . . . . 0.0 111.037 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.8 m-85 -72.0 -26.24 62.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.921 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.64 128.72 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.75 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.3 m-20 -59.02 104.24 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.471 0.653 . . . . 0.0 110.984 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 3.8 mp -58.93 154.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.894 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -124.24 -25.64 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.58 141.66 20.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.409 ' CG1' HG23 ' A' ' 32' ' ' ILE . 24.4 mt -143.31 118.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.318 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -127.29 128.31 45.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.981 0.419 . . . . 0.0 111.979 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 HG22 ' CD2' ' A' ' 46' ' ' HIS . 1.9 mp -109.98 111.61 58.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.951 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.36 143.22 57.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.323 2.016 . . . . 0.0 112.959 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HG ' ' CD2' ' A' ' 46' ' ' HIS . 1.7 mp -115.13 -173.59 2.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.746 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -80.06 -11.93 59.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 40' ' ' ASP . 3.9 m-85 73.87 -62.51 0.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.92 -54.06 15.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.373 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -92.1 -31.13 15.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.342 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 51.56 61.13 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -113.17 0.01 14.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.479 ' CD2' ' HG ' ' A' ' 39' ' ' LEU . 4.5 m80 62.97 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -105.1 -78.45 0.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.203 0.525 . . . . 0.0 110.172 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.826 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 172.91 40.65 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.924 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.64 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.6 m-85 -140.43 151.38 44.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.524 0.202 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.89 170.95 19.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -115.71 141.94 47.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.698 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 39.2 t -120.81 124.42 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -103.89 141.55 35.95 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.499 ' CD1' ' OD1' ' A' ' 59' ' ' ASP . 97.0 m-85 -124.5 153.12 42.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.146 0.498 . . . . 0.0 111.298 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.06 -31.4 62.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.104 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.494 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 65.6 mt -119.65 127.97 53.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.053 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.48 70.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.08 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.37 -35.15 63.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' CD1' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 59' ' ' ASP . . . -58.59 -41.38 85.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.534 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.26 -33.79 54.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.154 0.502 . . . . 0.0 110.67 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.03 -44.52 80.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.628 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.65 78.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 90.4 mt -67.1 -53.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.67 -16.22 59.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.016 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 29' ' ' PHE . 10.0 t-20 -99.86 -39.49 8.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 2.2 tpt -85.2 -22.47 28.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.757 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 10.9 t30 -53.38 113.63 1.22 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 66.96 49.64 1.13 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.68 -165.7 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -135.05 128.72 32.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.18 122.95 17.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.443 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 57.68 39.03 27.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.947 0.404 . . . . 0.0 110.024 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.0 13.75 69.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -120.66 137.8 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 m -75.63 120.51 21.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -110.98 152.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.29 0.566 . . . . 0.0 111.467 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 63.7 ttt180 -134.27 137.72 44.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.054 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 90.0 t -119.37 151.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 111.563 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 63.8 m-20 -157.9 164.5 36.83 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.601 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -1.73 15.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.734 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 72.53 149.51 0.1 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.844 0.354 . . . . 0.0 111.095 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.716 HD21 ' HB1' ' A' ' 60' ' ' ALA . 19.1 mt -112.98 160.9 17.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.922 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.3 t80 -114.87 136.93 52.56 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.763 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.491 HG11 HD21 ' A' ' 13' ' ' LEU . 18.1 t -108.39 123.59 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.681 0.277 . . . . 0.0 110.332 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.07 116.57 2.49 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.37 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.18 41.27 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.939 HD22 HG11 ' A' ' 17' ' ' VAL . 84.8 mt -95.03 -176.91 3.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.616 0.722 . . . . 0.0 112.749 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.56 -171.9 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.651 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.27 4.23 27.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.112 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.99 -21.28 16.32 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 13' ' ' LEU . 7.1 p -90.3 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 111.739 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.863 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -153.15 -174.74 5.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.972 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' HG21 ' A' ' 35' ' ' ILE . 3.9 p30 -64.36 -30.15 71.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 109.996 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -64.67 -48.63 74.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.88 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.63 -41.78 71.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.945 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 18' ' ' ASP . 2.2 mt -60.52 -35.57 76.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.693 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -60.3 -56.14 25.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.689 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.65 -40.35 84.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.293 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -70.63 -37.76 73.82 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.767 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.4 m-85 -95.52 -8.02 36.37 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.699 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.9 tp -63.29 -39.22 48.06 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.687 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.699 ' HD3' HG22 ' A' ' 27' ' ' ILE . 28.1 Cg_endo -61.8 -39.86 49.27 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.54 1.493 . . . . 0.0 111.331 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.544 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -74.41 -22.86 58.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.796 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 170.0 129.73 1.14 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.2 m-20 -60.19 104.06 0.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 111.27 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.689 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.9 mp -59.4 152.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.169 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 -31.76 4.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.852 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.93 146.32 23.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.431 -0.507 . . . . 0.0 112.004 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 32' ' ' ILE . 26.8 mt -141.96 118.54 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.885 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.44 130.47 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 112.156 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.617 178.77 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.76 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.684 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 9.1 m-85 -139.16 151.46 46.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 111.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 176.68 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.39 129.32 55.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 t -111.39 129.36 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.707 0.289 . . . . 0.0 110.772 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -114.12 137.9 51.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 24.2 m-85 -114.6 158.5 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.254 0.55 . . . . 0.0 111.637 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.79 -33.09 58.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.348 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 97.4 mt -113.03 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.857 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.44 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.735 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.43 -30.55 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.5 m-20 -61.05 -37.83 84.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.81 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.716 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.91 -41.76 88.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.746 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.04 -34.07 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.68 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.57 -45.7 71.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.954 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.75 87.44 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.746 HD12 ' HA ' ' A' ' 61' ' ' ALA . 95.5 mt -62.75 -50.94 77.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.829 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.6 -10.26 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.021 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.68 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.36 -45.04 4.78 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.01 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.469 ' HB2' HG21 ' A' ' 79' ' ' VAL . 13.6 mmt -83.62 -20.52 33.51 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 24.8 t-20 -61.53 113.63 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 65.41 39.26 5.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.7 -166.23 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.83 125.46 41.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 110.814 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.08 123.21 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 11.3 m-85 55.96 34.29 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 110.238 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 19.61 79.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.233 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -125.6 145.42 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 111.01 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -86.25 119.84 26.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.679 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.466 HD11 ' SD ' ' A' ' 67' ' ' MET . 12.6 pt -112.34 152.65 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 111.81 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -126.64 135.22 50.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.656 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 61.4 t -123.55 150.62 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.164 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -157.89 156.88 32.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.66 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.878 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 53' ' ' GLU . 2.5 m . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.615 HD11 ' HB1' ' A' ' 60' ' ' ALA . 9.6 mt -118.28 158.36 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.692 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.8 t80 -110.74 136.41 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 39.7 t -108.36 123.09 63.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.02 115.72 2.76 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.274 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 119.61 50.58 0.29 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 74.4 mt -107.49 -174.55 2.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.985 -0.608 . . . . 0.0 112.16 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.77 -167.13 1.93 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.41 -3.09 57.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.13 -31.71 20.28 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.644 HG11 HD13 ' A' ' 13' ' ' LEU . 9.1 p -73.03 144.04 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.619 0.723 . . . . 0.0 112.173 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.754 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -156.56 -178.91 7.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.936 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 42.0 t0 -62.9 -30.49 71.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.346 0.593 . . . . 0.0 110.386 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 7.8 pttp -67.15 -48.16 68.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.188 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -72.21 -44.92 63.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.081 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.843 HD23 ' CE1' ' A' ' 26' ' ' PHE . 1.6 mt -60.84 -38.14 84.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.701 ' HA ' HD13 ' A' ' 32' ' ' ILE . 19.0 t-80 -58.43 -55.33 36.43 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.998 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.34 76.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.645 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.4 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.843 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.9 m-85 -94.3 -11.27 30.44 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.754 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -59.87 -40.9 82.23 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.154 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.754 ' HD3' HG22 ' A' ' 27' ' ' ILE . 27.1 Cg_endo -60.97 -39.02 64.23 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.423 1.415 . . . . 0.0 110.808 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.626 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -73.29 -24.68 60.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.665 178.647 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.38 126.13 0.82 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.3 m-20 -54.39 105.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.237 0.541 . . . . 0.0 111.542 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' A' ' 26' ' ' PHE . 3.3 mp -63.53 151.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.799 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.37 -34.61 5.23 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.386 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -156.89 150.87 24.84 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.715 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 51' ' ' PHE . 28.1 mt -143.46 118.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.631 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.68 125.87 50.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.506 . . . . 0.0 111.918 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.173 178.315 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.768 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.768 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 17.0 m-85 -147.6 150.83 35.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.057 0.428 . . . . 0.0 111.139 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.04 170.04 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.257 0.551 . . . . 0.0 112.213 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -117.44 126.9 53.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.205 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.14 129.92 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.0 110.992 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.31 134.35 55.02 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 7.2 m-85 -107.71 161.18 15.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.13 0.49 . . . . 0.0 111.01 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.22 -29.48 57.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -123.73 131.33 53.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.82 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.284 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.87 -38.46 91.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.451 . . . . 0.0 110.819 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.4 m-20 -61.3 -37.49 83.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.615 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -58.14 -43.24 87.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.62 -33.63 55.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -65.98 -45.04 83.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.39 -35.54 80.76 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 61' ' ' ALA . 92.5 mt -63.46 -52.76 54.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.554 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.79 -10.63 59.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.841 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.9 t-20 -100.78 -41.39 6.89 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.51 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -88.76 -28.37 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 48.4 t30 -57.5 110.78 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 110.418 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.04 43.61 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.042 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.68 -161.57 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -132.22 124.47 29.02 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.609 ' HB2' HD12 ' A' ' 77' ' ' ILE . 7.7 tp -139.11 124.79 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 34.8 m-85 53.02 34.28 16.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.029 0.442 . . . . 0.0 110.59 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.0 12.05 84.3 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.729 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.78 143.4 51.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.17 0.509 . . . . 0.0 111.693 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.496 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 88.7 m -82.9 131.95 35.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.173 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -120.37 157.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.585 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 55.2 ttt180 -132.21 135.95 46.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.7 t -117.41 152.0 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 111.882 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -157.08 164.66 37.66 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.553 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.53 ' CD2' HD11 ' A' ' 64' ' ' ILE . 4.7 mt -122.84 160.6 25.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.6 t80 -110.31 136.35 49.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.316 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.94 122.83 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.99 113.84 2.04 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.057 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 120.84 46.41 0.34 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.115 HD22 HG11 ' A' ' 17' ' ' VAL . 67.6 mt -101.41 -176.76 3.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.307 0.575 . . . . 0.0 112.054 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.62 -171.71 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.925 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.36 0.0 34.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.68 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.5 -29.96 14.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.115 HG11 HD22 ' A' ' 13' ' ' LEU . 11.8 p -81.79 144.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.676 0.75 . . . . 0.0 111.579 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.667 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p30 -153.02 179.12 8.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.122 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 7.0 p-10 -58.89 -30.37 67.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.057 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.57 -47.55 72.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.798 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.5 -42.0 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.27 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.895 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.5 mt -60.34 -33.53 72.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.692 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -59.25 -55.7 31.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.637 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 27' ' ' ILE . . . -68.02 -44.53 76.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.427 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.01 93.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.895 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.4 m-85 -93.05 -10.36 36.4 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.685 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 tp -61.46 -40.24 69.61 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.818 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.685 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.85 -43.39 49.72 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.5 1.467 . . . . 0.0 111.333 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.7 m-85 -71.7 -21.25 61.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.01 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.6 131.72 1.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.523 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 m-20 -59.85 109.54 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.574 0.702 . . . . 0.0 111.554 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.0 mp -64.31 153.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.349 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -34.5 4.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.701 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -153.64 149.4 27.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 120.984 0.421 . . . . 0.0 111.672 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 19' ' ' ASP . 28.6 mt -143.7 120.1 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -121.1 126.59 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 111.364 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 49' ' ' PHE . 2.6 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.321 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.758 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.788 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.685 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.9 m-85 -144.54 151.26 38.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.004 0.402 . . . . 0.0 111.209 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.2 178.45 9.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.244 0.545 . . . . 0.0 112.004 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.5 m-85 -122.39 135.14 54.64 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.914 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.31 129.12 67.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -113.1 134.29 54.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 16.1 m-85 -109.08 160.64 15.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.393 0.616 . . . . 0.0 111.496 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 -30.85 51.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 88.4 mt -119.49 131.09 55.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.725 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -42.23 91.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.423 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.49 -32.38 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.0 m-20 -64.65 -38.33 90.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.592 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -59.32 -45.48 91.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.691 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.765 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.18 -33.7 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.441 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -67.26 -45.33 77.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.907 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.78 -34.71 78.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 96.7 mt -65.43 -52.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.445 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.42 -13.49 59.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.126 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 6.3 m-20 -99.34 -46.27 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.421 ' CE ' HD23 ' A' ' 72' ' ' LEU . 2.7 tpt -79.89 -23.29 41.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.776 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 11.0 t30 -56.84 114.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 110.795 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.82 30.05 2.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.1 OUTLIER -97.09 -174.47 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -137.79 130.04 29.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.719 0.295 . . . . 0.0 111.725 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 72' ' ' LEU . 4.4 pp -138.93 130.74 27.66 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 21' ' ' VAL . 41.9 m-85 58.65 40.59 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.104 0.478 . . . . 0.0 110.032 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.7 23.5 67.2 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.012 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -128.59 132.7 48.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 112.059 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.2 m -83.72 124.56 30.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.747 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.797 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -120.34 156.33 23.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.327 0.584 . . . . 0.0 111.697 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -129.85 137.64 50.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.661 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.8 t -121.05 151.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 t30 -157.98 164.41 36.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.257 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.529 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.466 HG13 ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.332 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.68 HD21 ' HB1' ' A' ' 60' ' ' ALA . 28.9 mt -118.18 155.29 30.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -110.05 133.45 53.19 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.87 123.53 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -123.11 121.53 4.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.957 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.16 38.88 0.91 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 17' ' ' VAL . 68.8 mt -93.56 179.11 5.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.83 0.824 . . . . 0.0 113.046 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -128.48 -175.21 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.328 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.43 -1.02 39.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.637 0.256 . . . . 0.0 111.26 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -37.22 14.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 13' ' ' LEU . 9.9 p -65.87 143.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.579 0.704 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.599 ' O ' HD12 ' A' ' 22' ' ' LEU . 17.9 p30 -151.89 178.31 9.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.856 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HA ' HG21 ' A' ' 35' ' ' ILE . 29.4 p-10 -61.69 -29.6 70.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.357 0.598 . . . . 0.0 109.551 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.76 -49.11 69.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.593 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.719 HG21 ' HZ ' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -71.72 -44.52 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.29 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.898 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mt -61.24 -34.24 74.81 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 109.579 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.709 ' HA ' HD13 ' A' ' 32' ' ' ILE . 25.8 t-80 -62.64 -54.91 32.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.584 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 27' ' ' ILE . . . -67.71 -41.52 83.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.897 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.68 75.91 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.898 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.9 m-85 -96.82 -9.4 28.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.696 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -61.29 -40.3 71.14 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.549 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.2 Cg_endo -57.38 -43.74 49.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.599 1.533 . . . . 0.0 111.162 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 3.3 m-85 -71.65 -24.08 61.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.029 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 169.95 129.82 1.14 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.48 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.494 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 16.3 m-20 -59.58 105.07 0.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.585 0.707 . . . . 0.0 111.23 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.4 mp -59.03 151.64 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.206 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.32 -32.55 5.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.679 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 9.7 t0 -155.07 146.67 23.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' CG1' HG21 ' A' ' 32' ' ' ILE . 42.9 mt -139.87 118.72 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.414 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -120.48 129.45 53.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.314 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 49' ' ' PHE . 4.6 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.723 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 19.0 m-85 -143.57 151.34 40.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 0.0 110.958 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 37' ' ' ILE . . . -153.83 176.2 12.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.384 0.611 . . . . 0.0 112.195 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 2.5 m-85 -124.34 125.53 44.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.211 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.2 t -107.13 124.98 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.551 0.215 . . . . 0.0 110.602 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -107.74 136.65 47.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' HG12 ' A' ' 52' ' ' VAL . 3.9 m-85 -114.17 158.59 21.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.027 0.441 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -77.17 -30.93 55.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.314 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 95.8 mt -115.01 124.68 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.664 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.71 -36.39 76.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.229 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.84 -31.93 68.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 110.486 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 7.6 m-20 -61.72 -38.03 86.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.68 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.55 -40.74 83.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.723 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.32 -34.24 56.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.252 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.66 -45.14 72.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.505 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -63.35 -35.02 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 61' ' ' ALA . 96.6 mt -66.98 -52.88 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.747 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.51 -12.67 60.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.894 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 7.0 t-20 -100.04 -29.35 12.58 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.603 ' HG3' HD11 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -104.49 -19.45 14.02 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 15.5 p-10 -52.76 113.42 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.02 45.34 4.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.749 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.09 -168.17 1.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.76 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 127.15 42.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.952 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' HG ' ' CD2' ' A' ' 73' ' ' PHE . 12.7 tp -139.47 123.78 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.719 ' HZ ' HG21 ' A' ' 21' ' ' VAL . 49.2 m-85 58.98 36.3 24.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 109.705 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.01 8.31 64.22 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.438 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 136.3 53.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.408 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -76.94 119.45 20.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.06 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.603 HD11 ' HG3' ' A' ' 67' ' ' MET . 22.4 pt -111.89 154.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 111.579 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.71 134.56 48.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.284 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 92.1 t -118.16 151.88 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.798 0.333 . . . . 0.0 111.666 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.7 t-20 -156.72 156.72 33.84 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.193 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.61 HG13 ' OE1' ' A' ' 53' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.924 0.392 . . . . 0.0 110.778 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.987 HD21 ' HB1' ' A' ' 60' ' ' ALA . 1.7 mt -115.36 157.91 23.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.783 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.663 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.7 t80 -116.25 137.31 52.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.47 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 79' ' ' VAL . 17.3 t -107.83 123.68 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -120.37 112.85 2.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.824 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.774 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 119.82 57.67 0.25 Allowed Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.957 HD22 HG11 ' A' ' 17' ' ' VAL . 48.0 mt -115.3 155.25 27.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -112.86 168.69 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.692 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -23.34 30.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.134 0.492 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 1.8 mt-10 -66.71 -38.51 86.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.462 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.957 HG11 HD22 ' A' ' 13' ' ' LEU . 12.1 p -74.52 142.75 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 111.593 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.899 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -155.29 -171.98 4.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.426 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.597 ' OD1' HD12 ' A' ' 35' ' ' ILE . 54.7 t0 -64.67 -30.64 71.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.562 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.448 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 9.4 ptmt -66.51 -48.64 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.624 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 17' ' ' VAL . 1.3 p -71.61 -43.61 70.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.311 0.576 . . . . 0.0 110.651 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.949 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.8 mt -60.21 -36.28 77.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.872 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.917 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -60.35 -55.63 31.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.06 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.92 80.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.827 . . . . 0.0 113.01 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.4 -31.92 67.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.949 ' CE1' HD23 ' A' ' 22' ' ' LEU . 2.6 m-85 -98.01 -12.5 21.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 23' ' ' HIS . 1.2 tp -61.76 -39.83 63.86 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.513 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.63 -44.57 40.36 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.233 1.289 . . . . 0.0 110.785 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -68.17 -22.1 64.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.921 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 162.12 133.47 1.48 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.488 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.0 m-20 -58.25 106.2 0.35 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.744 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.917 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.2 mp -57.72 149.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.887 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -114.7 -32.45 5.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.627 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.1 m-20 -154.92 145.27 22.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.988 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.597 HD12 ' OD1' ' A' ' 19' ' ' ASP . 31.0 mt -143.06 118.33 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.713 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -109.77 127.66 54.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.158 0.504 . . . . 0.0 112.098 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.411 178.624 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.763 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 23.6 m-85 -151.55 151.36 31.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.822 0.344 . . . . 0.0 111.507 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.83 174.82 13.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.935 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.3 m-85 -117.47 131.7 56.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.201 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.46 128.04 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.61 ' OE1' HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.11 136.94 52.56 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 6.6 m-85 -111.38 155.05 23.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.188 0.518 . . . . 0.0 111.103 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.12 -30.02 64.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.949 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.23 121.09 42.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.272 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.76 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.282 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -31.88 70.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.0 m-20 -68.07 -37.06 80.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.419 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.1 -44.22 87.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.962 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -52.57 -33.74 47.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.034 0.445 . . . . 0.0 110.37 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.42 -45.14 73.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.05 -34.68 78.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.951 HD11 HD22 ' A' ' 8' ' ' LEU . 93.2 mt -64.34 -52.38 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.086 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -78.22 -15.17 59.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.776 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 9.1 m120 -95.11 -48.9 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.493 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.3 tpt -73.75 -28.18 61.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.62 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 10.5 t-20 -60.7 121.93 13.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.171 0.51 . . . . 0.0 110.593 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 66.22 54.38 0.96 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.82 -166.57 1.46 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -131.03 124.95 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.8 tp -139.67 121.7 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 16' ' ' GLU . 34.2 m-85 58.47 40.56 23.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.217 0.532 . . . . 0.0 110.57 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.58 13.58 68.58 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.195 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -130.31 154.89 47.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -88.22 131.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 12' ' ' GLY . 29.6 pt -120.65 153.42 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 mmt180 -133.26 133.79 43.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.4 t -121.07 152.37 24.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.891 0.376 . . . . 0.0 111.283 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -158.01 160.06 37.06 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 tp . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.678 179.618 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG12 ' HD1' ' A' ' 51' ' ' PHE . 1.2 t . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.871 HD21 ' HB1' ' A' ' 60' ' ' ALA . 6.2 mt -118.8 153.74 33.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.963 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -109.2 135.64 49.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.981 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 25.0 t -108.91 123.45 64.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 110.396 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.3 123.21 5.06 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.726 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.96 48.74 0.71 Allowed Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.801 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 44.7 mt -105.79 -174.73 2.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.62 -0.79 . . . . 0.0 112.939 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.698 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -144.25 166.43 25.07 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.718 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -24.7 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.606 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.35 -40.16 96.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 13' ' ' LEU . 8.1 p -70.82 143.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.834 0.826 . . . . 0.0 112.518 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.568 ' H ' HG12 ' A' ' 21' ' ' VAL . 69.7 m-20 -156.02 175.97 13.27 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.789 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 10.0 p-10 -62.36 -28.94 70.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.87 -48.03 72.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.912 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 18' ' ' ASP . 3.8 p -72.57 -44.52 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 110.501 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.011 HD23 ' CE1' ' A' ' 26' ' ' PHE . 3.1 mt -60.25 -34.75 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.698 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.02 -55.51 24.97 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.784 178.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.88 79.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.436 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.01 58.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.011 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.9 m-85 -94.43 -9.06 36.79 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.815 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.696 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -62.59 -39.99 60.45 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.479 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HD3' HG22 ' A' ' 27' ' ' ILE . 23.6 Cg_endo -59.68 -42.65 44.81 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.387 1.391 . . . . 0.0 110.764 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -73.13 -23.68 60.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.876 178.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 171.36 132.69 1.52 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.624 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.0 m-20 -63.47 104.97 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.405 0.622 . . . . 0.0 111.303 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.6 mp -61.03 148.23 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.855 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.44 -34.13 5.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.514 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -153.71 149.61 27.68 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.405 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 51' ' ' PHE . 21.0 mt -143.37 121.07 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.081 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 127.03 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.853 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.608 178.686 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.801 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 13.2 m-85 -142.04 150.38 41.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.59 171.3 16.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.237 0.541 . . . . 0.0 112.007 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 35' ' ' ILE . 5.5 m-85 -121.82 126.6 49.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.88 124.24 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.516 0.198 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -111.38 136.51 50.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -113.64 157.17 22.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.343 0.592 . . . . 0.0 111.453 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -31.57 59.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.485 HD12 ' OD1' ' A' ' 59' ' ' ASP . 82.3 mt -115.54 126.81 54.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.388 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.34 87.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.712 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -30.73 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.485 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -64.5 -37.8 88.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.871 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.49 -45.04 89.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.37 -33.68 54.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.081 0.467 . . . . 0.0 110.656 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.05 -45.14 74.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.64 -34.13 76.43 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 61' ' ' ALA . 85.0 mt -67.13 -52.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.857 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.29 -13.99 60.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 8.5 m-20 -99.67 -36.38 9.51 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.508 ' HB3' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -91.63 -22.46 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 8.5 t30 -58.33 112.41 1.55 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 72.03 52.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.694 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.77 -172.47 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -121.57 127.0 50.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.297 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.594 ' HB2' HD13 ' A' ' 77' ' ' ILE . 3.4 tp -139.39 122.52 16.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.618 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 66.1 m-85 55.31 37.91 29.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.86 16.16 69.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.264 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 75' ' ' ARG . 1.6 mmt180 -124.29 146.07 49.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.105 0.479 . . . . 0.0 111.221 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -82.79 120.42 25.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.061 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 72' ' ' LEU . 19.0 pt -110.97 152.26 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.042 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -132.13 139.65 48.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.874 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.0 t -119.52 151.53 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.291 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.5 m120 -157.74 156.71 32.09 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.333 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.512 ' HG ' HD11 ' A' ' 64' ' ' ILE . 1.7 mt . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.652 0.263 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.616 HD21 ' HB1' ' A' ' 60' ' ' ALA . 12.7 mt -117.06 159.18 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.982 0.42 . . . . 0.0 111.396 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.7 t80 -113.16 136.29 52.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 79' ' ' VAL . 23.5 t -108.99 123.62 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.627 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -123.07 119.73 3.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.692 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 114.3 46.0 0.65 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.913 HD22 HG11 ' A' ' 17' ' ' VAL . 58.9 mt -102.02 159.43 15.37 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.749 -0.725 . . . . 0.0 111.918 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.798 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . . . -107.48 177.09 4.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -75.4 1.56 13.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.496 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.12 -26.62 15.94 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.913 HG11 HD22 ' A' ' 13' ' ' LEU . 7.5 p -76.57 138.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.425 0.631 . . . . 0.0 111.228 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -151.02 -175.05 4.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.322 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.609 ' OD1' HD12 ' A' ' 35' ' ' ILE . 39.9 t0 -62.16 -32.25 72.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.292 0.568 . . . . 0.0 109.617 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.75 -48.16 78.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.672 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.72 -43.86 69.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.178 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.008 HD23 ' CE1' ' A' ' 26' ' ' PHE . 6.4 mt -60.55 -36.83 79.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.702 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -60.63 -56.24 23.74 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.18 178.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.0 -43.41 78.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.712 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.41 68.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.008 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.3 m-85 -95.95 -12.61 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.191 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.7 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -60.93 -40.27 72.85 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -57.29 -43.99 47.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.503 1.469 . . . . 0.0 111.018 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.7 m-85 -69.9 -26.03 63.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.82 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.47 136.59 2.12 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.434 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.0 m-20 -63.4 103.37 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.494 0.664 . . . . 0.0 111.157 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.702 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.1 mp -56.01 149.53 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.289 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.44 -32.91 5.44 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.0 t0 -153.71 145.61 23.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.163 0.506 . . . . 0.0 111.892 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.609 HD12 ' OD1' ' A' ' 19' ' ' ASP . 41.5 mt -143.3 118.53 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.011 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -117.93 132.5 56.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.203 0.525 . . . . 0.0 111.611 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.033 179.212 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.813 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.5 m-85 -141.53 150.54 42.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.858 0.329 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.86 177.41 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.796 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -123.55 127.7 48.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.62 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.464 ' CG2' HD22 ' A' ' 22' ' ' LEU . 24.7 t -111.6 128.03 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -112.7 137.6 50.76 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 83.3 m-85 -112.3 154.21 26.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.156 0.503 . . . . 0.0 110.734 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -75.01 -25.91 59.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.989 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 87.5 mt -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.538 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.39 97.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.33 -30.15 70.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 8.6 m-20 -60.72 -43.51 97.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.273 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -60.86 -46.56 90.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.761 0.315 . . . . 0.0 110.336 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -54.61 -33.92 61.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.521 . . . . 0.0 110.45 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -66.73 -45.31 79.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.856 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -65.28 -33.34 75.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 61' ' ' ALA . 97.1 mt -66.12 -51.79 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.171 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -12.59 60.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.02 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.7 m-80 -105.15 -46.06 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.431 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 2.5 tpt -76.84 -30.02 56.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.734 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 5.0 t-20 -57.38 115.42 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mt-10 67.0 57.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 -166.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.531 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -135.98 125.56 25.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.41 123.54 17.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 21' ' ' VAL . 23.5 m-85 56.18 41.5 29.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.125 0.488 . . . . 0.0 110.142 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.77 65.95 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.449 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.798 ' HG3' ' HB2' ' A' ' 14' ' ' ALA . 37.9 mmt-85 -124.51 137.65 54.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.937 0.399 . . . . 0.0 111.758 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.4 m -84.38 119.96 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.985 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 12' ' ' GLY . 19.4 pt -113.26 152.86 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 0.0 111.589 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 15.9 ptp180 -131.49 136.87 48.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.027 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 97.3 t -117.33 152.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.081 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.4 m120 -148.21 164.21 34.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.2 pt? . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 121.145 0.498 . . . . 0.0 111.239 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.791 HD21 ' HB1' ' A' ' 60' ' ' ALA . 10.9 mt -118.14 160.46 21.52 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.014 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.7 t80 -114.17 136.51 52.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.645 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 13' ' ' LEU . 40.6 t -108.69 123.89 64.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.98 117.17 2.93 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.897 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 76' ' ' THR . . . 118.75 42.18 0.58 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.769 ' HB3' HG11 ' A' ' 17' ' ' VAL . 89.6 mt -97.99 -177.51 3.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.365 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -130.18 -172.35 2.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.547 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -82.42 2.92 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.565 0.222 . . . . 0.0 111.564 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.15 -30.24 13.62 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' A' ' 13' ' ' LEU . 13.2 p -69.0 142.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.718 0.77 . . . . 0.0 111.986 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.836 ' O ' HD12 ' A' ' 22' ' ' LEU . 7.7 m-20 -155.18 175.12 14.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 6.4 p-10 -57.62 -29.78 64.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HG2' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.28 -47.39 73.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.082 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.623 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -71.98 -44.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 18' ' ' ASP . 1.3 mt -60.39 -36.25 77.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.584 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.91 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -59.17 -55.73 31.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.886 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.48 84.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.364 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.85 65.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.641 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.6 m-85 -97.01 -9.86 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.16 -39.81 67.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.45 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 26.9 Cg_endo -60.73 -41.93 42.81 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.309 1.339 . . . . 0.0 110.834 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.0 m-85 -68.28 -26.02 65.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.476 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.22 132.03 1.32 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 3.2 m-20 -56.36 110.21 0.73 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.521 0.676 . . . . 0.0 111.834 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.91 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.3 mp -64.64 150.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.869 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.42 -34.81 4.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.661 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 2.3 m-20 -153.56 147.12 25.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 111.628 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 32' ' ' ILE . 45.3 mt -141.19 118.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.866 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.76 129.83 53.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.888 0.375 . . . . 0.0 111.584 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 50' ' ' ALA . 3.0 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.178 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.74 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 120.06 -0.3 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 15.8 m-85 -145.92 150.65 36.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.004 0.402 . . . . 0.0 111.16 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' A' ' 37' ' ' ILE . . . -156.91 174.32 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 18.1 m-85 -119.03 129.12 54.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.63 129.09 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.535 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -112.54 136.61 51.87 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 15.2 m-85 -111.73 157.46 20.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 0.0 111.497 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -74.89 -32.84 61.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.076 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.624 HD12 ' OD2' ' A' ' 59' ' ' ASP . 95.5 mt -113.5 117.39 31.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.395 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.27 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.684 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -66.5 -31.74 72.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.624 ' OD2' HD12 ' A' ' 56' ' ' LEU . 2.3 m-20 -61.21 -37.51 83.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.791 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -57.79 -41.63 82.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.737 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -55.11 -33.8 63.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.934 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.32 -45.25 73.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.202 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -62.83 -37.54 87.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.737 HD12 ' HA ' ' A' ' 61' ' ' ALA . 55.2 mt -63.7 -52.26 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.189 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.409 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 1.1 m-20 -73.36 -9.62 58.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.613 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 2.0 m120 -104.15 -39.25 6.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.528 ' HE3' ' CZ ' ' A' ' 26' ' ' PHE . 3.9 mmm -89.86 -19.59 24.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 65' ' ' ASP . 6.2 p30 -57.92 116.1 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 25.9 mt-10 65.24 42.07 4.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.5 OUTLIER -105.39 -165.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.5 124.64 32.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 77' ' ' ILE . 3.5 tp -139.38 129.86 25.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 55.09 28.4 10.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.3 4.49 89.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 14' ' ' ALA . 1.2 mtt85 -119.93 160.45 22.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.429 0.633 . . . . 0.0 111.533 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 8.8 m -91.12 124.75 35.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.061 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.783 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -114.79 156.28 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.213 0.53 . . . . 0.0 111.325 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -133.52 138.79 46.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.831 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 96.7 t -116.96 150.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 111.117 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -157.81 164.48 36.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.962 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.467 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 53' ' ' GLU . 10.4 m . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.868 0.366 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.507 HD11 ' HB1' ' A' ' 60' ' ' ALA . 13.2 mt -118.46 160.41 21.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.7 t80 -113.18 135.26 54.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.793 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 21.6 t -108.79 123.55 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.35 118.27 3.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.748 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.51 37.07 0.87 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 79.2 mt -91.42 -174.65 3.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.598 0.713 . . . . 0.0 112.233 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . . . -132.46 -171.53 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.124 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -84.63 5.27 28.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.583 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -32.29 13.0 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 13' ' ' LEU . 14.9 p -70.14 143.73 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.657 0.741 . . . . 0.0 112.213 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.733 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -153.3 179.5 8.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.823 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 2.6 p30 -62.42 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.192 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.03 -47.96 75.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 1.4 p -71.86 -46.37 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.899 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.3 mt -60.78 -37.22 81.15 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.02 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.931 ' HA ' HD13 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -57.14 -55.27 36.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.496 178.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.17 82.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.611 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.57 72.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.899 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.4 m-85 -95.78 -7.91 35.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.691 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -63.98 -39.62 46.71 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -58.68 -42.05 57.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.54 1.493 . . . . 0.0 111.012 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -72.03 -23.9 61.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.911 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.41 130.02 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 m-20 -57.18 107.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.365 0.602 . . . . 0.0 111.722 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.931 HD13 ' HA ' ' A' ' 23' ' ' HIS . 2.8 mp -60.55 152.88 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.113 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -32.74 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.793 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.57 145.65 23.71 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.112 0.482 . . . . 0.0 111.717 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 32' ' ' ILE . 30.3 mt -141.52 118.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.312 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -118.73 129.27 55.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.064 0.459 . . . . 0.0 112.049 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.947 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.779 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.903 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.689 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.0 m-85 -142.32 150.62 41.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.166 0.483 . . . . 0.0 110.802 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.93 173.57 16.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.107 0.48 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 6.2 m-85 -120.0 129.91 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.29 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.75 128.33 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.657 0.265 . . . . 0.0 110.77 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -115.44 136.77 52.75 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -113.24 159.12 19.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.153 0.502 . . . . 0.0 111.317 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.87 -31.57 56.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.532 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 93.7 mt -113.61 120.2 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.64 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.2 -35.82 70.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.363 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.06 -30.85 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.522 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -66.25 -37.55 85.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.25 -41.54 84.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.096 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.16 -33.81 54.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.09 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.69 -45.31 71.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.75 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 -36.3 83.07 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.715 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 63.6 mt -64.26 -53.1 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.702 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.68 -19.0 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.024 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 15.8 m-20 -94.0 -31.92 14.05 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.987 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.767 ' HG3' HD11 ' A' ' 77' ' ' ILE . 1.3 tpt -100.53 -15.8 17.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.715 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -50.5 111.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.733 0.302 . . . . 0.0 111.033 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 62.24 40.03 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 t -90.78 -168.29 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.456 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -127.13 125.6 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.403 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tp -139.32 125.36 19.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.299 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 79.7 m-85 58.18 35.78 25.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 109.916 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.38 75.66 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.244 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.402 ' CD ' ' HB2' ' A' ' 14' ' ' ALA . 6.2 mmt180 -126.61 143.95 51.06 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.155 0.502 . . . . 0.0 111.503 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.8 m -87.02 120.56 28.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.162 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.767 HD11 ' HG3' ' A' ' 67' ' ' MET . 7.4 pt -112.45 159.13 12.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.163 0.506 . . . . 0.0 111.695 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 mtt-85 -127.53 135.94 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 67' ' ' MET . 97.9 t -116.94 152.16 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -156.45 161.49 40.06 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.382 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.671 HG13 ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 17.1 mt -107.13 155.18 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.389 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 5.6 t80 -111.74 136.26 51.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.27 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 42.7 t -108.84 123.89 65.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.829 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.36 115.73 2.6 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.048 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.91 46.77 0.33 Allowed Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.833 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 54.9 mt -102.31 -176.06 3.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.615 0.722 . . . . 0.0 112.668 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -134.73 -172.73 3.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.491 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -83.42 6.14 21.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.567 0.222 . . . . 0.0 111.551 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.49 -21.82 16.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.794 0.33 . . . . 0.0 111.531 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.701 HG11 HD13 ' A' ' 13' ' ' LEU . 12.3 p -82.0 153.36 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 111.441 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.741 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.5 m-20 -163.88 -178.6 5.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.152 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.731 ' HA ' HG21 ' A' ' 35' ' ' ILE . 1.4 p30 -63.73 -29.27 70.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.288 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -66.89 -48.48 68.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.3 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 18' ' ' ASP . 2.2 p -71.74 -44.21 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.283 0.564 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.98 HD23 ' CE1' ' A' ' 26' ' ' PHE . 1.7 mt -60.63 -33.7 73.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.347 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.715 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -59.88 -55.3 35.88 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 178.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.3 85.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.41 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -69.38 -32.85 72.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.98 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.0 m-85 -99.86 -9.75 22.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.684 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.78 -39.58 61.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 24.5 Cg_endo -60.07 -41.84 48.93 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.393 1.395 . . . . 0.0 111.037 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CE1' ' ND2' ' A' ' 66' ' ' ASN . 1.8 m-85 -72.0 -26.24 62.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.921 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.64 128.72 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.75 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.3 m-20 -59.02 104.24 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.471 0.653 . . . . 0.0 110.984 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.715 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.8 mp -58.93 154.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.894 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 -25.64 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.58 141.66 20.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.731 HG21 ' HA ' ' A' ' 19' ' ' ASP . 24.4 mt -143.31 118.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.318 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -127.29 128.31 45.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.981 0.419 . . . . 0.0 111.979 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 49' ' ' PHE . 1.9 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.951 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.833 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.64 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.6 m-85 -140.43 151.38 44.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.524 0.202 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.89 170.95 19.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -115.71 141.94 47.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.698 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 39.2 t -120.81 124.42 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HG2' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -103.89 141.55 35.95 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.499 ' CD1' ' OD1' ' A' ' 59' ' ' ASP . 97.0 m-85 -124.5 153.12 42.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.146 0.498 . . . . 0.0 111.298 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.06 -31.4 62.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.104 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 65.6 mt -119.65 127.97 53.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.053 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.48 70.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.08 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.37 -35.15 63.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' CD1' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 59' ' ' ASP . . . -58.59 -41.38 85.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.534 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.26 -33.79 54.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.154 0.502 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.03 -44.52 80.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.628 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.65 78.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.774 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 90.4 mt -67.1 -53.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.67 -16.22 59.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.016 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.565 ' ND2' ' CE1' ' A' ' 29' ' ' PHE . 33.4 t30 -99.86 -39.49 8.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 79' ' ' VAL . 2.2 tpt -85.2 -22.47 28.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.774 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 10.9 t30 -53.38 113.63 1.22 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 66.96 49.64 1.13 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.68 -165.7 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -135.05 128.72 32.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB2' HD13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -139.18 122.95 17.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.443 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 57.68 39.03 27.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.947 0.404 . . . . 0.0 110.024 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.0 13.75 69.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -120.66 137.8 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 m -75.63 120.51 21.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 72' ' ' LEU . 22.3 pt -110.98 152.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.29 0.566 . . . . 0.0 111.467 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 63.7 ttt180 -134.27 137.72 44.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.054 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 90.0 t -119.37 151.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 111.563 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 63.8 m-20 -157.9 164.5 36.83 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.601 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.734 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 24.9 m 58.26 90.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.763 0.316 . . . . 0.0 110.911 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.436 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.5 m -92.34 -56.18 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 p 50.72 70.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' A' ' 3' ' ' THR . 9.9 mmmt -139.63 -171.54 3.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.758 0.313 . . . . 0.0 110.777 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -133.46 -5.05 2.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.569 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.703 HG23 ' HB3' ' A' ' 82' ' ' ALA . 1.9 m -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.504 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.716 HD21 ' HB1' ' A' ' 60' ' ' ALA . 19.1 mt -112.98 160.9 17.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.922 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.3 t80 -114.87 136.93 52.56 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.763 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.491 HG11 HD21 ' A' ' 13' ' ' LEU . 18.1 t -108.39 123.59 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.681 0.277 . . . . 0.0 110.332 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.07 116.57 2.49 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.37 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.18 41.27 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.939 HD22 HG11 ' A' ' 17' ' ' VAL . 84.8 mt -95.03 -176.91 3.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.616 0.722 . . . . 0.0 112.749 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.56 -171.9 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.651 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.27 4.23 27.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.112 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.99 -21.28 16.32 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 13' ' ' LEU . 7.1 p -90.3 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 111.739 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.863 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -153.15 -174.74 5.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.972 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' HG21 ' A' ' 35' ' ' ILE . 3.9 p30 -64.36 -30.15 71.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 109.996 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -64.67 -48.63 74.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.88 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.63 -41.78 71.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.945 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 18' ' ' ASP . 2.2 mt -60.52 -35.57 76.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.693 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -60.3 -56.14 25.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.689 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.65 -40.35 84.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.293 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -70.63 -37.76 73.82 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.767 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.4 m-85 -95.52 -8.02 36.37 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.699 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.9 tp -63.29 -39.22 48.06 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.687 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.699 ' HD3' HG22 ' A' ' 27' ' ' ILE . 28.1 Cg_endo -61.8 -39.86 49.27 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.54 1.493 . . . . 0.0 111.331 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.544 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -74.41 -22.86 58.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.796 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 170.0 129.73 1.14 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.2 m-20 -60.19 104.06 0.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 111.27 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.689 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.9 mp -59.4 152.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.169 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 -31.76 4.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.852 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.93 146.32 23.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.431 -0.507 . . . . 0.0 112.004 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 32' ' ' ILE . 26.8 mt -141.96 118.54 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.885 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.44 130.47 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 112.156 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -121.49 108.17 35.87 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.617 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' O ' ' CD2' ' A' ' 46' ' ' HIS . 72.5 Cg_endo -76.72 154.62 34.7 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.489 2.126 . . . . 0.0 113.166 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.518 HD22 ' O ' ' A' ' 44' ' ' GLU . 1.2 mt -137.98 168.63 19.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 10.0 m-20 -83.47 -178.89 7.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 42' ' ' GLU . 24.6 p90 -107.71 -30.8 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.717 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 41' ' ' TYR . 4.9 mt-10 -87.24 -32.9 19.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -114.59 -23.29 9.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.452 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' O ' HD22 ' A' ' 39' ' ' LEU . 11.7 pt-20 45.9 36.21 2.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.58 120.86 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.465 ' N ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -68.45 -168.38 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.52 -47.85 3.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.406 0.622 . . . . 0.0 109.36 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.76 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 159.31 45.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.672 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 9.1 m-85 -139.16 151.46 46.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 111.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 176.68 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.39 129.32 55.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 t -111.39 129.36 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.707 0.289 . . . . 0.0 110.772 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -114.12 137.9 51.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 24.2 m-85 -114.6 158.5 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.254 0.55 . . . . 0.0 111.637 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.79 -33.09 58.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.348 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 97.4 mt -113.03 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.857 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . . . -56.12 -43.44 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.735 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.43 -30.55 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.5 m-20 -61.05 -37.83 84.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.81 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.716 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.91 -41.76 88.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.746 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.04 -34.07 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.68 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.57 -45.7 71.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.954 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.75 87.44 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.746 HD12 ' HA ' ' A' ' 61' ' ' ALA . 95.5 mt -62.75 -50.94 77.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.829 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.6 -10.26 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.021 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.68 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.36 -45.04 4.78 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.01 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.469 ' HB2' HG21 ' A' ' 79' ' ' VAL . 13.6 mmt -83.62 -20.52 33.51 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 24.8 t-20 -61.53 113.63 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 65.41 39.26 5.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.7 -166.23 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.83 125.46 41.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 110.814 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.08 123.21 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 11.3 m-85 55.96 34.29 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 110.238 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 19.61 79.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.233 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -125.6 145.42 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 111.01 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -86.25 119.84 26.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.679 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.466 HD11 ' SD ' ' A' ' 67' ' ' MET . 12.6 pt -112.34 152.65 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 111.81 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -126.64 135.22 50.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.656 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 61.4 t -123.55 150.62 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.164 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -157.89 156.88 32.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.66 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -76.52 123.36 25.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.878 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 7' ' ' VAL . . . -62.66 175.72 0.77 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.62 146.94 44.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.21 -26.18 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.507 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 m -125.52 159.39 32.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.005 0.431 . . . . 0.0 111.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -136.46 154.55 50.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER 165.58 -24.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 53' ' ' GLU . 2.5 m -82.98 134.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 111.139 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.615 HD11 ' HB1' ' A' ' 60' ' ' ALA . 9.6 mt -118.28 158.36 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.692 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.8 t80 -110.74 136.41 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 39.7 t -108.36 123.09 63.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.02 115.72 2.76 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.274 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 119.61 50.58 0.29 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 74.4 mt -107.49 -174.55 2.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.985 -0.608 . . . . 0.0 112.16 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.77 -167.13 1.93 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.41 -3.09 57.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.13 -31.71 20.28 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.644 HG11 HD13 ' A' ' 13' ' ' LEU . 9.1 p -73.03 144.04 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.619 0.723 . . . . 0.0 112.173 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.754 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -156.56 -178.91 7.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.936 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 42.0 t0 -62.9 -30.49 71.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.346 0.593 . . . . 0.0 110.386 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 7.8 pttp -67.15 -48.16 68.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.188 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -72.21 -44.92 63.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.081 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.843 HD23 ' CE1' ' A' ' 26' ' ' PHE . 1.6 mt -60.84 -38.14 84.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.701 ' HA ' HD13 ' A' ' 32' ' ' ILE . 19.0 t-80 -58.43 -55.33 36.43 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.998 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.34 76.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.645 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.4 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.843 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.9 m-85 -94.3 -11.27 30.44 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.754 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -59.87 -40.9 82.23 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.154 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.754 ' HD3' HG22 ' A' ' 27' ' ' ILE . 27.1 Cg_endo -60.97 -39.02 64.23 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.423 1.415 . . . . 0.0 110.808 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.626 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -73.29 -24.68 60.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.665 178.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.38 126.13 0.82 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.3 m-20 -54.39 105.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.237 0.541 . . . . 0.0 111.542 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' A' ' 26' ' ' PHE . 3.3 mp -63.53 151.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.799 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.37 -34.61 5.23 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.386 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -156.89 150.87 24.84 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.715 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 51' ' ' PHE . 28.1 mt -143.46 118.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.631 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.68 125.87 50.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.506 . . . . 0.0 111.918 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.679 HG22 ' CD2' ' A' ' 46' ' ' HIS . 4.3 mt -110.58 108.02 58.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.173 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.35 77.12 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.449 2.099 . . . . 0.0 113.164 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 46' ' ' HIS . 1.2 mt -77.09 -179.96 5.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.463 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 12.4 m-20 -86.83 167.66 14.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -101.07 -22.64 14.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.017 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.0 -35.08 15.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.1 p -120.82 -28.25 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.654 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' O ' HD22 ' A' ' 39' ' ' LEU . 15.6 mt-10 59.91 46.54 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.223 0.535 . . . . 0.0 110.197 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -128.96 119.1 23.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.429 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.679 ' CD2' HG22 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -79.65 -169.05 1.78 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.504 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -119.64 -45.24 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.973 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.768 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . 161.99 47.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.779 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.768 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 17.0 m-85 -147.6 150.83 35.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.057 0.428 . . . . 0.0 111.139 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.04 170.04 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.257 0.551 . . . . 0.0 112.213 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -117.44 126.9 53.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.205 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.14 129.92 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.0 110.992 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.31 134.35 55.02 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 7.2 m-85 -107.71 161.18 15.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.13 0.49 . . . . 0.0 111.01 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.22 -29.48 57.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -123.73 131.33 53.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.82 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.284 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.87 -38.46 91.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.451 . . . . 0.0 110.819 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.4 m-20 -61.3 -37.49 83.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.615 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -58.14 -43.24 87.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.62 -33.63 55.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -65.98 -45.04 83.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.39 -35.54 80.76 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 61' ' ' ALA . 92.5 mt -63.46 -52.76 54.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.554 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.79 -10.63 59.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.841 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.9 t-20 -100.78 -41.39 6.89 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.51 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -88.76 -28.37 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 48.4 t30 -57.5 110.78 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 110.418 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.04 43.61 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.042 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.68 -161.57 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -132.22 124.47 29.02 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.609 ' HB2' HD12 ' A' ' 77' ' ' ILE . 7.7 tp -139.11 124.79 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 34.8 m-85 53.02 34.28 16.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.029 0.442 . . . . 0.0 110.59 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.0 12.05 84.3 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.729 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.78 143.4 51.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.17 0.509 . . . . 0.0 111.693 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.496 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 88.7 m -82.9 131.95 35.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.173 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -120.37 157.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.585 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 55.2 ttt180 -132.21 135.95 46.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.7 t -117.41 152.0 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 111.882 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -157.08 164.66 37.66 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 35.65 0.56 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.553 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.13 167.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.53 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.696 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.4 t -139.36 113.94 9.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.498 ' O ' HG22 ' A' ' 4' ' ' THR . 5.3 t -129.44 -11.21 4.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.757 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 3' ' ' THR . 8.8 t 45.18 34.29 1.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.562 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.73 -93.47 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.43 -35.95 0.0 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.041 0.448 . . . . 0.0 110.401 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 m -83.32 132.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.53 ' CD2' HD11 ' A' ' 64' ' ' ILE . 4.7 mt -122.84 160.6 25.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.6 t80 -110.31 136.35 49.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.316 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.94 122.83 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.99 113.84 2.04 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.057 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 120.84 46.41 0.34 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.115 HD22 HG11 ' A' ' 17' ' ' VAL . 67.6 mt -101.41 -176.76 3.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.307 0.575 . . . . 0.0 112.054 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.62 -171.71 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.925 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.36 0.0 34.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.68 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.5 -29.96 14.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.115 HG11 HD22 ' A' ' 13' ' ' LEU . 11.8 p -81.79 144.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.676 0.75 . . . . 0.0 111.579 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.667 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p30 -153.02 179.12 8.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.122 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 7.0 p-10 -58.89 -30.37 67.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.057 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.57 -47.55 72.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.798 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.5 -42.0 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.27 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.895 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.5 mt -60.34 -33.53 72.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.692 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -59.25 -55.7 31.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.637 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 27' ' ' ILE . . . -68.02 -44.53 76.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.427 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.01 93.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.895 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.4 m-85 -93.05 -10.36 36.4 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.685 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 tp -61.46 -40.24 69.61 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.818 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.685 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.85 -43.39 49.72 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.5 1.467 . . . . 0.0 111.333 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.7 m-85 -71.7 -21.25 61.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.01 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.6 131.72 1.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.523 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 m-20 -59.85 109.54 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.574 0.702 . . . . 0.0 111.554 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.0 mp -64.31 153.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.349 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -34.5 4.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.701 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -153.64 149.4 27.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 120.984 0.421 . . . . 0.0 111.672 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 19' ' ' ASP . 28.6 mt -143.7 120.1 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -121.1 126.59 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 111.364 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 49' ' ' PHE . 2.6 mt -111.65 108.19 56.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.321 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.21 125.79 14.19 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.123 . . . . 0.0 113.169 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 46' ' ' HIS . 2.0 mt -132.44 174.85 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.533 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.61 165.23 14.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.523 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -97.12 -24.29 15.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.01 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -100.72 -29.79 12.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.062 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 45' ' ' LYS . 65.8 p -112.4 -31.4 6.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.24 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.7 mt-10 57.59 37.67 27.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 111.237 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 7.2 mttp -114.23 114.33 25.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.703 ' N ' HD23 ' A' ' 39' ' ' LEU . 4.5 p80 -70.97 -179.8 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 110.852 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -63.7 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.834 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.758 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 172.85 38.17 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.375 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.685 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.9 m-85 -144.54 151.26 38.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.004 0.402 . . . . 0.0 111.209 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.2 178.45 9.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.244 0.545 . . . . 0.0 112.004 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.5 m-85 -122.39 135.14 54.64 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.914 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.31 129.12 67.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -113.1 134.29 54.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 16.1 m-85 -109.08 160.64 15.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.393 0.616 . . . . 0.0 111.496 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 -30.85 51.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 88.4 mt -119.49 131.09 55.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.725 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -42.23 91.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.423 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.49 -32.38 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.0 m-20 -64.65 -38.33 90.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.592 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -59.32 -45.48 91.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.691 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.765 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.18 -33.7 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.441 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -67.26 -45.33 77.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.907 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.78 -34.71 78.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 96.7 mt -65.43 -52.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.445 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.42 -13.49 59.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.126 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 6.3 m-20 -99.34 -46.27 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.421 ' CE ' HD23 ' A' ' 72' ' ' LEU . 2.7 tpt -79.89 -23.29 41.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.776 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 11.0 t30 -56.84 114.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 110.795 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.82 30.05 2.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.1 OUTLIER -97.09 -174.47 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -137.79 130.04 29.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.719 0.295 . . . . 0.0 111.725 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 72' ' ' LEU . 4.4 pp -138.93 130.74 27.66 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 21' ' ' VAL . 41.9 m-85 58.65 40.59 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.104 0.478 . . . . 0.0 110.032 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.7 23.5 67.2 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.012 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -128.59 132.7 48.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 112.059 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.2 m -83.72 124.56 30.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.747 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.797 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -120.34 156.33 23.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.327 0.584 . . . . 0.0 111.697 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -129.85 137.64 50.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.661 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.8 t -121.05 151.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 t30 -157.98 164.41 36.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.257 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -77.87 -24.55 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.529 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.12 160.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.1 mttp . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.812 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.102 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 5.2 m 62.91 159.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -128.12 -77.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.813 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m 59.09 92.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.18 101.19 13.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.378 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 8.2 mtp180 -134.63 1.59 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -123.68 131.17 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.332 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.68 HD21 ' HB1' ' A' ' 60' ' ' ALA . 28.9 mt -118.18 155.29 30.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -110.05 133.45 53.19 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.87 123.53 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -123.11 121.53 4.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.957 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.16 38.88 0.91 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 17' ' ' VAL . 68.8 mt -93.56 179.11 5.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.83 0.824 . . . . 0.0 113.046 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -128.48 -175.21 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.328 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.43 -1.02 39.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.637 0.256 . . . . 0.0 111.26 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -37.22 14.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 13' ' ' LEU . 9.9 p -65.87 143.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.579 0.704 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.599 ' O ' HD12 ' A' ' 22' ' ' LEU . 17.9 p30 -151.89 178.31 9.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.856 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HA ' HG21 ' A' ' 35' ' ' ILE . 29.4 p-10 -61.69 -29.6 70.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.357 0.598 . . . . 0.0 109.551 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.76 -49.11 69.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.593 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.719 HG21 ' HZ ' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -71.72 -44.52 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.29 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.898 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mt -61.24 -34.24 74.81 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 109.579 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.709 ' HA ' HD13 ' A' ' 32' ' ' ILE . 25.8 t-80 -62.64 -54.91 32.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.584 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 27' ' ' ILE . . . -67.71 -41.52 83.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.897 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.68 75.91 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.898 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.9 m-85 -96.82 -9.4 28.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.696 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -61.29 -40.3 71.14 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.549 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.2 Cg_endo -57.38 -43.74 49.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.599 1.533 . . . . 0.0 111.162 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 3.3 m-85 -71.65 -24.08 61.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.029 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 169.95 129.82 1.14 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.48 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.494 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 16.3 m-20 -59.58 105.07 0.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.585 0.707 . . . . 0.0 111.23 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.4 mp -59.03 151.64 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.206 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.32 -32.55 5.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.679 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 9.7 t0 -155.07 146.67 23.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' CG1' HG21 ' A' ' 32' ' ' ILE . 42.9 mt -139.87 118.72 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.414 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -120.48 129.45 53.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.314 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 49' ' ' PHE . 4.6 mt -115.05 108.19 48.72 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -44.82 125.69 6.73 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.869 2.379 . . . . 0.0 113.505 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 46' ' ' HIS . 1.9 mt -135.2 164.42 27.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.721 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 5.8 m-20 -87.32 170.37 11.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.772 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -98.6 -33.29 11.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.13 -23.32 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.62 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -116.93 -20.13 9.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.629 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 37.19 38.69 0.12 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.62 ' HG3' ' O ' ' A' ' 43' ' ' THR . 8.6 mttp -117.32 109.39 16.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.485 ' N ' HD23 ' A' ' 39' ' ' LEU . 41.1 p-80 -64.88 -179.89 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.782 0.325 . . . . 0.0 110.542 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -115.03 -65.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.074 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.723 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 177.26 40.1 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.284 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 19.0 m-85 -143.57 151.34 40.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 0.0 110.958 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 37' ' ' ILE . . . -153.83 176.2 12.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.384 0.611 . . . . 0.0 112.195 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 2.5 m-85 -124.34 125.53 44.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.211 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.2 t -107.13 124.98 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.551 0.215 . . . . 0.0 110.602 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -107.74 136.65 47.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' HG12 ' A' ' 52' ' ' VAL . 3.9 m-85 -114.17 158.59 21.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.027 0.441 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -77.17 -30.93 55.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.314 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 95.8 mt -115.01 124.68 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.664 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.71 -36.39 76.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.229 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.84 -31.93 68.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 110.486 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 7.6 m-20 -61.72 -38.03 86.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.68 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.55 -40.74 83.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.723 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.32 -34.24 56.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.252 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.66 -45.14 72.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.505 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -63.35 -35.02 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 61' ' ' ALA . 96.6 mt -66.98 -52.88 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.747 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.51 -12.67 60.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.894 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 7.0 t-20 -100.04 -29.35 12.58 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.603 ' HG3' HD11 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -104.49 -19.45 14.02 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 15.5 p-10 -52.76 113.42 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.02 45.34 4.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.749 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.09 -168.17 1.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.76 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 127.15 42.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.952 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' HG ' ' CD2' ' A' ' 73' ' ' PHE . 12.7 tp -139.47 123.78 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.719 ' HZ ' HG21 ' A' ' 21' ' ' VAL . 49.2 m-85 58.98 36.3 24.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 109.705 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.01 8.31 64.22 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.438 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 136.3 53.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.408 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -76.94 119.45 20.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.06 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.603 HD11 ' HG3' ' A' ' 67' ' ' MET . 22.4 pt -111.89 154.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 111.579 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.71 134.56 48.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.284 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 92.1 t -118.16 151.88 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.798 0.333 . . . . 0.0 111.666 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.7 t-20 -156.72 156.72 33.84 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.83 151.6 31.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.564 ' HB3' HG23 ' A' ' 7' ' ' VAL . . . -102.73 -165.07 1.14 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.995 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.776 -0.13 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.18 170.77 19.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.589 0.233 . . . . 0.0 110.509 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m 59.09 158.38 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.016 0.436 . . . . 0.0 110.912 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.4 p -71.45 -178.14 2.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.271 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -108.0 125.17 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.104 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -138.35 3.7 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.706 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.61 HG13 ' OE1' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -97.63 120.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.778 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.987 HD21 ' HB1' ' A' ' 60' ' ' ALA . 1.7 mt -115.36 157.91 23.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.783 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.663 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.7 t80 -116.25 137.31 52.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.47 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 79' ' ' VAL . 17.3 t -107.83 123.68 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -120.37 112.85 2.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.824 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.774 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 119.82 57.67 0.25 Allowed Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.957 HD22 HG11 ' A' ' 17' ' ' VAL . 48.0 mt -115.3 155.25 27.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -112.86 168.69 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.692 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -23.34 30.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.134 0.492 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 1.8 mt-10 -66.71 -38.51 86.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.462 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.957 HG11 HD22 ' A' ' 13' ' ' LEU . 12.1 p -74.52 142.75 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 111.593 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.899 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -155.29 -171.98 4.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.426 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.597 ' OD1' HD12 ' A' ' 35' ' ' ILE . 54.7 t0 -64.67 -30.64 71.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.562 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 9.4 ptmt -66.51 -48.64 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.624 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 17' ' ' VAL . 1.3 p -71.61 -43.61 70.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.311 0.576 . . . . 0.0 110.651 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.949 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.8 mt -60.21 -36.28 77.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.872 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.917 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -60.35 -55.63 31.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.06 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.92 80.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.827 . . . . 0.0 113.01 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.4 -31.92 67.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.949 ' CE1' HD23 ' A' ' 22' ' ' LEU . 2.6 m-85 -98.01 -12.5 21.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 23' ' ' HIS . 1.2 tp -61.76 -39.83 63.86 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.513 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.63 -44.57 40.36 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.233 1.289 . . . . 0.0 110.785 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -68.17 -22.1 64.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.921 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 162.12 133.47 1.48 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.488 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.0 m-20 -58.25 106.2 0.35 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.744 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.917 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.2 mp -57.72 149.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.887 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -114.7 -32.45 5.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.627 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.1 m-20 -154.92 145.27 22.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.988 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.597 HD12 ' OD1' ' A' ' 19' ' ' ASP . 31.0 mt -143.06 118.33 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.713 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -109.77 127.66 54.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.158 0.504 . . . . 0.0 112.098 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.0 mt -119.09 108.3 40.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.411 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 141.13 14.03 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 113.489 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.79 -169.18 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.868 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.73 143.87 26.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.757 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.36 43.12 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.212 0.53 . . . . 0.0 110.494 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.43 -40.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.272 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -99.11 -28.78 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.788 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 62.13 29.31 17.52 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.766 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -127.14 114.66 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -57.26 -178.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -40.92 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.62 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.763 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 144.77 49.52 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.864 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 23.6 m-85 -151.55 151.36 31.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.822 0.344 . . . . 0.0 111.507 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.83 174.82 13.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.935 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.3 m-85 -117.47 131.7 56.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.201 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.46 128.04 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.61 ' OE1' HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.11 136.94 52.56 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 6.6 m-85 -111.38 155.05 23.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.188 0.518 . . . . 0.0 111.103 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.12 -30.02 64.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.949 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.23 121.09 42.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.272 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.76 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.282 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -31.88 70.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.0 m-20 -68.07 -37.06 80.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.419 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.1 -44.22 87.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.962 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -52.57 -33.74 47.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.034 0.445 . . . . 0.0 110.37 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.42 -45.14 73.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.05 -34.68 78.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.951 HD11 HD22 ' A' ' 8' ' ' LEU . 93.2 mt -64.34 -52.38 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.086 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -78.22 -15.17 59.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.776 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 9.1 m120 -95.11 -48.9 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.493 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.3 tpt -73.75 -28.18 61.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.62 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 10.5 t-20 -60.7 121.93 13.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.171 0.51 . . . . 0.0 110.593 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 66.22 54.38 0.96 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.82 -166.57 1.46 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -131.03 124.95 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.8 tp -139.67 121.7 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 16' ' ' GLU . 34.2 m-85 58.47 40.56 23.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.217 0.532 . . . . 0.0 110.57 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.58 13.58 68.58 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.195 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -130.31 154.89 47.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -88.22 131.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 12' ' ' GLY . 29.6 pt -120.65 153.42 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 mmt180 -133.26 133.79 43.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.4 t -121.07 152.37 24.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.891 0.376 . . . . 0.0 111.283 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -158.01 160.06 37.06 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 5' ' ' LYS . 8.8 tp -72.18 141.37 49.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.678 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.556 ' HB3' HG23 ' A' ' 7' ' ' VAL . . . -83.87 94.76 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.069 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 117.5 23.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -80.34 139.8 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.481 HG23 ' HB1' ' A' ' 57' ' ' ALA . 6.0 t -94.27 46.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.093 0.473 . . . . 0.0 110.635 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 1.9 mptt 61.43 159.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.63 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 9.3 mtm180 -147.66 18.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.056 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG12 ' HD1' ' A' ' 51' ' ' PHE . 1.2 t -121.77 129.91 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.871 HD21 ' HB1' ' A' ' 60' ' ' ALA . 6.2 mt -118.8 153.74 33.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.963 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -109.2 135.64 49.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.981 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 25.0 t -108.91 123.45 64.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 110.396 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.3 123.21 5.06 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.726 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.96 48.74 0.71 Allowed Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.801 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 44.7 mt -105.79 -174.73 2.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.62 -0.79 . . . . 0.0 112.939 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.698 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -144.25 166.43 25.07 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.718 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -24.7 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.606 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.35 -40.16 96.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 13' ' ' LEU . 8.1 p -70.82 143.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.834 0.826 . . . . 0.0 112.518 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.568 ' H ' HG12 ' A' ' 21' ' ' VAL . 69.7 m-20 -156.02 175.97 13.27 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.789 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 10.0 p-10 -62.36 -28.94 70.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.87 -48.03 72.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.912 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 18' ' ' ASP . 3.8 p -72.57 -44.52 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 110.501 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.011 HD23 ' CE1' ' A' ' 26' ' ' PHE . 3.1 mt -60.25 -34.75 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.698 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.02 -55.51 24.97 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.784 178.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.88 79.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.436 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.01 58.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.011 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.9 m-85 -94.43 -9.06 36.79 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.815 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.696 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -62.59 -39.99 60.45 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.479 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HD3' HG22 ' A' ' 27' ' ' ILE . 23.6 Cg_endo -59.68 -42.65 44.81 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.387 1.391 . . . . 0.0 110.764 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -73.13 -23.68 60.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.876 178.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 171.36 132.69 1.52 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.624 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.0 m-20 -63.47 104.97 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.405 0.622 . . . . 0.0 111.303 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.6 mp -61.03 148.23 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.855 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.44 -34.13 5.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.514 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -153.71 149.61 27.68 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.405 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 51' ' ' PHE . 21.0 mt -143.37 121.07 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.081 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 127.03 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.853 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.469 ' O ' HD13 ' A' ' 39' ' ' LEU . 3.9 mp -114.02 108.17 51.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.608 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' C ' HD13 ' A' ' 39' ' ' LEU . 89.1 Cg_endo -79.8 142.23 15.76 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.507 2.138 . . . . 0.0 113.377 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -146.37 -167.33 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.301 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 1.9 m-20 -68.22 151.89 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -83.72 -17.42 41.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -110.44 -34.7 6.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.38 -3.11 15.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.605 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.581 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.7 pt-20 34.72 49.88 0.4 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' N ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -116.52 107.67 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.844 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.401 ' N ' ' HB3' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -70.47 -177.92 1.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.412 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -115.77 -56.33 2.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.134 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.801 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 171.5 45.61 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.381 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 13.2 m-85 -142.04 150.38 41.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.59 171.3 16.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.237 0.541 . . . . 0.0 112.007 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 35' ' ' ILE . 5.5 m-85 -121.82 126.6 49.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.88 124.24 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.516 0.198 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -111.38 136.51 50.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -113.64 157.17 22.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.343 0.592 . . . . 0.0 111.453 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -31.57 59.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.485 HD12 ' OD1' ' A' ' 59' ' ' ASP . 82.3 mt -115.54 126.81 54.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.388 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB1' HG23 ' A' ' 4' ' ' THR . . . -58.1 -43.34 87.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.712 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -30.73 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -64.5 -37.8 88.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.871 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.49 -45.04 89.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.37 -33.68 54.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.081 0.467 . . . . 0.0 110.656 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.05 -45.14 74.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.64 -34.13 76.43 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 61' ' ' ALA . 85.0 mt -67.13 -52.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.857 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.29 -13.99 60.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 8.5 m-20 -99.67 -36.38 9.51 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.508 ' HB3' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -91.63 -22.46 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 8.5 t30 -58.33 112.41 1.55 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 72.03 52.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.694 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.77 -172.47 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -121.57 127.0 50.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.297 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.594 ' HB2' HD13 ' A' ' 77' ' ' ILE . 3.4 tp -139.39 122.52 16.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.618 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 66.1 m-85 55.31 37.91 29.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.86 16.16 69.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.264 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 75' ' ' ARG . 1.6 mmt180 -124.29 146.07 49.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.105 0.479 . . . . 0.0 111.221 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -82.79 120.42 25.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.061 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 72' ' ' LEU . 19.0 pt -110.97 152.26 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.042 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -132.13 139.65 48.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.874 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.0 t -119.52 151.53 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.291 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.5 m120 -157.74 156.71 32.09 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.333 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 5' ' ' LYS . 1.7 mt -85.03 118.99 24.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.009 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 5' ' ' LYS . . . -85.24 166.42 16.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 111.023 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.4 p -121.05 29.01 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 t -172.36 90.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 57.23 80.14 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 121.28 7.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -159.49 61.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.257 0.551 . . . . 0.0 111.336 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 m -85.77 134.64 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.742 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.616 HD21 ' HB1' ' A' ' 60' ' ' ALA . 12.7 mt -117.06 159.18 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.982 0.42 . . . . 0.0 111.396 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.7 t80 -113.16 136.29 52.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 79' ' ' VAL . 23.5 t -108.99 123.62 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.627 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -123.07 119.73 3.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.692 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 114.3 46.0 0.65 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.913 HD22 HG11 ' A' ' 17' ' ' VAL . 58.9 mt -102.02 159.43 15.37 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.749 -0.725 . . . . 0.0 111.918 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.798 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . . . -107.48 177.09 4.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -75.4 1.56 13.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.496 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.12 -26.62 15.94 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.913 HG11 HD22 ' A' ' 13' ' ' LEU . 7.5 p -76.57 138.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.425 0.631 . . . . 0.0 111.228 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -151.02 -175.05 4.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.322 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.609 ' OD1' HD12 ' A' ' 35' ' ' ILE . 39.9 t0 -62.16 -32.25 72.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.292 0.568 . . . . 0.0 109.617 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.75 -48.16 78.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.672 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.72 -43.86 69.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.178 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.008 HD23 ' CE1' ' A' ' 26' ' ' PHE . 6.4 mt -60.55 -36.83 79.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.702 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -60.63 -56.24 23.74 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.18 178.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.0 -43.41 78.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.712 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.41 68.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.008 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.3 m-85 -95.95 -12.61 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.191 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.7 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -60.93 -40.27 72.85 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -57.29 -43.99 47.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.503 1.469 . . . . 0.0 111.018 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.7 m-85 -69.9 -26.03 63.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.82 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.47 136.59 2.12 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.434 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.0 m-20 -63.4 103.37 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.494 0.664 . . . . 0.0 111.157 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.702 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.1 mp -56.01 149.53 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.289 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.44 -32.91 5.44 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.0 t0 -153.71 145.61 23.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.163 0.506 . . . . 0.0 111.892 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.609 HD12 ' OD1' ' A' ' 19' ' ' ASP . 41.5 mt -143.3 118.53 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.011 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -117.93 132.5 56.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.203 0.525 . . . . 0.0 111.611 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt -120.15 110.25 36.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.033 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.68 143.85 38.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.238 1.959 . . . . 0.0 112.503 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 44' ' ' GLU . 1.4 mp -102.88 -164.14 1.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.018 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 41' ' ' TYR . 1.5 m-20 -96.09 -17.6 20.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.39 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 81.39 -47.87 0.24 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.69 0.396 . . . . 0.0 110.326 -179.274 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 1.9 pt-20 -78.65 -41.23 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.535 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -111.75 -16.49 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.528 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER 61.92 42.71 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.612 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 8.0 pttm -132.03 123.52 27.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.046 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -66.33 -175.71 0.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -118.09 -67.44 0.99 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.105 0.479 . . . . 0.0 110.15 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.813 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -175.9 37.83 0.1 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.252 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.5 m-85 -141.53 150.54 42.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.858 0.329 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.86 177.41 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.796 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -123.55 127.7 48.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.62 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.464 ' CG2' HD22 ' A' ' 22' ' ' LEU . 24.7 t -111.6 128.03 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -112.7 137.6 50.76 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 83.3 m-85 -112.3 154.21 26.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.156 0.503 . . . . 0.0 110.734 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -75.01 -25.91 59.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.989 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 87.5 mt -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.538 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.595 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -60.6 -43.39 97.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.33 -30.15 70.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 8.6 m-20 -60.72 -43.51 97.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.273 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -60.86 -46.56 90.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.761 0.315 . . . . 0.0 110.336 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -54.61 -33.92 61.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.521 . . . . 0.0 110.45 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -66.73 -45.31 79.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.856 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -65.28 -33.34 75.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 61' ' ' ALA . 97.1 mt -66.12 -51.79 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.171 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -12.59 60.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.02 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.7 m-80 -105.15 -46.06 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.431 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 2.5 tpt -76.84 -30.02 56.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.734 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 5.0 t-20 -57.38 115.42 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mt-10 67.0 57.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 -166.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.531 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -135.98 125.56 25.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.41 123.54 17.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 21' ' ' VAL . 23.5 m-85 56.18 41.5 29.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.125 0.488 . . . . 0.0 110.142 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.77 65.95 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.449 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.798 ' HG3' ' HB2' ' A' ' 14' ' ' ALA . 37.9 mmt-85 -124.51 137.65 54.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.937 0.399 . . . . 0.0 111.758 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.4 m -84.38 119.96 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.985 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 12' ' ' GLY . 19.4 pt -113.26 152.86 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 0.0 111.589 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 15.9 ptp180 -131.49 136.87 48.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.027 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 97.3 t -117.33 152.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.081 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.4 m120 -148.21 164.21 34.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.2 pt? -101.44 110.12 22.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.145 0.498 . . . . 0.0 111.239 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.29 82.67 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.949 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 tttt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.851 -179.779 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.55 -53.17 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.704 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 p -117.21 121.29 40.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.624 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 5' ' ' LYS . 1.8 m -126.13 -74.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.2 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.515 ' HG2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -164.85 163.79 21.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.673 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 5' ' ' LYS . 11.0 mtm180 174.14 -34.06 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.959 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 m -86.67 134.39 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 111.556 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.791 HD21 ' HB1' ' A' ' 60' ' ' ALA . 10.9 mt -118.14 160.46 21.52 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.014 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.7 t80 -114.17 136.51 52.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.645 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 13' ' ' LEU . 40.6 t -108.69 123.89 64.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.98 117.17 2.93 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.897 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 76' ' ' THR . . . 118.75 42.18 0.58 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.769 ' HB3' HG11 ' A' ' 17' ' ' VAL . 89.6 mt -97.99 -177.51 3.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.365 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -130.18 -172.35 2.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.547 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -82.42 2.92 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.565 0.222 . . . . 0.0 111.564 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.15 -30.24 13.62 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' A' ' 13' ' ' LEU . 13.2 p -69.0 142.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.718 0.77 . . . . 0.0 111.986 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.836 ' O ' HD12 ' A' ' 22' ' ' LEU . 7.7 m-20 -155.18 175.12 14.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 6.4 p-10 -57.62 -29.78 64.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HG2' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.28 -47.39 73.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.082 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.623 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -71.98 -44.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 18' ' ' ASP . 1.3 mt -60.39 -36.25 77.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.584 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.91 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -59.17 -55.73 31.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.886 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.48 84.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.364 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.85 65.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.641 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.6 m-85 -97.01 -9.86 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.16 -39.81 67.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.45 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 26.9 Cg_endo -60.73 -41.93 42.81 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.309 1.339 . . . . 0.0 110.834 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.0 m-85 -68.28 -26.02 65.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.476 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.22 132.03 1.32 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 3.2 m-20 -56.36 110.21 0.73 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.521 0.676 . . . . 0.0 111.834 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.91 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.3 mp -64.64 150.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.869 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.42 -34.81 4.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.661 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 2.3 m-20 -153.56 147.12 25.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 111.628 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 32' ' ' ILE . 45.3 mt -141.19 118.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.866 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.76 129.83 53.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.888 0.375 . . . . 0.0 111.584 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 50' ' ' ALA . 3.0 mt -120.42 120.43 29.87 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.178 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.42 139.57 14.64 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.386 2.058 . . . . 0.0 113.036 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.88 -162.2 0.94 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.175 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.27 -16.94 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 82.81 -48.7 0.16 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.595 0.358 . . . . 0.0 110.823 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -78.64 -42.18 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.014 0.435 . . . . 0.0 110.487 179.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.61 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 14.4 t -111.34 2.9 17.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.437 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HG3' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER 39.41 32.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 43' ' ' THR . 4.2 mttp -116.41 122.51 45.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.646 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.428 ' ND1' HG22 ' A' ' 37' ' ' ILE . 78.5 m-70 -57.9 175.51 0.19 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.81 -67.44 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.818 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.74 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . 176.02 35.09 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 15.8 m-85 -145.92 150.65 36.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.004 0.402 . . . . 0.0 111.16 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' A' ' 37' ' ' ILE . . . -156.91 174.32 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 18.1 m-85 -119.03 129.12 54.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.63 129.09 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.535 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -112.54 136.61 51.87 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 15.2 m-85 -111.73 157.46 20.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 0.0 111.497 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -74.89 -32.84 61.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.076 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.624 HD12 ' OD2' ' A' ' 59' ' ' ASP . 95.5 mt -113.5 117.39 31.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.395 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.27 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.684 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -66.5 -31.74 72.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.624 ' OD2' HD12 ' A' ' 56' ' ' LEU . 2.3 m-20 -61.21 -37.51 83.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.791 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -57.79 -41.63 82.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.737 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -55.11 -33.8 63.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.934 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.32 -45.25 73.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.202 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -62.83 -37.54 87.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.737 HD12 ' HA ' ' A' ' 61' ' ' ALA . 55.2 mt -63.7 -52.26 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.189 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.409 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 1.1 m-20 -73.36 -9.62 58.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.613 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 2.0 m120 -104.15 -39.25 6.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.528 ' HE3' ' CZ ' ' A' ' 26' ' ' PHE . 3.9 mmm -89.86 -19.59 24.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 65' ' ' ASP . 6.2 p30 -57.92 116.1 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 25.9 mt-10 65.24 42.07 4.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.5 OUTLIER -105.39 -165.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.5 124.64 32.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 77' ' ' ILE . 3.5 tp -139.38 129.86 25.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 55.09 28.4 10.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.3 4.49 89.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 14' ' ' ALA . 1.2 mtt85 -119.93 160.45 22.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.429 0.633 . . . . 0.0 111.533 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 8.8 m -91.12 124.75 35.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.061 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.783 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -114.79 156.28 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.213 0.53 . . . . 0.0 111.325 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -133.52 138.79 46.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.831 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 96.7 t -116.96 150.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 111.117 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -157.81 164.48 36.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.962 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.515 HD12 ' HG2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -62.06 -105.68 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.467 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 81' ' ' LEU . . . 172.32 -53.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.848 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.9 m -131.27 -176.87 4.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.471 HG23 HH11 ' A' ' 6' ' ' ARG . 0.2 OUTLIER 68.29 115.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.662 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.457 HG22 ' CD ' ' A' ' 5' ' ' LYS . 39.4 m -101.82 -40.68 6.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.239 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HD2' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -175.03 145.18 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.124 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.471 HH11 HG23 ' A' ' 3' ' ' THR . 9.6 mmm-85 -139.98 -45.65 0.43 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.121 0.486 . . . . 0.0 109.971 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 53' ' ' GLU . 10.4 m -86.31 132.03 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.658 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.507 HD11 ' HB1' ' A' ' 60' ' ' ALA . 13.2 mt -118.46 160.41 21.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.7 t80 -113.18 135.26 54.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.793 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 21.6 t -108.79 123.55 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.35 118.27 3.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.748 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.51 37.07 0.87 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 79.2 mt -91.42 -174.65 3.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.598 0.713 . . . . 0.0 112.233 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . . . -132.46 -171.53 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.124 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -84.63 5.27 28.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.583 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -32.29 13.0 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 13' ' ' LEU . 14.9 p -70.14 143.73 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.657 0.741 . . . . 0.0 112.213 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.733 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -153.3 179.5 8.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.823 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 2.6 p30 -62.42 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.192 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.03 -47.96 75.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 1.4 p -71.86 -46.37 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.899 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.3 mt -60.78 -37.22 81.15 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.02 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.931 ' HA ' HD13 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -57.14 -55.27 36.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.496 178.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.17 82.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.611 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.57 72.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.899 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.4 m-85 -95.78 -7.91 35.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.691 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -63.98 -39.62 46.71 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -58.68 -42.05 57.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.54 1.493 . . . . 0.0 111.012 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -72.03 -23.9 61.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.911 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.41 130.02 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 m-20 -57.18 107.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.365 0.602 . . . . 0.0 111.722 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.931 HD13 ' HA ' ' A' ' 23' ' ' HIS . 2.8 mp -60.55 152.88 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.113 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -32.74 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.793 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.57 145.65 23.71 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.112 0.482 . . . . 0.0 111.717 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 32' ' ' ILE . 30.3 mt -141.52 118.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.312 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -118.73 129.27 55.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.064 0.459 . . . . 0.0 112.049 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.55 109.01 46.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.21 145.25 54.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.407 2.072 . . . . 0.0 113.198 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 ' CA ' ' A' ' 44' ' ' GLU . 7.1 mt -103.78 -176.51 3.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.883 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -16.04 59.41 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.725 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER 74.44 1.47 3.85 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HG3' HG23 ' A' ' 43' ' ' THR . 3.2 pt-20 -147.58 -41.81 0.17 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.92 0.39 . . . . 0.0 110.505 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.525 HG23 ' HG3' ' A' ' 42' ' ' GLU . 25.6 p -100.87 -21.55 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' CA ' HD22 ' A' ' 39' ' ' LEU . 2.6 pt-20 40.28 62.38 1.33 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.706 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.93 -0.13 8.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.735 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 63.01 152.81 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.95 0.405 . . . . 0.0 111.15 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -114.67 -74.4 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.157 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.779 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 174.76 41.74 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.903 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.689 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.0 m-85 -142.32 150.62 41.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.166 0.483 . . . . 0.0 110.802 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.93 173.57 16.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.107 0.48 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 6.2 m-85 -120.0 129.91 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.29 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.75 128.33 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.657 0.265 . . . . 0.0 110.77 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -115.44 136.77 52.75 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -113.24 159.12 19.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.153 0.502 . . . . 0.0 111.317 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.87 -31.57 56.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.532 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 93.7 mt -113.61 120.2 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.64 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.2 -35.82 70.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.363 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.06 -30.85 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.522 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -66.25 -37.55 85.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.25 -41.54 84.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.096 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.16 -33.81 54.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.09 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.69 -45.31 71.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.75 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 -36.3 83.07 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.715 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 63.6 mt -64.26 -53.1 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.702 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.68 -19.0 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.024 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 15.8 m-20 -94.0 -31.92 14.05 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.987 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.767 ' HG3' HD11 ' A' ' 77' ' ' ILE . 1.3 tpt -100.53 -15.8 17.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.715 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -50.5 111.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.733 0.302 . . . . 0.0 111.033 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 62.24 40.03 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 t -90.78 -168.29 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.456 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -127.13 125.6 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.403 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tp -139.32 125.36 19.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.299 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 79.7 m-85 58.18 35.78 25.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 109.916 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.38 75.66 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.244 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.402 ' CD ' ' HB2' ' A' ' 14' ' ' ALA . 6.2 mmt180 -126.61 143.95 51.06 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.155 0.502 . . . . 0.0 111.503 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.8 m -87.02 120.56 28.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.162 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.767 HD11 ' HG3' ' A' ' 67' ' ' MET . 7.4 pt -112.45 159.13 12.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.163 0.506 . . . . 0.0 111.695 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 mtt-85 -127.53 135.94 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 67' ' ' MET . 97.9 t -116.94 152.16 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -156.45 161.49 40.06 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.382 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.463 HD13 ' HD2' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -100.78 103.55 14.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.95 169.97 13.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.999 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.87 -41.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.048 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.93 138.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.739 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 t -104.52 113.2 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HB2' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -135.13 176.22 8.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -130.28 -0.05 4.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.671 HG13 ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -111.61 118.57 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 111.015 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 17.1 mt -107.13 155.18 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.389 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 5.6 t80 -111.74 136.26 51.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.27 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 42.7 t -108.84 123.89 65.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.829 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.36 115.73 2.6 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.048 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.91 46.77 0.33 Allowed Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.833 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 54.9 mt -102.31 -176.06 3.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.615 0.722 . . . . 0.0 112.668 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -134.73 -172.73 3.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.491 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -83.42 6.14 21.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.567 0.222 . . . . 0.0 111.551 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.49 -21.82 16.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.794 0.33 . . . . 0.0 111.531 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.701 HG11 HD13 ' A' ' 13' ' ' LEU . 12.3 p -82.0 153.36 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 111.441 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.741 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.5 m-20 -163.88 -178.6 5.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.152 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.731 ' HA ' HG21 ' A' ' 35' ' ' ILE . 1.4 p30 -63.73 -29.27 70.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.288 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -66.89 -48.48 68.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.3 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 18' ' ' ASP . 2.2 p -71.74 -44.21 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.283 0.564 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.98 HD23 ' CE1' ' A' ' 26' ' ' PHE . 1.7 mt -60.63 -33.7 73.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.347 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.715 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -59.88 -55.3 35.88 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 178.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.3 85.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.41 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -69.38 -32.85 72.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.98 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.0 m-85 -99.86 -9.75 22.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.684 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.78 -39.58 61.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 24.5 Cg_endo -60.07 -41.84 48.93 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.393 1.395 . . . . 0.0 111.037 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CE1' ' ND2' ' A' ' 66' ' ' ASN . 1.8 m-85 -72.0 -26.24 62.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.921 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.64 128.72 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.75 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.3 m-20 -59.02 104.24 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.471 0.653 . . . . 0.0 110.984 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.715 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.8 mp -58.93 154.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.894 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 -25.64 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.58 141.66 20.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.731 HG21 ' HA ' ' A' ' 19' ' ' ASP . 24.4 mt -143.31 118.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.318 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -127.29 128.31 45.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.981 0.419 . . . . 0.0 111.979 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 49' ' ' PHE . 1.9 mp -109.98 111.61 58.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.951 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.36 143.22 57.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.323 2.016 . . . . 0.0 112.959 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.683 HD21 ' CE1' ' A' ' 46' ' ' HIS . 1.7 mp -115.13 -173.59 2.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.746 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -80.06 -11.93 59.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 40' ' ' ASP . 3.9 m-85 73.87 -62.51 0.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.92 -54.06 15.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.373 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -92.1 -31.13 15.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.342 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 1.7 mt-10 51.56 61.13 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -113.17 0.01 14.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.683 ' CE1' HD21 ' A' ' 39' ' ' LEU . 4.5 m80 62.97 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -105.1 -78.45 0.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.203 0.525 . . . . 0.0 110.172 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.833 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 172.91 40.65 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.924 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.64 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.6 m-85 -140.43 151.38 44.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.524 0.202 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.89 170.95 19.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -115.71 141.94 47.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.698 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 39.2 t -120.81 124.42 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HG2' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -103.89 141.55 35.95 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.499 ' CD1' ' OD1' ' A' ' 59' ' ' ASP . 97.0 m-85 -124.5 153.12 42.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.146 0.498 . . . . 0.0 111.298 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.06 -31.4 62.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.104 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 65.6 mt -119.65 127.97 53.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.053 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.48 70.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.08 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.37 -35.15 63.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' CD1' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 59' ' ' ASP . . . -58.59 -41.38 85.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.534 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.26 -33.79 54.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.154 0.502 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.03 -44.52 80.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.628 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.65 78.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.774 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 90.4 mt -67.1 -53.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.67 -16.22 59.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.016 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.565 ' ND2' ' CE1' ' A' ' 29' ' ' PHE . 33.4 t30 -99.86 -39.49 8.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 79' ' ' VAL . 2.2 tpt -85.2 -22.47 28.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.774 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 10.9 t30 -53.38 113.63 1.22 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 66.96 49.64 1.13 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.68 -165.7 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -135.05 128.72 32.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB2' HD13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -139.18 122.95 17.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.443 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 57.68 39.03 27.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.947 0.404 . . . . 0.0 110.024 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.0 13.75 69.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -120.66 137.8 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 m -75.63 120.51 21.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 72' ' ' LEU . 22.3 pt -110.98 152.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.29 0.566 . . . . 0.0 111.467 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 63.7 ttt180 -134.27 137.72 44.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.054 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 90.0 t -119.37 151.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 111.563 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 63.8 m-20 -157.9 164.5 36.83 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.601 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -71.91 -1.73 15.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.734 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 81' ' ' LEU . . . 72.53 149.51 0.1 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.844 0.354 . . . . 0.0 111.095 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.716 HD21 ' HB1' ' A' ' 60' ' ' ALA . 19.1 mt -112.98 160.9 17.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.922 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.3 t80 -114.87 136.93 52.56 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.763 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.491 HG11 HD21 ' A' ' 13' ' ' LEU . 18.1 t -108.39 123.59 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.681 0.277 . . . . 0.0 110.332 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.07 116.57 2.49 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.37 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.18 41.27 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.939 HD22 HG11 ' A' ' 17' ' ' VAL . 84.8 mt -95.03 -176.91 3.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.616 0.722 . . . . 0.0 112.749 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.56 -171.9 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.651 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.27 4.23 27.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.112 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.99 -21.28 16.32 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 13' ' ' LEU . 7.1 p -90.3 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 111.739 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.863 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -153.15 -174.74 5.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.972 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' HG21 ' A' ' 35' ' ' ILE . 3.9 p30 -64.36 -30.15 71.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 109.996 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -64.67 -48.63 74.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.88 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.63 -41.78 71.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.945 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 18' ' ' ASP . 2.2 mt -60.52 -35.57 76.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.693 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -60.3 -56.14 25.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.689 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.65 -40.35 84.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.293 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -70.63 -37.76 73.82 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.767 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.4 m-85 -95.52 -8.02 36.37 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.699 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.9 tp -63.29 -39.22 48.06 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.687 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.699 ' HD3' HG22 ' A' ' 27' ' ' ILE . 28.1 Cg_endo -61.8 -39.86 49.27 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.54 1.493 . . . . 0.0 111.331 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.544 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -74.41 -22.86 58.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.796 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 170.0 129.73 1.14 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.2 m-20 -60.19 104.06 0.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 111.27 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.689 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.9 mp -59.4 152.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.169 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 -31.76 4.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.852 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.93 146.32 23.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.431 -0.507 . . . . 0.0 112.004 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 32' ' ' ILE . 26.8 mt -141.96 118.54 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.885 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.44 130.47 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 112.156 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.617 178.77 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.76 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.684 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 9.1 m-85 -139.16 151.46 46.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 111.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 176.68 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.39 129.32 55.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 t -111.39 129.36 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.707 0.289 . . . . 0.0 110.772 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -114.12 137.9 51.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 24.2 m-85 -114.6 158.5 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.254 0.55 . . . . 0.0 111.637 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.79 -33.09 58.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.348 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 97.4 mt -113.03 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.857 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.44 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.735 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.43 -30.55 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.5 m-20 -61.05 -37.83 84.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.81 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.716 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.91 -41.76 88.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.746 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.04 -34.07 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.68 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.57 -45.7 71.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.954 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.75 87.44 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.746 HD12 ' HA ' ' A' ' 61' ' ' ALA . 95.5 mt -62.75 -50.94 77.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.829 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.6 -10.26 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.021 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.68 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.36 -45.04 4.78 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.01 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.469 ' HB2' HG21 ' A' ' 79' ' ' VAL . 13.6 mmt -83.62 -20.52 33.51 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 24.8 t-20 -61.53 113.63 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 65.41 39.26 5.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.7 -166.23 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.83 125.46 41.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 110.814 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.08 123.21 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 11.3 m-85 55.96 34.29 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 110.238 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 19.61 79.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.233 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -125.6 145.42 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 111.01 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -86.25 119.84 26.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.679 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.466 HD11 ' SD ' ' A' ' 67' ' ' MET . 12.6 pt -112.34 152.65 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 111.81 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -126.64 135.22 50.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.656 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 61.4 t -123.55 150.62 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.164 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -157.89 156.88 32.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.66 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.878 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 53' ' ' GLU . 2.5 m . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.615 HD11 ' HB1' ' A' ' 60' ' ' ALA . 9.6 mt -118.28 158.36 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.692 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.8 t80 -110.74 136.41 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 39.7 t -108.36 123.09 63.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.02 115.72 2.76 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.274 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 119.61 50.58 0.29 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 74.4 mt -107.49 -174.55 2.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.985 -0.608 . . . . 0.0 112.16 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.77 -167.13 1.93 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.41 -3.09 57.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.13 -31.71 20.28 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.644 HG11 HD13 ' A' ' 13' ' ' LEU . 9.1 p -73.03 144.04 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.619 0.723 . . . . 0.0 112.173 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.754 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -156.56 -178.91 7.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.936 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 42.0 t0 -62.9 -30.49 71.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.346 0.593 . . . . 0.0 110.386 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 7.8 pttp -67.15 -48.16 68.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.188 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -72.21 -44.92 63.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.081 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.843 HD23 ' CE1' ' A' ' 26' ' ' PHE . 1.6 mt -60.84 -38.14 84.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.701 ' HA ' HD13 ' A' ' 32' ' ' ILE . 19.0 t-80 -58.43 -55.33 36.43 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.998 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.34 76.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.645 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.4 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.843 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.9 m-85 -94.3 -11.27 30.44 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.754 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -59.87 -40.9 82.23 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.154 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.754 ' HD3' HG22 ' A' ' 27' ' ' ILE . 27.1 Cg_endo -60.97 -39.02 64.23 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.423 1.415 . . . . 0.0 110.808 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.626 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -73.29 -24.68 60.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.665 178.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.38 126.13 0.82 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.3 m-20 -54.39 105.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.237 0.541 . . . . 0.0 111.542 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' A' ' 26' ' ' PHE . 3.3 mp -63.53 151.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.799 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.37 -34.61 5.23 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.386 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -156.89 150.87 24.84 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.715 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 51' ' ' PHE . 28.1 mt -143.46 118.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.631 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.68 125.87 50.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.506 . . . . 0.0 111.918 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.173 178.315 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.768 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.768 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 17.0 m-85 -147.6 150.83 35.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.057 0.428 . . . . 0.0 111.139 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.04 170.04 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.257 0.551 . . . . 0.0 112.213 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -117.44 126.9 53.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.205 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.14 129.92 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.0 110.992 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.31 134.35 55.02 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 7.2 m-85 -107.71 161.18 15.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.13 0.49 . . . . 0.0 111.01 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.22 -29.48 57.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -123.73 131.33 53.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.82 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.284 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.87 -38.46 91.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.451 . . . . 0.0 110.819 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.4 m-20 -61.3 -37.49 83.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.615 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -58.14 -43.24 87.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.62 -33.63 55.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -65.98 -45.04 83.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.39 -35.54 80.76 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 61' ' ' ALA . 92.5 mt -63.46 -52.76 54.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.554 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.79 -10.63 59.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.841 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.9 t-20 -100.78 -41.39 6.89 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.51 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -88.76 -28.37 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 48.4 t30 -57.5 110.78 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 110.418 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.04 43.61 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.042 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.68 -161.57 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -132.22 124.47 29.02 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.609 ' HB2' HD12 ' A' ' 77' ' ' ILE . 7.7 tp -139.11 124.79 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 34.8 m-85 53.02 34.28 16.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.029 0.442 . . . . 0.0 110.59 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.0 12.05 84.3 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.729 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.78 143.4 51.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.17 0.509 . . . . 0.0 111.693 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.496 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 88.7 m -82.9 131.95 35.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.173 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -120.37 157.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.585 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 55.2 ttt180 -132.21 135.95 46.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.7 t -117.41 152.0 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 111.882 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -157.08 164.66 37.66 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.553 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.53 ' CD2' HD11 ' A' ' 64' ' ' ILE . 4.7 mt -122.84 160.6 25.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.6 t80 -110.31 136.35 49.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.316 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.94 122.83 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.99 113.84 2.04 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.057 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 120.84 46.41 0.34 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.115 HD22 HG11 ' A' ' 17' ' ' VAL . 67.6 mt -101.41 -176.76 3.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.307 0.575 . . . . 0.0 112.054 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.62 -171.71 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.925 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.36 0.0 34.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.68 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.5 -29.96 14.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.115 HG11 HD22 ' A' ' 13' ' ' LEU . 11.8 p -81.79 144.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.676 0.75 . . . . 0.0 111.579 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.667 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p30 -153.02 179.12 8.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.122 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 7.0 p-10 -58.89 -30.37 67.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.057 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.57 -47.55 72.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.798 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.5 -42.0 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.27 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.895 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.5 mt -60.34 -33.53 72.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.692 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -59.25 -55.7 31.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.637 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 27' ' ' ILE . . . -68.02 -44.53 76.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.427 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.01 93.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.895 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.4 m-85 -93.05 -10.36 36.4 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.685 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 tp -61.46 -40.24 69.61 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.818 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.685 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.85 -43.39 49.72 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.5 1.467 . . . . 0.0 111.333 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.7 m-85 -71.7 -21.25 61.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.01 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.6 131.72 1.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.523 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 m-20 -59.85 109.54 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.574 0.702 . . . . 0.0 111.554 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.0 mp -64.31 153.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.349 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -34.5 4.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.701 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -153.64 149.4 27.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 120.984 0.421 . . . . 0.0 111.672 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 19' ' ' ASP . 28.6 mt -143.7 120.1 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -121.1 126.59 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 111.364 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 49' ' ' PHE . 2.6 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.321 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.758 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.788 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.685 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.9 m-85 -144.54 151.26 38.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.004 0.402 . . . . 0.0 111.209 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.2 178.45 9.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.244 0.545 . . . . 0.0 112.004 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.5 m-85 -122.39 135.14 54.64 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.914 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.31 129.12 67.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -113.1 134.29 54.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 16.1 m-85 -109.08 160.64 15.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.393 0.616 . . . . 0.0 111.496 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 -30.85 51.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 88.4 mt -119.49 131.09 55.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.725 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -42.23 91.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.423 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.49 -32.38 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.0 m-20 -64.65 -38.33 90.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.592 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -59.32 -45.48 91.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.691 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.765 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.18 -33.7 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.441 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -67.26 -45.33 77.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.907 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.78 -34.71 78.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 96.7 mt -65.43 -52.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.445 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.42 -13.49 59.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.126 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 6.3 m-20 -99.34 -46.27 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.421 ' CE ' HD23 ' A' ' 72' ' ' LEU . 2.7 tpt -79.89 -23.29 41.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.776 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 11.0 t30 -56.84 114.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 110.795 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.82 30.05 2.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.1 OUTLIER -97.09 -174.47 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -137.79 130.04 29.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.719 0.295 . . . . 0.0 111.725 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 72' ' ' LEU . 4.4 pp -138.93 130.74 27.66 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 21' ' ' VAL . 41.9 m-85 58.65 40.59 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.104 0.478 . . . . 0.0 110.032 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.7 23.5 67.2 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.012 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -128.59 132.7 48.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 112.059 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.2 m -83.72 124.56 30.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.747 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.797 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -120.34 156.33 23.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.327 0.584 . . . . 0.0 111.697 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -129.85 137.64 50.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.661 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.8 t -121.05 151.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 t30 -157.98 164.41 36.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.257 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.529 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.466 HG13 ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.332 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.68 HD21 ' HB1' ' A' ' 60' ' ' ALA . 28.9 mt -118.18 155.29 30.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -110.05 133.45 53.19 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.87 123.53 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -123.11 121.53 4.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.957 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.16 38.88 0.91 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 17' ' ' VAL . 68.8 mt -93.56 179.11 5.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.83 0.824 . . . . 0.0 113.046 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -128.48 -175.21 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.328 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.43 -1.02 39.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.637 0.256 . . . . 0.0 111.26 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -37.22 14.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 13' ' ' LEU . 9.9 p -65.87 143.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.579 0.704 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.599 ' O ' HD12 ' A' ' 22' ' ' LEU . 17.9 p30 -151.89 178.31 9.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.856 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HA ' HG21 ' A' ' 35' ' ' ILE . 29.4 p-10 -61.69 -29.6 70.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.357 0.598 . . . . 0.0 109.551 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.76 -49.11 69.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.593 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.719 HG21 ' HZ ' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -71.72 -44.52 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.29 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.898 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mt -61.24 -34.24 74.81 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 109.579 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.709 ' HA ' HD13 ' A' ' 32' ' ' ILE . 25.8 t-80 -62.64 -54.91 32.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.584 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 27' ' ' ILE . . . -67.71 -41.52 83.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.897 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.68 75.91 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.898 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.9 m-85 -96.82 -9.4 28.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.696 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -61.29 -40.3 71.14 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.549 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.2 Cg_endo -57.38 -43.74 49.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.599 1.533 . . . . 0.0 111.162 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 3.3 m-85 -71.65 -24.08 61.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.029 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 169.95 129.82 1.14 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.48 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.494 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 16.3 m-20 -59.58 105.07 0.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.585 0.707 . . . . 0.0 111.23 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.4 mp -59.03 151.64 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.206 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.32 -32.55 5.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.679 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 9.7 t0 -155.07 146.67 23.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' CG1' HG21 ' A' ' 32' ' ' ILE . 42.9 mt -139.87 118.72 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.414 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -120.48 129.45 53.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.314 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 49' ' ' PHE . 4.6 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.723 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 19.0 m-85 -143.57 151.34 40.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 0.0 110.958 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 37' ' ' ILE . . . -153.83 176.2 12.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.384 0.611 . . . . 0.0 112.195 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 2.5 m-85 -124.34 125.53 44.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.211 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.2 t -107.13 124.98 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.551 0.215 . . . . 0.0 110.602 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -107.74 136.65 47.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' HG12 ' A' ' 52' ' ' VAL . 3.9 m-85 -114.17 158.59 21.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.027 0.441 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -77.17 -30.93 55.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.314 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 95.8 mt -115.01 124.68 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.664 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.71 -36.39 76.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.229 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.84 -31.93 68.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 110.486 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 7.6 m-20 -61.72 -38.03 86.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.68 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.55 -40.74 83.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.723 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.32 -34.24 56.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.252 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.66 -45.14 72.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.505 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -63.35 -35.02 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 61' ' ' ALA . 96.6 mt -66.98 -52.88 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.747 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.51 -12.67 60.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.894 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 7.0 t-20 -100.04 -29.35 12.58 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.603 ' HG3' HD11 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -104.49 -19.45 14.02 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 15.5 p-10 -52.76 113.42 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.02 45.34 4.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.749 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.09 -168.17 1.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.76 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 127.15 42.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.952 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' HG ' ' CD2' ' A' ' 73' ' ' PHE . 12.7 tp -139.47 123.78 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.719 ' HZ ' HG21 ' A' ' 21' ' ' VAL . 49.2 m-85 58.98 36.3 24.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 109.705 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.01 8.31 64.22 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.438 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 136.3 53.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.408 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -76.94 119.45 20.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.06 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.603 HD11 ' HG3' ' A' ' 67' ' ' MET . 22.4 pt -111.89 154.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 111.579 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.71 134.56 48.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.284 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 92.1 t -118.16 151.88 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.798 0.333 . . . . 0.0 111.666 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.7 t-20 -156.72 156.72 33.84 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.193 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.61 HG13 ' OE1' ' A' ' 53' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.924 0.392 . . . . 0.0 110.778 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.987 HD21 ' HB1' ' A' ' 60' ' ' ALA . 1.7 mt -115.36 157.91 23.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.783 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.663 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.7 t80 -116.25 137.31 52.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.47 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 79' ' ' VAL . 17.3 t -107.83 123.68 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -120.37 112.85 2.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.824 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.774 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 119.82 57.67 0.25 Allowed Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.957 HD22 HG11 ' A' ' 17' ' ' VAL . 48.0 mt -115.3 155.25 27.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -112.86 168.69 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.692 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -23.34 30.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.134 0.492 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 1.8 mt-10 -66.71 -38.51 86.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.462 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.957 HG11 HD22 ' A' ' 13' ' ' LEU . 12.1 p -74.52 142.75 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 111.593 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.899 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -155.29 -171.98 4.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.426 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.597 ' OD1' HD12 ' A' ' 35' ' ' ILE . 54.7 t0 -64.67 -30.64 71.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.562 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.448 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 9.4 ptmt -66.51 -48.64 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.624 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 17' ' ' VAL . 1.3 p -71.61 -43.61 70.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.311 0.576 . . . . 0.0 110.651 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.949 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.8 mt -60.21 -36.28 77.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.872 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.917 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -60.35 -55.63 31.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.06 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.92 80.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.827 . . . . 0.0 113.01 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.4 -31.92 67.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.949 ' CE1' HD23 ' A' ' 22' ' ' LEU . 2.6 m-85 -98.01 -12.5 21.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 23' ' ' HIS . 1.2 tp -61.76 -39.83 63.86 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.513 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.63 -44.57 40.36 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.233 1.289 . . . . 0.0 110.785 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -68.17 -22.1 64.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.921 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 162.12 133.47 1.48 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.488 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.0 m-20 -58.25 106.2 0.35 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.744 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.917 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.2 mp -57.72 149.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.887 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -114.7 -32.45 5.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.627 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.1 m-20 -154.92 145.27 22.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.988 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.597 HD12 ' OD1' ' A' ' 19' ' ' ASP . 31.0 mt -143.06 118.33 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.713 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -109.77 127.66 54.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.158 0.504 . . . . 0.0 112.098 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.411 178.624 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.763 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 23.6 m-85 -151.55 151.36 31.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.822 0.344 . . . . 0.0 111.507 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.83 174.82 13.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.935 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.3 m-85 -117.47 131.7 56.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.201 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.46 128.04 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.61 ' OE1' HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.11 136.94 52.56 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 6.6 m-85 -111.38 155.05 23.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.188 0.518 . . . . 0.0 111.103 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.12 -30.02 64.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.949 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.23 121.09 42.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.272 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.76 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.282 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -31.88 70.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.0 m-20 -68.07 -37.06 80.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.419 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.1 -44.22 87.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.962 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -52.57 -33.74 47.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.034 0.445 . . . . 0.0 110.37 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.42 -45.14 73.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.05 -34.68 78.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.951 HD11 HD22 ' A' ' 8' ' ' LEU . 93.2 mt -64.34 -52.38 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.086 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -78.22 -15.17 59.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.776 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 9.1 m120 -95.11 -48.9 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.493 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.3 tpt -73.75 -28.18 61.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.62 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.4 OUTLIER -60.7 121.93 13.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.171 0.51 . . . . 0.0 110.593 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 66.22 54.38 0.96 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.82 -166.57 1.46 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -131.03 124.95 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.8 tp -139.67 121.7 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 16' ' ' GLU . 34.2 m-85 58.47 40.56 23.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.217 0.532 . . . . 0.0 110.57 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.58 13.58 68.58 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.195 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -130.31 154.89 47.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -88.22 131.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 12' ' ' GLY . 29.6 pt -120.65 153.42 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 mmt180 -133.26 133.79 43.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.4 t -121.07 152.37 24.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.891 0.376 . . . . 0.0 111.283 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -158.01 160.06 37.06 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 tp . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.678 179.618 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG12 ' HD1' ' A' ' 51' ' ' PHE . 1.2 t . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.871 HD21 ' HB1' ' A' ' 60' ' ' ALA . 6.2 mt -118.8 153.74 33.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.963 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -109.2 135.64 49.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.981 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 25.0 t -108.91 123.45 64.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 110.396 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.3 123.21 5.06 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.726 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.96 48.74 0.71 Allowed Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.801 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 44.7 mt -105.79 -174.73 2.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.62 -0.79 . . . . 0.0 112.939 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.698 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -144.25 166.43 25.07 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.718 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -24.7 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.606 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.35 -40.16 96.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 13' ' ' LEU . 8.1 p -70.82 143.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.834 0.826 . . . . 0.0 112.518 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.568 ' H ' HG12 ' A' ' 21' ' ' VAL . 69.7 m-20 -156.02 175.97 13.27 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.789 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 10.0 p-10 -62.36 -28.94 70.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.87 -48.03 72.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.912 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 18' ' ' ASP . 3.8 p -72.57 -44.52 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 110.501 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.011 HD23 ' CE1' ' A' ' 26' ' ' PHE . 3.1 mt -60.25 -34.75 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.698 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.02 -55.51 24.97 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.784 178.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.88 79.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.436 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.01 58.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.011 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.9 m-85 -94.43 -9.06 36.79 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.815 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.696 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -62.59 -39.99 60.45 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.479 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HD3' HG22 ' A' ' 27' ' ' ILE . 23.6 Cg_endo -59.68 -42.65 44.81 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.387 1.391 . . . . 0.0 110.764 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -73.13 -23.68 60.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.876 178.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 171.36 132.69 1.52 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.624 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.0 m-20 -63.47 104.97 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.405 0.622 . . . . 0.0 111.303 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.6 mp -61.03 148.23 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.855 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.44 -34.13 5.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.514 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -153.71 149.61 27.68 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.405 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 51' ' ' PHE . 21.0 mt -143.37 121.07 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.081 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 127.03 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.853 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.608 178.686 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.801 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 13.2 m-85 -142.04 150.38 41.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.59 171.3 16.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.237 0.541 . . . . 0.0 112.007 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 35' ' ' ILE . 5.5 m-85 -121.82 126.6 49.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.88 124.24 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.516 0.198 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -111.38 136.51 50.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -113.64 157.17 22.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.343 0.592 . . . . 0.0 111.453 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -31.57 59.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.485 HD12 ' OD1' ' A' ' 59' ' ' ASP . 82.3 mt -115.54 126.81 54.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.388 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.34 87.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.712 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -30.73 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.485 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -64.5 -37.8 88.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.871 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.49 -45.04 89.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.37 -33.68 54.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.081 0.467 . . . . 0.0 110.656 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.05 -45.14 74.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.64 -34.13 76.43 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 61' ' ' ALA . 85.0 mt -67.13 -52.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.857 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.29 -13.99 60.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 8.5 m-20 -99.67 -36.38 9.51 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.508 ' HB3' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -91.63 -22.46 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 8.5 t30 -58.33 112.41 1.55 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 72.03 52.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.694 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.77 -172.47 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -121.57 127.0 50.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.297 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.594 ' HB2' HD13 ' A' ' 77' ' ' ILE . 3.4 tp -139.39 122.52 16.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.618 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 66.1 m-85 55.31 37.91 29.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.86 16.16 69.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.264 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 75' ' ' ARG . 1.6 mmt180 -124.29 146.07 49.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.105 0.479 . . . . 0.0 111.221 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -82.79 120.42 25.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.061 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 72' ' ' LEU . 19.0 pt -110.97 152.26 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.042 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -132.13 139.65 48.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.874 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.0 t -119.52 151.53 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.291 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.5 m120 -157.74 156.71 32.09 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.333 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.512 ' HG ' HD11 ' A' ' 64' ' ' ILE . 1.7 mt . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.652 0.263 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.616 HD21 ' HB1' ' A' ' 60' ' ' ALA . 12.7 mt -117.06 159.18 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.982 0.42 . . . . 0.0 111.396 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.7 t80 -113.16 136.29 52.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 79' ' ' VAL . 23.5 t -108.99 123.62 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.627 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -123.07 119.73 3.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.692 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 114.3 46.0 0.65 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.913 HD22 HG11 ' A' ' 17' ' ' VAL . 58.9 mt -102.02 159.43 15.37 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.749 -0.725 . . . . 0.0 111.918 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.798 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . . . -107.48 177.09 4.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -75.4 1.56 13.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.496 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.12 -26.62 15.94 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.913 HG11 HD22 ' A' ' 13' ' ' LEU . 7.5 p -76.57 138.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.425 0.631 . . . . 0.0 111.228 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -151.02 -175.05 4.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.322 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.609 ' OD1' HD12 ' A' ' 35' ' ' ILE . 39.9 t0 -62.16 -32.25 72.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.292 0.568 . . . . 0.0 109.617 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.75 -48.16 78.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.672 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.72 -43.86 69.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.178 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.008 HD23 ' CE1' ' A' ' 26' ' ' PHE . 6.4 mt -60.55 -36.83 79.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.702 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -60.63 -56.24 23.74 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.18 178.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.0 -43.41 78.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.712 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.41 68.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.008 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.3 m-85 -95.95 -12.61 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.191 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.7 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -60.93 -40.27 72.85 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -57.29 -43.99 47.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.503 1.469 . . . . 0.0 111.018 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.7 m-85 -69.9 -26.03 63.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.82 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.47 136.59 2.12 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.434 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.0 m-20 -63.4 103.37 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.494 0.664 . . . . 0.0 111.157 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.702 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.1 mp -56.01 149.53 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.289 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.44 -32.91 5.44 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.0 t0 -153.71 145.61 23.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.163 0.506 . . . . 0.0 111.892 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.609 HD12 ' OD1' ' A' ' 19' ' ' ASP . 41.5 mt -143.3 118.53 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.011 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -117.93 132.5 56.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.203 0.525 . . . . 0.0 111.611 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.033 179.212 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.813 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.5 m-85 -141.53 150.54 42.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.858 0.329 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.86 177.41 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.796 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -123.55 127.7 48.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.62 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.464 ' CG2' HD22 ' A' ' 22' ' ' LEU . 24.7 t -111.6 128.03 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -112.7 137.6 50.76 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 83.3 m-85 -112.3 154.21 26.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.156 0.503 . . . . 0.0 110.734 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -75.01 -25.91 59.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.989 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 87.5 mt -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.538 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -43.39 97.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.33 -30.15 70.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 8.6 m-20 -60.72 -43.51 97.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.273 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -60.86 -46.56 90.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.761 0.315 . . . . 0.0 110.336 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -54.61 -33.92 61.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.521 . . . . 0.0 110.45 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -66.73 -45.31 79.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.856 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -65.28 -33.34 75.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 61' ' ' ALA . 97.1 mt -66.12 -51.79 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.171 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -12.59 60.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.02 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.7 m-80 -105.15 -46.06 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.431 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 2.5 tpt -76.84 -30.02 56.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.734 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 5.0 t-20 -57.38 115.42 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mt-10 67.0 57.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 -166.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.531 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -135.98 125.56 25.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.41 123.54 17.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 21' ' ' VAL . 23.5 m-85 56.18 41.5 29.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.125 0.488 . . . . 0.0 110.142 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.77 65.95 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.449 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.798 ' HG3' ' HB2' ' A' ' 14' ' ' ALA . 37.9 mmt-85 -124.51 137.65 54.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.937 0.399 . . . . 0.0 111.758 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.4 m -84.38 119.96 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.985 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 12' ' ' GLY . 19.4 pt -113.26 152.86 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 0.0 111.589 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 15.9 ptp180 -131.49 136.87 48.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.027 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 97.3 t -117.33 152.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.081 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.4 m120 -148.21 164.21 34.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.2 pt? . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 121.145 0.498 . . . . 0.0 111.239 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.791 HD21 ' HB1' ' A' ' 60' ' ' ALA . 10.9 mt -118.14 160.46 21.52 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.014 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.7 t80 -114.17 136.51 52.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.645 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 13' ' ' LEU . 40.6 t -108.69 123.89 64.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.98 117.17 2.93 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.897 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 76' ' ' THR . . . 118.75 42.18 0.58 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.769 ' HB3' HG11 ' A' ' 17' ' ' VAL . 89.6 mt -97.99 -177.51 3.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.365 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -130.18 -172.35 2.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.547 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -82.42 2.92 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.565 0.222 . . . . 0.0 111.564 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.15 -30.24 13.62 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' A' ' 13' ' ' LEU . 13.2 p -69.0 142.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.718 0.77 . . . . 0.0 111.986 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.836 ' O ' HD12 ' A' ' 22' ' ' LEU . 7.7 m-20 -155.18 175.12 14.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 6.4 p-10 -57.62 -29.78 64.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HG2' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.28 -47.39 73.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.082 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.623 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -71.98 -44.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 18' ' ' ASP . 1.3 mt -60.39 -36.25 77.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.584 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.91 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -59.17 -55.73 31.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.886 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.48 84.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.364 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.85 65.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.641 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.6 m-85 -97.01 -9.86 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.16 -39.81 67.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.45 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 26.9 Cg_endo -60.73 -41.93 42.81 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.309 1.339 . . . . 0.0 110.834 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.0 m-85 -68.28 -26.02 65.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.476 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.22 132.03 1.32 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 3.2 m-20 -56.36 110.21 0.73 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.521 0.676 . . . . 0.0 111.834 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.91 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.3 mp -64.64 150.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.869 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.42 -34.81 4.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.661 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 2.3 m-20 -153.56 147.12 25.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 111.628 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 32' ' ' ILE . 45.3 mt -141.19 118.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.866 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.76 129.83 53.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.888 0.375 . . . . 0.0 111.584 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 50' ' ' ALA . 3.0 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.178 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.74 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 120.06 -0.3 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 15.8 m-85 -145.92 150.65 36.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.004 0.402 . . . . 0.0 111.16 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' A' ' 37' ' ' ILE . . . -156.91 174.32 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 18.1 m-85 -119.03 129.12 54.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.63 129.09 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.535 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -112.54 136.61 51.87 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 15.2 m-85 -111.73 157.46 20.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 0.0 111.497 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -74.89 -32.84 61.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.076 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.624 HD12 ' OD2' ' A' ' 59' ' ' ASP . 95.5 mt -113.5 117.39 31.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.395 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.27 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.684 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -66.5 -31.74 72.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.624 ' OD2' HD12 ' A' ' 56' ' ' LEU . 2.3 m-20 -61.21 -37.51 83.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.791 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -57.79 -41.63 82.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.737 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -55.11 -33.8 63.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.934 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.32 -45.25 73.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.202 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -62.83 -37.54 87.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.737 HD12 ' HA ' ' A' ' 61' ' ' ALA . 55.2 mt -63.7 -52.26 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.189 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.409 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 1.1 m-20 -73.36 -9.62 58.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.613 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 2.0 m120 -104.15 -39.25 6.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.528 ' HE3' ' CZ ' ' A' ' 26' ' ' PHE . 3.9 mmm -89.86 -19.59 24.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 65' ' ' ASP . 6.2 p30 -57.92 116.1 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 25.9 mt-10 65.24 42.07 4.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.5 OUTLIER -105.39 -165.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.5 124.64 32.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 77' ' ' ILE . 3.5 tp -139.38 129.86 25.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 55.09 28.4 10.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.3 4.49 89.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 14' ' ' ALA . 1.2 mtt85 -119.93 160.45 22.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.429 0.633 . . . . 0.0 111.533 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 8.8 m -91.12 124.75 35.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.061 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.783 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -114.79 156.28 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.213 0.53 . . . . 0.0 111.325 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -133.52 138.79 46.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.831 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 96.7 t -116.96 150.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 111.117 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -157.81 164.48 36.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.962 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.467 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 53' ' ' GLU . 10.4 m . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.868 0.366 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.507 HD11 ' HB1' ' A' ' 60' ' ' ALA . 13.2 mt -118.46 160.41 21.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.7 t80 -113.18 135.26 54.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.793 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 21.6 t -108.79 123.55 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.35 118.27 3.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.748 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.51 37.07 0.87 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 79.2 mt -91.42 -174.65 3.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.598 0.713 . . . . 0.0 112.233 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . . . -132.46 -171.53 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.124 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -84.63 5.27 28.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.583 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -32.29 13.0 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 13' ' ' LEU . 14.9 p -70.14 143.73 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.657 0.741 . . . . 0.0 112.213 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.733 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -153.3 179.5 8.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.823 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 2.6 p30 -62.42 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.192 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.03 -47.96 75.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 1.4 p -71.86 -46.37 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.899 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.3 mt -60.78 -37.22 81.15 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.02 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.931 ' HA ' HD13 ' A' ' 32' ' ' ILE . 16.7 t-160 -57.14 -55.27 36.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.496 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.17 82.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.611 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.57 72.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.899 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.4 m-85 -95.78 -7.91 35.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.691 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -63.98 -39.62 46.71 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -58.68 -42.05 57.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.54 1.493 . . . . 0.0 111.012 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -72.03 -23.9 61.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.911 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.41 130.02 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 m-20 -57.18 107.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.365 0.602 . . . . 0.0 111.722 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.931 HD13 ' HA ' ' A' ' 23' ' ' HIS . 2.8 mp -60.55 152.88 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.113 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -32.74 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.793 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.57 145.65 23.71 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.112 0.482 . . . . 0.0 111.717 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 32' ' ' ILE . 30.3 mt -141.52 118.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.312 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -118.73 129.27 55.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.064 0.459 . . . . 0.0 112.049 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.779 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.903 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.689 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.0 m-85 -142.32 150.62 41.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.166 0.483 . . . . 0.0 110.802 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.93 173.57 16.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.107 0.48 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 6.2 m-85 -120.0 129.91 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.29 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.75 128.33 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.657 0.265 . . . . 0.0 110.77 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -115.44 136.77 52.75 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -113.24 159.12 19.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.153 0.502 . . . . 0.0 111.317 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.87 -31.57 56.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.532 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 93.7 mt -113.61 120.2 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.64 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.2 -35.82 70.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.363 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.06 -30.85 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.522 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -66.25 -37.55 85.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.25 -41.54 84.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.096 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.16 -33.81 54.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.09 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.69 -45.31 71.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.75 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 -36.3 83.07 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.715 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 63.6 mt -64.26 -53.1 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.702 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.68 -19.0 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.024 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 15.8 m-20 -94.0 -31.92 14.05 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.987 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.767 ' HG3' HD11 ' A' ' 77' ' ' ILE . 1.3 tpt -100.53 -15.8 17.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.715 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -50.5 111.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.733 0.302 . . . . 0.0 111.033 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 62.24 40.03 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 t -90.78 -168.29 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.456 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -127.13 125.6 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.403 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tp -139.32 125.36 19.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.299 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 79.7 m-85 58.18 35.78 25.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 109.916 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.38 75.66 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.244 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.402 ' CD ' ' HB2' ' A' ' 14' ' ' ALA . 6.2 mmt180 -126.61 143.95 51.06 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.155 0.502 . . . . 0.0 111.503 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.8 m -87.02 120.56 28.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.162 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.767 HD11 ' HG3' ' A' ' 67' ' ' MET . 7.4 pt -112.45 159.13 12.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.163 0.506 . . . . 0.0 111.695 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 mtt-85 -127.53 135.94 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 67' ' ' MET . 97.9 t -116.94 152.16 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -156.45 161.49 40.06 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.382 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.671 HG13 ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 17.1 mt -107.13 155.18 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.389 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 5.6 t80 -111.74 136.26 51.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.27 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 42.7 t -108.84 123.89 65.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.829 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.36 115.73 2.6 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.048 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.91 46.77 0.33 Allowed Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.833 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 54.9 mt -102.31 -176.06 3.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.615 0.722 . . . . 0.0 112.668 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -134.73 -172.73 3.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.491 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -83.42 6.14 21.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.567 0.222 . . . . 0.0 111.551 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.49 -21.82 16.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.794 0.33 . . . . 0.0 111.531 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.701 HG11 HD13 ' A' ' 13' ' ' LEU . 12.3 p -82.0 153.36 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 111.441 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.741 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.5 m-20 -163.88 -178.6 5.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.152 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.731 ' HA ' HG21 ' A' ' 35' ' ' ILE . 1.4 p30 -63.73 -29.27 70.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.288 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -66.89 -48.48 68.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.3 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 18' ' ' ASP . 2.2 p -71.74 -44.21 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.283 0.564 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.98 HD23 ' CE1' ' A' ' 26' ' ' PHE . 1.7 mt -60.63 -33.7 73.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.347 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.715 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -59.88 -55.3 35.88 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 178.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.3 85.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.41 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -69.38 -32.85 72.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.98 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.0 m-85 -99.86 -9.75 22.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.684 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.78 -39.58 61.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 24.5 Cg_endo -60.07 -41.84 48.93 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.393 1.395 . . . . 0.0 111.037 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.8 m-85 -72.0 -26.24 62.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.921 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.64 128.72 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.75 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.3 m-20 -59.02 104.24 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.471 0.653 . . . . 0.0 110.984 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.715 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.8 mp -58.93 154.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.894 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 -25.64 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.58 141.66 20.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.731 HG21 ' HA ' ' A' ' 19' ' ' ASP . 24.4 mt -143.31 118.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.318 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -127.29 128.31 45.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.981 0.419 . . . . 0.0 111.979 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 49' ' ' PHE . 1.9 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.951 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.833 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.64 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.6 m-85 -140.43 151.38 44.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.524 0.202 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.89 170.95 19.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -115.71 141.94 47.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.698 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 39.2 t -120.81 124.42 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HG2' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -103.89 141.55 35.95 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.499 ' CD1' ' OD1' ' A' ' 59' ' ' ASP . 97.0 m-85 -124.5 153.12 42.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.146 0.498 . . . . 0.0 111.298 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.06 -31.4 62.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.104 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 65.6 mt -119.65 127.97 53.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.053 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.48 70.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.08 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.37 -35.15 63.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' CD1' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 59' ' ' ASP . . . -58.59 -41.38 85.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.534 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.26 -33.79 54.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.154 0.502 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.03 -44.52 80.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.628 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.65 78.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.774 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 90.4 mt -67.1 -53.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.67 -16.22 59.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.016 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 29' ' ' PHE . 10.0 t-20 -99.86 -39.49 8.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 79' ' ' VAL . 2.2 tpt -85.2 -22.47 28.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.774 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 10.9 t30 -53.38 113.63 1.22 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 66.96 49.64 1.13 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.68 -165.7 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -135.05 128.72 32.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB2' HD13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -139.18 122.95 17.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.443 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 57.68 39.03 27.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.947 0.404 . . . . 0.0 110.024 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.0 13.75 69.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -120.66 137.8 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 m -75.63 120.51 21.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 72' ' ' LEU . 22.3 pt -110.98 152.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.29 0.566 . . . . 0.0 111.467 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 63.7 ttt180 -134.27 137.72 44.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.054 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 90.0 t -119.37 151.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 111.563 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 63.8 m-20 -157.9 164.5 36.83 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.601 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.734 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 24.9 m 58.26 90.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.763 0.316 . . . . 0.0 110.911 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.436 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.5 m -92.34 -56.18 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.964 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 p 50.72 70.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' A' ' 3' ' ' THR . 9.9 mmmt -139.63 -171.54 3.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.758 0.313 . . . . 0.0 110.777 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -133.46 -5.05 2.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.569 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.703 HG23 ' HB3' ' A' ' 82' ' ' ALA . 1.9 m -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 110.504 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.716 HD21 ' HB1' ' A' ' 60' ' ' ALA . 19.1 mt -112.98 160.9 17.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.922 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.3 t80 -114.87 136.93 52.56 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.763 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.491 HG11 HD21 ' A' ' 13' ' ' LEU . 18.1 t -108.39 123.59 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.681 0.277 . . . . 0.0 110.332 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.07 116.57 2.49 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.37 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.18 41.27 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.939 HD22 HG11 ' A' ' 17' ' ' VAL . 84.8 mt -95.03 -176.91 3.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.616 0.722 . . . . 0.0 112.749 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.56 -171.9 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.651 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.27 4.23 27.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.112 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.99 -21.28 16.32 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 13' ' ' LEU . 7.1 p -90.3 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 111.739 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.863 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -153.15 -174.74 5.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.972 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' HG21 ' A' ' 35' ' ' ILE . 3.9 p30 -64.36 -30.15 71.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 109.996 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -64.67 -48.63 74.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.88 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.63 -41.78 71.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.945 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 18' ' ' ASP . 2.2 mt -60.52 -35.57 76.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.693 ' O ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -60.3 -56.14 25.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.689 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.65 -40.35 84.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.293 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -70.63 -37.76 73.82 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.767 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.4 m-85 -95.52 -8.02 36.37 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.699 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.9 tp -63.29 -39.22 48.06 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.687 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.699 ' HD3' HG22 ' A' ' 27' ' ' ILE . 28.1 Cg_endo -61.8 -39.86 49.27 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.54 1.493 . . . . 0.0 111.331 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.544 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -74.41 -22.86 58.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.796 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 170.0 129.73 1.14 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.2 m-20 -60.19 104.06 0.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 111.27 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.689 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.9 mp -59.4 152.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.169 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.47 -31.76 4.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.852 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.93 146.32 23.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.431 -0.507 . . . . 0.0 112.004 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 32' ' ' ILE . 26.8 mt -141.96 118.54 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.885 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.44 130.47 53.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 112.156 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -121.49 108.17 35.87 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.617 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' O ' ' CD2' ' A' ' 46' ' ' HIS . 72.5 Cg_endo -76.72 154.62 34.7 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.489 2.126 . . . . 0.0 113.166 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.518 HD22 ' O ' ' A' ' 44' ' ' GLU . 1.2 mt -137.98 168.63 19.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 10.0 m-20 -83.47 -178.89 7.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 42' ' ' GLU . 24.6 p90 -107.71 -30.8 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.717 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HG3' ' CE2' ' A' ' 41' ' ' TYR . 4.9 mt-10 -87.24 -32.9 19.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -114.59 -23.29 9.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.452 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' O ' HD22 ' A' ' 39' ' ' LEU . 11.7 pt-20 45.9 36.21 2.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.58 120.86 15.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.465 ' N ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -68.45 -168.38 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.451 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.52 -47.85 3.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.406 0.622 . . . . 0.0 109.36 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.76 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 159.31 45.69 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.672 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 9.1 m-85 -139.16 151.46 46.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 111.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 176.68 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -118.39 129.32 55.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 t -111.39 129.36 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.707 0.289 . . . . 0.0 110.772 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -114.12 137.9 51.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 24.2 m-85 -114.6 158.5 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.254 0.55 . . . . 0.0 111.637 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.79 -33.09 58.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.348 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 97.4 mt -113.03 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.857 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . . . -56.12 -43.44 78.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.735 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -66.43 -30.55 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.5 m-20 -61.05 -37.83 84.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.81 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.716 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.91 -41.76 88.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.746 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.04 -34.07 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.68 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.57 -45.7 71.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.954 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.75 87.44 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.746 HD12 ' HA ' ' A' ' 61' ' ' ALA . 95.5 mt -62.75 -50.94 77.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.829 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.6 -10.26 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.021 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.68 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.36 -45.04 4.78 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.613 -0.435 . . . . 0.0 112.01 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.469 ' HB2' HG21 ' A' ' 79' ' ' VAL . 13.6 mmt -83.62 -20.52 33.51 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 24.8 t-20 -61.53 113.63 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 65.41 39.26 5.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.7 -166.23 1.26 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -126.83 125.46 41.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 110.814 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.08 123.21 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 11.3 m-85 55.96 34.29 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 110.238 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 19.61 79.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.233 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -125.6 145.42 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 111.01 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -86.25 119.84 26.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.679 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.466 HD11 ' SD ' ' A' ' 67' ' ' MET . 12.6 pt -112.34 152.65 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 111.81 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -126.64 135.22 50.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.656 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 61.4 t -123.55 150.62 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 111.164 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -157.89 156.88 32.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.66 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -76.52 123.36 25.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.878 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 7' ' ' VAL . . . -62.66 175.72 0.77 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.62 146.94 44.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.21 -26.18 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.507 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 m -125.52 159.39 32.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.005 0.431 . . . . 0.0 111.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -136.46 154.55 50.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER 165.58 -24.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 53' ' ' GLU . 2.5 m -82.98 134.53 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 111.139 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.615 HD11 ' HB1' ' A' ' 60' ' ' ALA . 9.6 mt -118.28 158.36 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.692 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.8 t80 -110.74 136.41 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.488 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 39.7 t -108.36 123.09 63.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.02 115.72 2.76 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.274 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 119.61 50.58 0.29 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 74.4 mt -107.49 -174.55 2.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.985 -0.608 . . . . 0.0 112.16 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.77 -167.13 1.93 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.41 -3.09 57.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.13 -31.71 20.28 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.644 HG11 HD13 ' A' ' 13' ' ' LEU . 9.1 p -73.03 144.04 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.619 0.723 . . . . 0.0 112.173 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.754 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -156.56 -178.91 7.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.936 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 42.0 t0 -62.9 -30.49 71.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.346 0.593 . . . . 0.0 110.386 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 7.8 pttp -67.15 -48.16 68.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.188 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -72.21 -44.92 63.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.081 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.843 HD23 ' CE1' ' A' ' 26' ' ' PHE . 1.6 mt -60.84 -38.14 84.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.701 ' HA ' HD13 ' A' ' 32' ' ' ILE . 19.0 t-80 -58.43 -55.33 36.43 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.998 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 -44.34 76.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.645 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.4 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.843 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.9 m-85 -94.3 -11.27 30.44 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.754 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -59.87 -40.9 82.23 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.154 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.754 ' HD3' HG22 ' A' ' 27' ' ' ILE . 27.1 Cg_endo -60.97 -39.02 64.23 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.423 1.415 . . . . 0.0 110.808 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.626 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -73.29 -24.68 60.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.665 178.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.38 126.13 0.82 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.3 m-20 -54.39 105.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.237 0.541 . . . . 0.0 111.542 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' A' ' 26' ' ' PHE . 3.3 mp -63.53 151.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.799 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.37 -34.61 5.23 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.386 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -156.89 150.87 24.84 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.715 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 51' ' ' PHE . 28.1 mt -143.46 118.5 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.631 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.68 125.87 50.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.506 . . . . 0.0 111.918 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.679 HG22 ' CD2' ' A' ' 46' ' ' HIS . 4.3 mt -110.58 108.02 58.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.173 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.35 77.12 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.449 2.099 . . . . 0.0 113.164 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 46' ' ' HIS . 1.2 mt -77.09 -179.96 5.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.463 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 12.4 m-20 -86.83 167.66 14.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -101.07 -22.64 14.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.017 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.0 -35.08 15.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.007 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.1 p -120.82 -28.25 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.654 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' O ' HD22 ' A' ' 39' ' ' LEU . 15.6 mt-10 59.91 46.54 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.223 0.535 . . . . 0.0 110.197 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -128.96 119.1 23.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.429 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.679 ' CD2' HG22 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -79.65 -169.05 1.78 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.504 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -119.64 -45.24 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.973 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.768 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . 161.99 47.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.779 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.768 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 17.0 m-85 -147.6 150.83 35.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.057 0.428 . . . . 0.0 111.139 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.04 170.04 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.257 0.551 . . . . 0.0 112.213 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -117.44 126.9 53.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.205 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.14 129.92 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.0 110.992 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.31 134.35 55.02 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 7.2 m-85 -107.71 161.18 15.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.13 0.49 . . . . 0.0 111.01 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.22 -29.48 57.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -123.73 131.33 53.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.82 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.284 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.87 -38.46 91.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.451 . . . . 0.0 110.819 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.4 m-20 -61.3 -37.49 83.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.615 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -58.14 -43.24 87.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.62 -33.63 55.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -65.98 -45.04 83.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.39 -35.54 80.76 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 61' ' ' ALA . 92.5 mt -63.46 -52.76 54.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.554 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.79 -10.63 59.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.841 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.9 t-20 -100.78 -41.39 6.89 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.51 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -88.76 -28.37 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 48.4 t30 -57.5 110.78 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 110.418 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.04 43.61 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.042 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.68 -161.57 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.53 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -132.22 124.47 29.02 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.609 ' HB2' HD12 ' A' ' 77' ' ' ILE . 7.7 tp -139.11 124.79 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 34.8 m-85 53.02 34.28 16.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.029 0.442 . . . . 0.0 110.59 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.0 12.05 84.3 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.729 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.78 143.4 51.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.17 0.509 . . . . 0.0 111.693 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.496 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 88.7 m -82.9 131.95 35.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.173 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -120.37 157.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.585 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 55.2 ttt180 -132.21 135.95 46.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.7 t -117.41 152.0 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 111.882 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -157.08 164.66 37.66 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 35.65 0.56 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.553 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.13 167.84 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.53 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.696 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.4 t -139.36 113.94 9.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.825 0.345 . . . . 0.0 111.193 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.498 ' O ' HG22 ' A' ' 4' ' ' THR . 5.3 t -129.44 -11.21 4.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.757 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 3' ' ' THR . 8.8 t 45.18 34.29 1.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.562 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.73 -93.47 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.43 -35.95 0.0 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.041 0.448 . . . . 0.0 110.401 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 m -83.32 132.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.53 ' CD2' HD11 ' A' ' 64' ' ' ILE . 4.7 mt -122.84 160.6 25.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.6 t80 -110.31 136.35 49.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.316 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.94 122.83 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.99 113.84 2.04 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.057 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 120.84 46.41 0.34 Allowed Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.115 HD22 HG11 ' A' ' 17' ' ' VAL . 67.6 mt -101.41 -176.76 3.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.307 0.575 . . . . 0.0 112.054 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.62 -171.71 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.925 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.36 0.0 34.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.68 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.5 -29.96 14.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.115 HG11 HD22 ' A' ' 13' ' ' LEU . 11.8 p -81.79 144.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.676 0.75 . . . . 0.0 111.579 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.667 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p30 -153.02 179.12 8.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.122 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 7.0 p-10 -58.89 -30.37 67.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.057 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.57 -47.55 72.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.798 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.5 -42.0 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.27 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.895 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.5 mt -60.34 -33.53 72.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.692 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -59.25 -55.7 31.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.637 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 27' ' ' ILE . . . -68.02 -44.53 76.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.427 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.01 93.89 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.895 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.4 m-85 -93.05 -10.36 36.4 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.685 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 tp -61.46 -40.24 69.61 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.818 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.685 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.85 -43.39 49.72 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.5 1.467 . . . . 0.0 111.333 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.7 m-85 -71.7 -21.25 61.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.01 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.6 131.72 1.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.523 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 m-20 -59.85 109.54 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.574 0.702 . . . . 0.0 111.554 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.0 mp -64.31 153.04 7.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.349 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -34.5 4.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.701 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -153.64 149.4 27.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 120.984 0.421 . . . . 0.0 111.672 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 19' ' ' ASP . 28.6 mt -143.7 120.1 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -121.1 126.59 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 111.364 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 49' ' ' PHE . 2.6 mt -111.65 108.19 56.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.321 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.21 125.79 14.19 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.123 . . . . 0.0 113.169 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 46' ' ' HIS . 2.0 mt -132.44 174.85 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.533 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.61 165.23 14.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.523 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -97.12 -24.29 15.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.01 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -100.72 -29.79 12.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.062 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 45' ' ' LYS . 65.8 p -112.4 -31.4 6.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.24 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.7 mt-10 57.59 37.67 27.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 111.237 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 7.2 mttp -114.23 114.33 25.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.703 ' N ' HD23 ' A' ' 39' ' ' LEU . 4.5 p80 -70.97 -179.8 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 110.852 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.85 -63.7 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.834 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.758 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 172.85 38.17 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.375 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.685 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.9 m-85 -144.54 151.26 38.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.004 0.402 . . . . 0.0 111.209 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.2 178.45 9.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.244 0.545 . . . . 0.0 112.004 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.5 m-85 -122.39 135.14 54.64 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.914 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 t -111.31 129.12 67.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -113.1 134.29 54.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 16.1 m-85 -109.08 160.64 15.89 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.393 0.616 . . . . 0.0 111.496 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 -30.85 51.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 88.4 mt -119.49 131.09 55.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.725 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -42.23 91.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.423 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.49 -32.38 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 2.0 m-20 -64.65 -38.33 90.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.592 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -59.32 -45.48 91.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.691 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.765 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.18 -33.7 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.441 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -67.26 -45.33 77.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.907 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.78 -34.71 78.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 96.7 mt -65.43 -52.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.445 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.42 -13.49 59.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.126 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 6.3 m-20 -99.34 -46.27 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.421 ' CE ' HD23 ' A' ' 72' ' ' LEU . 2.7 tpt -79.89 -23.29 41.94 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.776 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 11.0 t30 -56.84 114.15 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 110.795 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.82 30.05 2.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.1 OUTLIER -97.09 -174.47 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -137.79 130.04 29.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.719 0.295 . . . . 0.0 111.725 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 72' ' ' LEU . 4.4 pp -138.93 130.74 27.66 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 21' ' ' VAL . 41.9 m-85 58.65 40.59 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.104 0.478 . . . . 0.0 110.032 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.7 23.5 67.2 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.012 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -128.59 132.7 48.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 112.059 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.2 m -83.72 124.56 30.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.747 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.797 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -120.34 156.33 23.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.327 0.584 . . . . 0.0 111.697 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -129.85 137.64 50.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.661 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.8 t -121.05 151.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 t30 -157.98 164.41 36.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.257 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -77.87 -24.55 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.529 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 59.12 160.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.1 mttp . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.812 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.102 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 5.2 m 62.91 159.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -128.12 -77.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.813 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m 59.09 92.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.18 101.19 13.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.378 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 8.2 mtp180 -134.63 1.59 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -123.68 131.17 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.332 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.68 HD21 ' HB1' ' A' ' 60' ' ' ALA . 28.9 mt -118.18 155.29 30.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -110.05 133.45 53.19 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.697 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.87 123.53 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -123.11 121.53 4.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.957 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.16 38.88 0.91 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 17' ' ' VAL . 68.8 mt -93.56 179.11 5.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.83 0.824 . . . . 0.0 113.046 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -128.48 -175.21 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.328 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -80.43 -1.02 39.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.637 0.256 . . . . 0.0 111.26 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -37.22 14.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 13' ' ' LEU . 9.9 p -65.87 143.62 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.579 0.704 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.599 ' O ' HD12 ' A' ' 22' ' ' LEU . 17.9 p30 -151.89 178.31 9.54 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.856 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HA ' HG21 ' A' ' 35' ' ' ILE . 29.4 p-10 -61.69 -29.6 70.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.357 0.598 . . . . 0.0 109.551 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.76 -49.11 69.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.593 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.719 HG21 ' HZ ' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -71.72 -44.52 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.29 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.898 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mt -61.24 -34.24 74.81 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 109.579 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.709 ' HA ' HD13 ' A' ' 32' ' ' ILE . 25.8 t-80 -62.64 -54.91 32.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.584 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 27' ' ' ILE . . . -67.71 -41.52 83.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.897 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.68 75.91 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.898 ' CE1' HD23 ' A' ' 22' ' ' LEU . 4.9 m-85 -96.82 -9.4 28.79 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.696 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -61.29 -40.3 71.14 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.549 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.2 Cg_endo -57.38 -43.74 49.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.599 1.533 . . . . 0.0 111.162 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 3.3 m-85 -71.65 -24.08 61.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.029 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 169.95 129.82 1.14 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.48 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.494 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 16.3 m-20 -59.58 105.07 0.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.585 0.707 . . . . 0.0 111.23 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.4 mp -59.03 151.64 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.206 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.32 -32.55 5.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.679 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 9.7 t0 -155.07 146.67 23.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' CG1' HG21 ' A' ' 32' ' ' ILE . 42.9 mt -139.87 118.72 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.414 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -120.48 129.45 53.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.314 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 49' ' ' PHE . 4.6 mt -115.05 108.19 48.72 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -44.82 125.69 6.73 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.869 2.379 . . . . 0.0 113.505 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 46' ' ' HIS . 1.9 mt -135.2 164.42 27.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.721 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 5.8 m-20 -87.32 170.37 11.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.772 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -98.6 -33.29 11.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.13 -23.32 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.62 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -116.93 -20.13 9.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.629 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 37.19 38.69 0.12 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.62 ' HG3' ' O ' ' A' ' 43' ' ' THR . 8.6 mttp -117.32 109.39 16.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.485 ' N ' HD23 ' A' ' 39' ' ' LEU . 8.7 p80 -64.88 -179.89 0.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.782 0.325 . . . . 0.0 110.542 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -115.03 -65.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.074 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.723 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 177.26 40.1 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.284 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 19.0 m-85 -143.57 151.34 40.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.776 0.322 . . . . 0.0 110.958 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 37' ' ' ILE . . . -153.83 176.2 12.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.384 0.611 . . . . 0.0 112.195 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 2.5 m-85 -124.34 125.53 44.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.211 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.2 t -107.13 124.98 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.551 0.215 . . . . 0.0 110.602 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -107.74 136.65 47.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE1' HG12 ' A' ' 52' ' ' VAL . 3.9 m-85 -114.17 158.59 21.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.027 0.441 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -77.17 -30.93 55.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.314 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 95.8 mt -115.01 124.68 52.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.664 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.71 -36.39 76.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.229 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.84 -31.93 68.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 110.486 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 7.6 m-20 -61.72 -38.03 86.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.68 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.55 -40.74 83.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.723 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.32 -34.24 56.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.252 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.66 -45.14 72.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.505 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -63.35 -35.02 79.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 61' ' ' ALA . 96.6 mt -66.98 -52.88 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.747 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.51 -12.67 60.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.894 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 7.0 t-20 -100.04 -29.35 12.58 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.603 ' HG3' HD11 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -104.49 -19.45 14.02 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 64' ' ' ILE . 15.5 p-10 -52.76 113.42 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.402 . . . . 0.0 110.767 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.02 45.34 4.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.749 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.09 -168.17 1.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.76 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 127.15 42.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.952 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' HG ' ' CD2' ' A' ' 73' ' ' PHE . 12.7 tp -139.47 123.78 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.719 ' HZ ' HG21 ' A' ' 21' ' ' VAL . 49.2 m-85 58.98 36.3 24.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 109.705 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.01 8.31 64.22 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.438 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 136.3 53.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.992 0.425 . . . . 0.0 111.408 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -76.94 119.45 20.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.06 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.603 HD11 ' HG3' ' A' ' 67' ' ' MET . 22.4 pt -111.89 154.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 111.579 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.71 134.56 48.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.284 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 92.1 t -118.16 151.88 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.798 0.333 . . . . 0.0 111.666 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.7 t-20 -156.72 156.72 33.84 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 pp -78.83 151.6 31.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.564 ' HB3' HG23 ' A' ' 7' ' ' VAL . . . -102.73 -165.07 1.14 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.995 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.776 -0.13 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.18 170.77 19.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.589 0.233 . . . . 0.0 110.509 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m 59.09 158.38 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.016 0.436 . . . . 0.0 110.912 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.4 p -71.45 -178.14 2.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.271 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -108.0 125.17 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.104 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -138.35 3.7 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.706 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.61 HG13 ' OE1' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -97.63 120.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.778 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.987 HD21 ' HB1' ' A' ' 60' ' ' ALA . 1.7 mt -115.36 157.91 23.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.783 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.663 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.7 t80 -116.25 137.31 52.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.47 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 79' ' ' VAL . 17.3 t -107.83 123.68 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' HA2' ' HD1' ' A' ' 49' ' ' PHE . . . -120.37 112.85 2.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.824 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.774 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 119.82 57.67 0.25 Allowed Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.957 HD22 HG11 ' A' ' 17' ' ' VAL . 48.0 mt -115.3 155.25 27.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -112.86 168.69 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.692 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -23.34 30.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.134 0.492 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 1.8 mt-10 -66.71 -38.51 86.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.462 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.957 HG11 HD22 ' A' ' 13' ' ' LEU . 12.1 p -74.52 142.75 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 111.593 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.899 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -155.29 -171.98 4.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.426 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.597 ' OD1' HD12 ' A' ' 35' ' ' ILE . 54.7 t0 -64.67 -30.64 71.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.562 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 9.4 ptmt -66.51 -48.64 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.624 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 17' ' ' VAL . 1.3 p -71.61 -43.61 70.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.311 0.576 . . . . 0.0 110.651 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.949 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.8 mt -60.21 -36.28 77.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.872 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.917 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -60.35 -55.63 31.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.06 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.92 80.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.827 . . . . 0.0 113.01 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.4 -31.92 67.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.949 ' CE1' HD23 ' A' ' 22' ' ' LEU . 2.6 m-85 -98.01 -12.5 21.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 23' ' ' HIS . 1.2 tp -61.76 -39.83 63.86 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.513 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 17.9 Cg_endo -57.63 -44.57 40.36 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.233 1.289 . . . . 0.0 110.785 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -68.17 -22.1 64.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.921 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 162.12 133.47 1.48 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.488 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.0 m-20 -58.25 106.2 0.35 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.744 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.917 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.2 mp -57.72 149.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.887 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -114.7 -32.45 5.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.627 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.1 m-20 -154.92 145.27 22.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.988 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.597 HD12 ' OD1' ' A' ' 19' ' ' ASP . 31.0 mt -143.06 118.33 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.713 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -109.77 127.66 54.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.158 0.504 . . . . 0.0 112.098 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.0 mt -119.09 108.3 40.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.411 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 141.13 14.03 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.273 1.982 . . . . 0.0 113.489 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.79 -169.18 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.868 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.73 143.87 26.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.757 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.36 43.12 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.212 0.53 . . . . 0.0 110.494 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.43 -40.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.272 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -99.11 -28.78 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.788 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 62.13 29.31 17.52 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.766 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -127.14 114.66 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -57.26 -178.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -40.92 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.62 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.763 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 144.77 49.52 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.864 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 23.6 m-85 -151.55 151.36 31.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.822 0.344 . . . . 0.0 111.507 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.83 174.82 13.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.935 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.3 m-85 -117.47 131.7 56.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.201 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.46 128.04 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.61 ' OE1' HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.11 136.94 52.56 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 6.6 m-85 -111.38 155.05 23.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.188 0.518 . . . . 0.0 111.103 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.12 -30.02 64.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.949 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.23 121.09 42.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.272 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.76 70.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.282 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -31.88 70.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 5.0 m-20 -68.07 -37.06 80.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.419 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.1 -44.22 87.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.962 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -52.57 -33.74 47.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.034 0.445 . . . . 0.0 110.37 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.42 -45.14 73.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -63.05 -34.68 78.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.951 HD11 HD22 ' A' ' 8' ' ' LEU . 93.2 mt -64.34 -52.38 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.086 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -78.22 -15.17 59.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.776 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 9.1 m120 -95.11 -48.9 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.493 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.3 tpt -73.75 -28.18 61.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.62 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.4 OUTLIER -60.7 121.93 13.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.171 0.51 . . . . 0.0 110.593 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 66.22 54.38 0.96 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.82 -166.57 1.46 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.638 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -131.03 124.95 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.8 tp -139.67 121.7 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.701 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 16' ' ' GLU . 34.2 m-85 58.47 40.56 23.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.217 0.532 . . . . 0.0 110.57 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.58 13.58 68.58 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.195 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -130.31 154.89 47.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 110.934 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -88.22 131.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 12' ' ' GLY . 29.6 pt -120.65 153.42 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 1.1 mmt180 -133.26 133.79 43.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 55.4 t -121.07 152.37 24.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.891 0.376 . . . . 0.0 111.283 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -158.01 160.06 37.06 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.55 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 5' ' ' LYS . 8.8 tp -72.18 141.37 49.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.678 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.556 ' HB3' HG23 ' A' ' 7' ' ' VAL . . . -83.87 94.76 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.069 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 117.5 23.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -80.34 139.8 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.481 HG23 ' HB1' ' A' ' 57' ' ' ALA . 6.0 t -94.27 46.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.093 0.473 . . . . 0.0 110.635 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 1.9 mptt 61.43 159.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.63 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 9.3 mtm180 -147.66 18.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.056 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG12 ' HD1' ' A' ' 51' ' ' PHE . 1.2 t -121.77 129.91 75.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.871 HD21 ' HB1' ' A' ' 60' ' ' ALA . 6.2 mt -118.8 153.74 33.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.963 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.3 t80 -109.2 135.64 49.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.981 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 25.0 t -108.91 123.45 64.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 110.396 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.3 123.21 5.06 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.726 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.96 48.74 0.71 Allowed Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.801 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 44.7 mt -105.79 -174.73 2.6 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.62 -0.79 . . . . 0.0 112.939 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.698 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -144.25 166.43 25.07 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.718 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -24.7 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.606 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.35 -40.16 96.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 13' ' ' LEU . 8.1 p -70.82 143.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.834 0.826 . . . . 0.0 112.518 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.568 ' H ' HG12 ' A' ' 21' ' ' VAL . 69.7 m-20 -156.02 175.97 13.27 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.789 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 10.0 p-10 -62.36 -28.94 70.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.87 -48.03 72.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.912 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 18' ' ' ASP . 3.8 p -72.57 -44.52 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 110.501 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.011 HD23 ' CE1' ' A' ' 26' ' ' PHE . 3.1 mt -60.25 -34.75 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.698 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -63.02 -55.51 24.97 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.784 178.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.88 79.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.436 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.01 58.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.011 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.9 m-85 -94.43 -9.06 36.79 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.815 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.696 HG22 ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -62.59 -39.99 60.45 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.479 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HD3' HG22 ' A' ' 27' ' ' ILE . 23.6 Cg_endo -59.68 -42.65 44.81 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 121.387 1.391 . . . . 0.0 110.764 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -73.13 -23.68 60.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.876 178.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 171.36 132.69 1.52 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.624 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 8.0 m-20 -63.47 104.97 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.405 0.622 . . . . 0.0 111.303 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.6 mp -61.03 148.23 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.855 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.44 -34.13 5.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.514 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -153.71 149.61 27.68 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.405 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 51' ' ' PHE . 21.0 mt -143.37 121.07 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.081 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 127.03 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.062 0.458 . . . . 0.0 111.853 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.469 ' O ' HD13 ' A' ' 39' ' ' LEU . 3.9 mp -114.02 108.17 51.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.608 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' C ' HD13 ' A' ' 39' ' ' LEU . 89.1 Cg_endo -79.8 142.23 15.76 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.507 2.138 . . . . 0.0 113.377 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -146.37 -167.33 2.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.301 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 1.9 m-20 -68.22 151.89 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -83.72 -17.42 41.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -110.44 -34.7 6.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.38 -3.11 15.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.605 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.581 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.7 pt-20 34.72 49.88 0.4 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' N ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -116.52 107.67 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.844 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.401 ' N ' ' HB3' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -70.47 -177.92 1.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.412 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -115.77 -56.33 2.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.134 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.801 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 171.5 45.61 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.381 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 13.2 m-85 -142.04 150.38 41.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.59 171.3 16.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.237 0.541 . . . . 0.0 112.007 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 35' ' ' ILE . 5.5 m-85 -121.82 126.6 49.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.88 124.24 66.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.516 0.198 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -111.38 136.51 50.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -113.64 157.17 22.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.343 0.592 . . . . 0.0 111.453 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.64 -31.57 59.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.485 HD12 ' OD1' ' A' ' 59' ' ' ASP . 82.3 mt -115.54 126.81 54.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.388 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB1' HG23 ' A' ' 4' ' ' THR . . . -58.1 -43.34 87.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.712 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -30.73 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -64.5 -37.8 88.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.871 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -58.49 -45.04 89.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.37 -33.68 54.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.081 0.467 . . . . 0.0 110.656 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.05 -45.14 74.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.64 -34.13 76.43 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 61' ' ' ALA . 85.0 mt -67.13 -52.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.857 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.29 -13.99 60.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 8.5 m-20 -99.67 -36.38 9.51 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.508 ' HB3' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -91.63 -22.46 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 8.5 t30 -58.33 112.41 1.55 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 72.03 52.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.694 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.77 -172.47 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -121.57 127.0 50.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.297 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.594 ' HB2' HD13 ' A' ' 77' ' ' ILE . 3.4 tp -139.39 122.52 16.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.618 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 66.1 m-85 55.31 37.91 29.58 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.86 16.16 69.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.264 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 75' ' ' ARG . 1.6 mmt180 -124.29 146.07 49.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.105 0.479 . . . . 0.0 111.221 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -82.79 120.42 25.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.061 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 72' ' ' LEU . 19.0 pt -110.97 152.26 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.042 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -132.13 139.65 48.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.874 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 85.0 t -119.52 151.53 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.291 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 1.5 m120 -157.74 156.71 32.09 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.333 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 5' ' ' LYS . 1.7 mt -85.03 118.99 24.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.009 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 5' ' ' LYS . . . -85.24 166.42 16.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 111.023 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.4 p -121.05 29.01 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 t -172.36 90.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 57.23 80.14 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 121.28 7.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -159.49 61.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.257 0.551 . . . . 0.0 111.336 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 m -85.77 134.64 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.742 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.616 HD21 ' HB1' ' A' ' 60' ' ' ALA . 12.7 mt -117.06 159.18 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.982 0.42 . . . . 0.0 111.396 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 3.7 t80 -113.16 136.29 52.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 79' ' ' VAL . 23.5 t -108.99 123.62 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.884 0.373 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.627 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -123.07 119.73 3.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.692 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 77' ' ' ILE . . . 114.3 46.0 0.65 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.913 HD22 HG11 ' A' ' 17' ' ' VAL . 58.9 mt -102.02 159.43 15.37 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.749 -0.725 . . . . 0.0 111.918 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.798 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . . . -107.48 177.09 4.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.38 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -75.4 1.56 13.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.496 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.12 -26.62 15.94 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.913 HG11 HD22 ' A' ' 13' ' ' LEU . 7.5 p -76.57 138.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.425 0.631 . . . . 0.0 111.228 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -151.02 -175.05 4.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.322 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.609 ' OD1' HD12 ' A' ' 35' ' ' ILE . 39.9 t0 -62.16 -32.25 72.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.292 0.568 . . . . 0.0 109.617 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -63.75 -48.16 78.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.672 ' CG1' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -71.72 -43.86 69.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.178 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.008 HD23 ' CE1' ' A' ' 26' ' ' PHE . 6.4 mt -60.55 -36.83 79.41 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.702 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -60.63 -56.24 23.74 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.18 178.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.0 -43.41 78.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.712 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.41 68.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.008 ' CE1' HD23 ' A' ' 22' ' ' LEU . 3.3 m-85 -95.95 -12.61 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.191 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.7 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -60.93 -40.27 72.85 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.522 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -57.29 -43.99 47.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.503 1.469 . . . . 0.0 111.018 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.7 m-85 -69.9 -26.03 63.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.82 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.47 136.59 2.12 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.434 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 4.0 m-20 -63.4 103.37 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.494 0.664 . . . . 0.0 111.157 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.702 HD13 ' HA ' ' A' ' 23' ' ' HIS . 4.1 mp -56.01 149.53 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.289 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.44 -32.91 5.44 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.872 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.0 t0 -153.71 145.61 23.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.163 0.506 . . . . 0.0 111.892 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.609 HD12 ' OD1' ' A' ' 19' ' ' ASP . 41.5 mt -143.3 118.53 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.011 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -117.93 132.5 56.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.203 0.525 . . . . 0.0 111.611 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt -120.15 110.25 36.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.033 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.68 143.85 38.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.238 1.959 . . . . 0.0 112.503 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 44' ' ' GLU . 1.4 mp -102.88 -164.14 1.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.018 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 41' ' ' TYR . 1.5 m-20 -96.09 -17.6 20.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.39 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 81.39 -47.87 0.24 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.69 0.396 . . . . 0.0 110.326 -179.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 1.9 pt-20 -78.65 -41.23 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.535 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -111.75 -16.49 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.528 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 0.6 OUTLIER 61.92 42.71 9.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.612 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 8.0 pttm -132.03 123.52 27.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.046 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -66.33 -175.71 0.37 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.644 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -118.09 -67.44 0.99 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.105 0.479 . . . . 0.0 110.15 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.813 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -175.9 37.83 0.1 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.252 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.674 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.5 m-85 -141.53 150.54 42.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.858 0.329 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.86 177.41 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.022 0.439 . . . . 0.0 111.796 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -123.55 127.7 48.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.62 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.464 ' CG2' HD22 ' A' ' 22' ' ' LEU . 24.7 t -111.6 128.03 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -112.7 137.6 50.76 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 83.3 m-85 -112.3 154.21 26.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.156 0.503 . . . . 0.0 110.734 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -75.01 -25.91 59.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.989 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 87.5 mt -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.538 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.595 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -60.6 -43.39 97.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.33 -30.15 70.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 8.6 m-20 -60.72 -43.51 97.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.273 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -60.86 -46.56 90.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.761 0.315 . . . . 0.0 110.336 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -54.61 -33.92 61.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.521 . . . . 0.0 110.45 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -66.73 -45.31 79.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.856 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -65.28 -33.34 75.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 61' ' ' ALA . 97.1 mt -66.12 -51.79 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.171 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -12.59 60.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.02 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.7 m-80 -105.15 -46.06 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.431 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 2.5 tpt -76.84 -30.02 56.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.734 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 5.0 t-20 -57.38 115.42 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mt-10 67.0 57.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.268 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 -166.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.531 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -135.98 125.56 25.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.41 123.54 17.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 21' ' ' VAL . 23.5 m-85 56.18 41.5 29.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.125 0.488 . . . . 0.0 110.142 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.77 65.95 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.449 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.798 ' HG3' ' HB2' ' A' ' 14' ' ' ALA . 37.9 mmt-85 -124.51 137.65 54.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.937 0.399 . . . . 0.0 111.758 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.4 m -84.38 119.96 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.985 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 12' ' ' GLY . 19.4 pt -113.26 152.86 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 0.0 111.589 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 15.9 ptp180 -131.49 136.87 48.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.027 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 97.3 t -117.33 152.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 111.081 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 7.4 m120 -148.21 164.21 34.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.2 pt? -101.44 110.12 22.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.145 0.498 . . . . 0.0 111.239 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.29 82.67 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.949 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.9 tttt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.851 -179.779 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.55 -53.17 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.704 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 p -117.21 121.29 40.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.624 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 5' ' ' LYS . 1.8 m -126.13 -74.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.2 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.515 ' HG2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -164.85 163.79 21.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.673 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 5' ' ' LYS . 11.0 mtm180 174.14 -34.06 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.959 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 m -86.67 134.39 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 111.556 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.791 HD21 ' HB1' ' A' ' 60' ' ' ALA . 10.9 mt -118.14 160.46 21.52 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.014 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.7 t80 -114.17 136.51 52.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.645 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 13' ' ' LEU . 40.6 t -108.69 123.89 64.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.98 117.17 2.93 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.897 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 76' ' ' THR . . . 118.75 42.18 0.58 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.769 ' HB3' HG11 ' A' ' 17' ' ' VAL . 89.6 mt -97.99 -177.51 3.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.365 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -130.18 -172.35 2.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.547 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -82.42 2.92 30.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.565 0.222 . . . . 0.0 111.564 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.15 -30.24 13.62 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' A' ' 13' ' ' LEU . 13.2 p -69.0 142.35 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.718 0.77 . . . . 0.0 111.986 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.836 ' O ' HD12 ' A' ' 22' ' ' LEU . 7.7 m-20 -155.18 175.12 14.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 6.4 p-10 -57.62 -29.78 64.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HG2' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.28 -47.39 73.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.082 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.623 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -71.98 -44.79 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.836 HD12 ' O ' ' A' ' 18' ' ' ASP . 1.3 mt -60.39 -36.25 77.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.584 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.91 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -59.17 -55.73 31.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.886 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.48 84.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.364 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.85 65.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.641 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.6 m-85 -97.01 -9.86 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.16 -39.81 67.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.45 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 26.9 Cg_endo -60.73 -41.93 42.81 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.309 1.339 . . . . 0.0 110.834 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.0 m-85 -68.28 -26.02 65.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.476 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 165.22 132.03 1.32 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 3.2 m-20 -56.36 110.21 0.73 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.521 0.676 . . . . 0.0 111.834 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.91 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.3 mp -64.64 150.9 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.869 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.42 -34.81 4.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.661 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 2.3 m-20 -153.56 147.12 25.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 111.628 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 32' ' ' ILE . 45.3 mt -141.19 118.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.866 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -120.76 129.83 53.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.888 0.375 . . . . 0.0 111.584 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 50' ' ' ALA . 3.0 mt -120.42 120.43 29.87 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.178 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.42 139.57 14.64 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.386 2.058 . . . . 0.0 113.036 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.88 -162.2 0.94 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.175 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.27 -16.94 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 82.81 -48.7 0.16 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.595 0.358 . . . . 0.0 110.823 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -78.64 -42.18 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.014 0.435 . . . . 0.0 110.487 179.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.61 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 14.4 t -111.34 2.9 17.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.437 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HG3' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER 39.41 32.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 43' ' ' THR . 4.2 mttp -116.41 122.51 45.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.769 0.318 . . . . 0.0 110.646 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.428 ' ND1' HG22 ' A' ' 37' ' ' ILE . 78.5 m-70 -57.9 175.51 0.19 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.81 -67.44 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.818 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.74 ' O ' ' CD1' ' A' ' 49' ' ' PHE . . . 176.02 35.09 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 15.8 m-85 -145.92 150.65 36.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.004 0.402 . . . . 0.0 111.16 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' A' ' 37' ' ' ILE . . . -156.91 174.32 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 18.1 m-85 -119.03 129.12 54.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.63 129.09 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.535 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -112.54 136.61 51.87 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 15.2 m-85 -111.73 157.46 20.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 0.0 111.497 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -74.89 -32.84 61.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.076 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.624 HD12 ' OD2' ' A' ' 59' ' ' ASP . 95.5 mt -113.5 117.39 31.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.395 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.27 58.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.684 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -66.5 -31.74 72.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.624 ' OD2' HD12 ' A' ' 56' ' ' LEU . 2.3 m-20 -61.21 -37.51 83.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.645 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.791 ' HB1' HD21 ' A' ' 8' ' ' LEU . . . -57.79 -41.63 82.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.611 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.737 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -55.11 -33.8 63.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.934 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.32 -45.25 73.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.202 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . . . -62.83 -37.54 87.17 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.737 HD12 ' HA ' ' A' ' 61' ' ' ALA . 55.2 mt -63.7 -52.26 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.189 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.409 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 1.1 m-20 -73.36 -9.62 58.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.613 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 2.0 m120 -104.15 -39.25 6.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.528 ' HE3' ' CZ ' ' A' ' 26' ' ' PHE . 3.9 mmm -89.86 -19.59 24.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 65' ' ' ASP . 6.2 p30 -57.92 116.1 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 25.9 mt-10 65.24 42.07 4.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' MET . 0.5 OUTLIER -105.39 -165.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.5 124.64 32.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.893 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 77' ' ' ILE . 3.5 tp -139.38 129.86 25.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.66 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 55.09 28.4 10.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.3 4.49 89.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 14' ' ' ALA . 1.2 mtt85 -119.93 160.45 22.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.429 0.633 . . . . 0.0 111.533 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 8.8 m -91.12 124.75 35.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.061 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.783 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -114.79 156.28 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.213 0.53 . . . . 0.0 111.325 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -133.52 138.79 46.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.831 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 96.7 t -116.96 150.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.733 0.301 . . . . 0.0 111.117 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -157.81 164.48 36.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.962 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.515 HD12 ' HG2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -62.06 -105.68 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.467 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 81' ' ' LEU . . . 172.32 -53.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.848 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.9 m -131.27 -176.87 4.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.471 HG23 HH11 ' A' ' 6' ' ' ARG . 0.2 OUTLIER 68.29 115.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.662 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.457 HG22 ' CD ' ' A' ' 5' ' ' LYS . 39.4 m -101.82 -40.68 6.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.239 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HD2' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -175.03 145.18 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.124 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.471 HH11 HG23 ' A' ' 3' ' ' THR . 9.6 mmm-85 -139.98 -45.65 0.43 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.121 0.486 . . . . 0.0 109.971 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 53' ' ' GLU . 10.4 m -86.31 132.03 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.658 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.507 HD11 ' HB1' ' A' ' 60' ' ' ALA . 13.2 mt -118.46 160.41 21.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.7 t80 -113.18 135.26 54.01 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.793 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 21.6 t -108.79 123.55 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.35 118.27 3.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.748 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.51 37.07 0.87 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 79.2 mt -91.42 -174.65 3.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.598 0.713 . . . . 0.0 112.233 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . . . -132.46 -171.53 2.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.124 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -84.63 5.27 28.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.583 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -32.29 13.0 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 13' ' ' LEU . 14.9 p -70.14 143.73 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.657 0.741 . . . . 0.0 112.213 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.733 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -153.3 179.5 8.7 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.823 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' HIS . 2.6 p30 -62.42 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.192 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.03 -47.96 75.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 1.4 p -71.86 -46.37 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.654 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.899 HD23 ' CE1' ' A' ' 26' ' ' PHE . 2.3 mt -60.78 -37.22 81.15 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.02 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.931 ' HA ' HD13 ' A' ' 32' ' ' ILE . 16.7 t-160 -57.14 -55.27 36.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.496 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.17 82.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.611 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.57 72.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.899 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.4 m-85 -95.78 -7.91 35.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.691 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.3 tp -63.98 -39.62 46.71 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 19.1 Cg_endo -58.68 -42.05 57.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.54 1.493 . . . . 0.0 111.012 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 2.1 m-85 -72.03 -23.9 61.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.911 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 59' ' ' ASP . . . 167.41 130.02 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 m-20 -57.18 107.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.365 0.602 . . . . 0.0 111.722 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.931 HD13 ' HA ' ' A' ' 23' ' ' HIS . 2.8 mp -60.55 152.88 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.113 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -32.74 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.793 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.57 145.65 23.71 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.112 0.482 . . . . 0.0 111.717 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 32' ' ' ILE . 30.3 mt -141.52 118.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.312 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -118.73 129.27 55.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.064 0.459 . . . . 0.0 112.049 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.55 109.01 46.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.21 145.25 54.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.407 2.072 . . . . 0.0 113.198 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 ' CA ' ' A' ' 44' ' ' GLU . 7.1 mt -103.78 -176.51 3.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.883 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -16.04 59.41 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.725 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER 74.44 1.47 3.85 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HG3' HG23 ' A' ' 43' ' ' THR . 3.2 pt-20 -147.58 -41.81 0.17 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.92 0.39 . . . . 0.0 110.505 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.525 HG23 ' HG3' ' A' ' 42' ' ' GLU . 25.6 p -100.87 -21.55 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.537 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' CA ' HD22 ' A' ' 39' ' ' LEU . 2.6 pt-20 40.28 62.38 1.33 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.706 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.93 -0.13 8.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.735 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 63.01 152.81 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.95 0.405 . . . . 0.0 111.15 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -114.67 -74.4 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.157 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.779 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 174.76 41.74 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.903 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.689 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.0 m-85 -142.32 150.62 41.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.166 0.483 . . . . 0.0 110.802 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.93 173.57 16.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.107 0.48 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 6.2 m-85 -120.0 129.91 54.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.29 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.75 128.33 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.657 0.265 . . . . 0.0 110.77 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -115.44 136.77 52.75 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -113.24 159.12 19.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.153 0.502 . . . . 0.0 111.317 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.87 -31.57 56.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.532 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 93.7 mt -113.61 120.2 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.64 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.2 -35.82 70.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.363 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.06 -30.85 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.522 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -66.25 -37.55 85.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 64' ' ' ILE . . . -58.25 -41.54 84.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.096 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.16 -33.81 54.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.09 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 66' ' ' ASN . . . -68.69 -45.31 71.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.75 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 -36.3 83.07 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.715 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 63.6 mt -64.26 -53.1 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.702 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.68 -19.0 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.024 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 15.8 m-20 -94.0 -31.92 14.05 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.987 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.767 ' HG3' HD11 ' A' ' 77' ' ' ILE . 1.3 tpt -100.53 -15.8 17.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.715 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -50.5 111.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.733 0.302 . . . . 0.0 111.033 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 62.24 40.03 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 t -90.78 -168.29 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.456 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -127.13 125.6 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.403 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tp -139.32 125.36 19.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.299 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 79.7 m-85 58.18 35.78 25.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 109.916 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.38 75.66 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.244 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.402 ' CD ' ' HB2' ' A' ' 14' ' ' ALA . 6.2 mmt180 -126.61 143.95 51.06 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.155 0.502 . . . . 0.0 111.503 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.8 m -87.02 120.56 28.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.162 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.767 HD11 ' HG3' ' A' ' 67' ' ' MET . 7.4 pt -112.45 159.13 12.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.163 0.506 . . . . 0.0 111.695 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 mtt-85 -127.53 135.94 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 67' ' ' MET . 97.9 t -116.94 152.16 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -156.45 161.49 40.06 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.382 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.463 HD13 ' HD2' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -100.78 103.55 14.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.95 169.97 13.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.999 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.591 -0.204 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.87 -41.19 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.048 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.93 138.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.739 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 t -104.52 113.2 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HB2' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -135.13 176.22 8.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -130.28 -0.05 4.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.5 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.671 HG13 ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -111.61 118.57 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 111.015 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' ASN . 17.1 mt -107.13 155.18 20.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.389 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 5.6 t80 -111.74 136.26 51.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.27 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 42.7 t -108.84 123.89 65.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.829 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.36 115.73 2.6 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.048 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.91 46.77 0.33 Allowed Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.833 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 54.9 mt -102.31 -176.06 3.01 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.615 0.722 . . . . 0.0 112.668 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -134.73 -172.73 3.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.491 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -83.42 6.14 21.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.567 0.222 . . . . 0.0 111.551 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.49 -21.82 16.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.794 0.33 . . . . 0.0 111.531 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.701 HG11 HD13 ' A' ' 13' ' ' LEU . 12.3 p -82.0 153.36 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 111.441 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.741 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.5 m-20 -163.88 -178.6 5.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.152 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.731 ' HA ' HG21 ' A' ' 35' ' ' ILE . 1.4 p30 -63.73 -29.27 70.51 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.288 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -66.89 -48.48 68.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.3 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 18' ' ' ASP . 2.2 p -71.74 -44.21 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.283 0.564 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.98 HD23 ' CE1' ' A' ' 26' ' ' PHE . 1.7 mt -60.63 -33.7 73.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.347 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.715 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -59.88 -55.3 35.88 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 178.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.3 85.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.41 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' CE2' ' A' ' 29' ' ' PHE . . . -69.38 -32.85 72.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.98 ' CE1' HD23 ' A' ' 22' ' ' LEU . 5.0 m-85 -99.86 -9.75 22.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.684 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 tp -61.78 -39.58 61.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 27' ' ' ILE . 24.5 Cg_endo -60.07 -41.84 48.93 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.393 1.395 . . . . 0.0 111.037 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 26' ' ' PHE . 1.8 m-85 -72.0 -26.24 62.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.921 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.64 128.72 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.75 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' HA ' ' CD1' ' A' ' 27' ' ' ILE . 5.3 m-20 -59.02 104.24 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.471 0.653 . . . . 0.0 110.984 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.715 HD13 ' HA ' ' A' ' 23' ' ' HIS . 3.8 mp -58.93 154.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.894 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 -25.64 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.46 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -153.58 141.66 20.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.731 HG21 ' HA ' ' A' ' 19' ' ' ASP . 24.4 mt -143.31 118.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.318 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -127.29 128.31 45.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.981 0.419 . . . . 0.0 111.979 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 49' ' ' PHE . 1.9 mp -109.98 111.61 58.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.951 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.36 143.22 57.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.323 2.016 . . . . 0.0 112.959 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.683 HD21 ' CE1' ' A' ' 46' ' ' HIS . 1.7 mp -115.13 -173.59 2.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.746 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -80.06 -11.93 59.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 40' ' ' ASP . 3.9 m-85 73.87 -62.51 0.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.92 -54.06 15.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.373 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -92.1 -31.13 15.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.342 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 1.7 mt-10 51.56 61.13 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -113.17 0.01 14.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.683 ' CE1' HD21 ' A' ' 39' ' ' LEU . 4.5 m80 62.97 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.869 0.366 . . . . 0.0 110.529 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.7 mtm105 -105.1 -78.45 0.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.203 0.525 . . . . 0.0 110.172 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.833 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . 172.91 40.65 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.924 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.64 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 11.6 m-85 -140.43 151.38 44.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.524 0.202 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.89 170.95 19.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -115.71 141.94 47.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.698 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 39.2 t -120.81 124.42 72.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.441 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HG2' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -103.89 141.55 35.95 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.499 ' CD1' ' OD1' ' A' ' 59' ' ' ASP . 97.0 m-85 -124.5 153.12 42.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.146 0.498 . . . . 0.0 111.298 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.06 -31.4 62.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.104 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 65.6 mt -119.65 127.97 53.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.053 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.48 70.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.08 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -74.37 -35.15 63.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' CD1' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 59' ' ' ASP . . . -58.59 -41.38 85.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.534 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 64' ' ' ILE . . . -53.26 -33.79 54.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.154 0.502 . . . . 0.0 110.67 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.03 -44.52 80.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.628 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.65 78.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.774 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 90.4 mt -67.1 -53.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.67 -16.22 59.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.016 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.409 ' OD1' ' CE1' ' A' ' 29' ' ' PHE . 10.0 t-20 -99.86 -39.49 8.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 79' ' ' VAL . 2.2 tpt -85.2 -22.47 28.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.774 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 10.9 t30 -53.38 113.63 1.22 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 66.96 49.64 1.13 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.68 -165.7 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -135.05 128.72 32.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.79 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB2' HD13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -139.18 122.95 17.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.443 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 57.68 39.03 27.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.947 0.404 . . . . 0.0 110.024 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.0 13.75 69.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -120.66 137.8 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 m -75.63 120.51 21.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 72' ' ' LEU . 22.3 pt -110.98 152.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.29 0.566 . . . . 0.0 111.467 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 63.7 ttt180 -134.27 137.72 44.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.054 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 90.0 t -119.37 151.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 111.563 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 63.8 m-20 -157.9 164.5 36.83 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.601 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -71.91 -1.73 15.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.734 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 81' ' ' LEU . . . 72.53 149.51 0.1 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.844 0.354 . . . . 0.0 111.095 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 -179.947 . . . . . . . . 0 0 . 1 stop_ save_